<!DOCTYPE html>

<html class="client-nojs" dir="ltr" lang="en">
<head>
<meta charset="utf-8"/>
<title>GlaxoSmithKline - Wikipedia</title>
<script>document.documentElement.className = document.documentElement.className.replace( /(^|\s)client-nojs(\s|$)/, "$1client-js$2" );</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"GlaxoSmithKline","wgTitle":"GlaxoSmithKline","wgCurRevisionId":861485001,"wgRevisionId":861485001,"wgArticleId":192517,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Webarchive template wayback links","Use British English from September 2013","Use dmy dates from January 2018","OpenCorporates groupings","Biotechnology companies of the United Kingdom","Companies based in the London Borough of Hounslow","Companies listed on the New York Stock Exchange","Dental companies","GlaxoSmithKline","Medical controversies","Multinational companies headquartered in England","Pharmaceutical companies established in 2000","British companies established in 2000","Pharmaceutical companies of the United Kingdom","Vaccine producers","Orphan drug companies","Life sciences industry","2000 establishments in the United Kingdom","Biotechnology companies established in 2000","Companies formed by merger","Companies based in Philadelphia"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"GlaxoSmithKline","wgRelevantArticleId":192517,"wgRequestId":"W8HUswpAICwAAKS8QzcAAABE","wgCSPNonce":false,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgWikiEditorEnabledModules":[],"wgBetaFeaturesFeatures":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsShouldSendModuleToUser":true,"wgPopupsConflictsWithNavPopupGadget":false,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en","usePageImages":true,"usePageDescriptions":true},"wgMFExpandAllSectionsUserOption":true,"wgMFEnableFontChanger":true,"wgMFDisplayWikibaseDescriptions":{"search":true,"nearby":true,"watchlist":true,"tagline":false},"wgRelatedArticles":null,"wgRelatedArticlesUseCirrusSearch":true,"wgRelatedArticlesOnlyUseCirrusSearch":false,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCentralNoticeCookiesToDelete":[],"wgCentralNoticeCategoriesUsingLegacy":["Fundraising","fundraising"],"wgWikibaseItemId":"Q212322","wgScoreNoteLanguages":{"arabic":"العربية","catalan":"català","deutsch":"Deutsch","english":"English","espanol":"español","italiano":"italiano","nederlands":"Nederlands","norsk":"norsk","portugues":"português","suomi":"suomi","svenska":"svenska","vlaams":"West-Vlams"},"wgScoreDefaultNoteLanguage":"nederlands","wgCentralAuthMobileDomain":false,"wgCodeMirrorEnabled":true,"wgVisualEditorToolbarScrollOffset":0,"wgVisualEditorUnsupportedEditParams":["undo","undoafter","veswitched"],"wgEditSubmitButtonLabelPublish":true});mw.loader.state({"ext.gadget.charinsert-styles":"ready","ext.globalCssJs.user.styles":"ready","ext.globalCssJs.site.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","ext.globalCssJs.site":"ready","user":"ready","user.options":"ready","user.tokens":"loading","ext.cite.styles":"ready","mediawiki.legacy.shared":"ready","mediawiki.legacy.commonPrint":"ready","mediawiki.toc.styles":"ready","wikibase.client.init":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","ext.3d.styles":"ready","mediawiki.skinning.interface":"ready","skins.vector.styles":"ready"});mw.loader.implement("user.tokens@0tffind",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});RLPAGEMODULES=["ext.cite.a11y","site","mediawiki.page.startup","mediawiki.user","mediawiki.page.ready","mediawiki.toc","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.watchlist-notice","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.navigationTiming","ext.uls.eventlogger","ext.uls.init","ext.uls.compactlinks","ext.uls.interface","ext.3d","ext.centralNotice.geoIP","ext.centralNotice.startUp","skins.vector.js"];mw.loader.load(RLPAGEMODULES);});</script>
<link href="/w/load.php?debug=false&amp;lang=en&amp;modules=ext.3d.styles%7Cext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.skinning.interface%7Cmediawiki.toc.styles%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<script async="" src="/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector"></script>
<meta content="" name="ResourceLoaderDynamicStyles"/>
<link href="/w/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.charinsert-styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<link href="/w/load.php?debug=false&amp;lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<meta content="MediaWiki 1.32.0-wmf.24" name="generator"/>
<meta content="origin" name="referrer"/>
<meta content="origin-when-crossorigin" name="referrer"/>
<meta content="origin-when-cross-origin" name="referrer"/>
<meta content="https://upload.wikimedia.org/wikipedia/en/thumb/f/f8/GSK_logo_svg.svg/1200px-GSK_logo_svg.svg.png" property="og:image"/>
<link href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/GlaxoSmithKline" rel="alternate"/>
<link href="/w/index.php?title=GlaxoSmithKline&amp;action=edit" rel="alternate" title="Edit this page" type="application/x-wiki"/>
<link href="/w/index.php?title=GlaxoSmithKline&amp;action=edit" rel="edit" title="Edit this page"/>
<link href="/static/apple-touch/wikipedia.png" rel="apple-touch-icon"/>
<link href="/static/favicon/wikipedia.ico" rel="shortcut icon"/>
<link href="/w/opensearch_desc.php" rel="search" title="Wikipedia (en)" type="application/opensearchdescription+xml"/>
<link href="//en.wikipedia.org/w/api.php?action=rsd" rel="EditURI" type="application/rsd+xml"/>
<link href="//creativecommons.org/licenses/by-sa/3.0/" rel="license"/>
<link href="https://en.wikipedia.org/wiki/GlaxoSmithKline" rel="canonical"/>
<link href="//login.wikimedia.org" rel="dns-prefetch"/>
<link href="//meta.wikimedia.org" rel="dns-prefetch"/>
<!--[if lt IE 9]><script src="/w/load.php?debug=false&amp;lang=en&amp;modules=html5shiv&amp;only=scripts&amp;skin=vector&amp;sync=1"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-GlaxoSmithKline rootpage-GlaxoSmithKline skin-vector action-view"> <div class="noprint" id="mw-page-base"></div>
<div class="noprint" id="mw-head-base"></div>
<div class="mw-body" id="content" role="main">
<a id="top"></a>
<div class="mw-body-content" id="siteNotice"><!-- CentralNotice --></div><div class="mw-indicators mw-body-content">
</div>
<h1 class="firstHeading" id="firstHeading" lang="en">GlaxoSmithKline</h1> <div class="mw-body-content" id="bodyContent">
<div class="noprint" id="siteSub">From Wikipedia, the free encyclopedia</div> <div id="contentSub"></div>
<div id="jump-to-nav"></div> <a class="mw-jump-link" href="#mw-head">Jump to navigation</a>
<a class="mw-jump-link" href="#p-search">Jump to search</a>
<div class="mw-content-ltr" dir="ltr" id="mw-content-text" lang="en"><div class="mw-parser-output"><p class="mw-empty-elt">
</p>
<table class="infobox vcard" style="width:22em"><caption class="fn org">GlaxoSmithKline plc</caption><tbody><tr><td class="logo" colspan="2" style="text-align:center">
<a class="image" href="/wiki/File:GSK_logo_svg.svg"><img alt="GSK logo svg.svg" data-file-height="69" data-file-width="80" height="129" src="//upload.wikimedia.org/wikipedia/en/thumb/f/f8/GSK_logo_svg.svg/150px-GSK_logo_svg.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/f8/GSK_logo_svg.svg/225px-GSK_logo_svg.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/f8/GSK_logo_svg.svg/300px-GSK_logo_svg.svg.png 2x" width="150"/></a></td></tr><tr><td class="logo" colspan="2" style="text-align:center">
<a class="image" href="/wiki/File:GlaxoSmithKline_building,_London,_30_July_2007_(cropped).jpg"><img alt="GlaxoSmithKline building, London, 30 July 2007 (cropped).jpg" data-file-height="1772" data-file-width="1382" height="282" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/GlaxoSmithKline_building%2C_London%2C_30_July_2007_%28cropped%29.jpg/220px-GlaxoSmithKline_building%2C_London%2C_30_July_2007_%28cropped%29.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/GlaxoSmithKline_building%2C_London%2C_30_July_2007_%28cropped%29.jpg/330px-GlaxoSmithKline_building%2C_London%2C_30_July_2007_%28cropped%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9e/GlaxoSmithKline_building%2C_London%2C_30_July_2007_%28cropped%29.jpg/440px-GlaxoSmithKline_building%2C_London%2C_30_July_2007_%28cropped%29.jpg 2x" width="220"/></a><div>GSK's head office in Brentford, London</div></td></tr><tr><th scope="row" style="padding-right:0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height:1.35em;">
<a href="/wiki/Public_limited_company" title="Public limited company">Public limited company</a></td></tr><tr><th scope="row" style="padding-right:0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height:1.35em;">
<a href="/wiki/London_Stock_Exchange" title="London Stock Exchange">LSE</a>: <a class="external text" href="https://www.londonstockexchange.com/exchange/searchengine/search.html?lang=en&amp;x=0&amp;y=0&amp;q=GSK" rel="nofollow">GSK</a><br/><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>: <a class="external text" href="https://www.nyse.com/quote/XNYS:GSK" rel="nofollow">GSK</a><br/><a href="/wiki/FTSE_100_Index" title="FTSE 100 Index">FTSE 100 Component</a></td></tr><tr><th scope="row" style="padding-right:0.5em;">Industry</th><td class="category" style="line-height:1.35em;">
<a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">Pharmaceutical</a><br/><a href="/wiki/Biotechnology" title="Biotechnology">Biotechnology</a><br/><a href="/wiki/Fast-moving_consumer_goods" title="Fast-moving consumer goods">Consumer goods</a></td></tr><tr><th scope="row" style="padding-right:0.5em;">Predecessor</th><td style="line-height:1.35em;">
Glaxo plc <br/> Wellcome plc <br/> Beecham Group plc <br/> Smith Kline &amp; French Inc</td></tr><tr><th scope="row" style="padding-right:0.5em;">Founded</th><td style="line-height:1.35em;">
December 2000<span class="noprint">; 17 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">2000-12</span>)</span></td></tr><tr><th scope="row" style="padding-right:0.5em;">Headquarters</th><td class="label" style="line-height:1.35em;">
980 Great West Rd, <a href="/wiki/Brentford" title="Brentford">Brentford</a>, <a href="/wiki/London" title="London">London</a>, <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a></td></tr><tr><th scope="row" style="padding-right:0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Area served</div></th><td style="line-height:1.35em;">
Worldwide</td></tr><tr><th scope="row" style="padding-right:0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height:1.35em;">
<div class="plainlist"><ul><li><a href="/wiki/Philip_Hampton" title="Philip Hampton">Sir Philip Hampton</a><br/><span style="font-size:85%;">(Chairman)</span></li><li><a href="/wiki/Emma_Walmsley" title="Emma Walmsley">Emma Walmsley</a><br/><span style="font-size:85%;">(CEO)</span></li></ul></div></td></tr><tr><th scope="row" style="padding-right:0.5em;">Products</th><td style="line-height:1.35em;">
<a class="mw-redirect" href="/wiki/Pharmaceutical" title="Pharmaceutical">Pharmaceuticals</a>, <a href="/wiki/Vaccine" title="Vaccine">vaccines</a>, oral healthcare, nutritional products, <a href="/wiki/Over-the-counter_drug" title="Over-the-counter drug">over-the-counter medicines</a></td></tr><tr><th scope="row" style="padding-right:0.5em;">Revenue</th><td style="line-height:1.35em;">
<a href="/wiki/Pound_sterling" title="Pound sterling">£</a>30.186 billion (2017)<sup class="reference" id="cite_ref-prelims_1-0"><a href="#cite_note-prelims-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right:0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td style="line-height:1.35em;">
£4.087 billion (2017)<sup class="reference" id="cite_ref-prelims_1-1"><a href="#cite_note-prelims-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right:0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height:1.35em;">
£2.169 billion (2017)<sup class="reference" id="cite_ref-prelims_1-2"><a href="#cite_note-prelims-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right:0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height:1.35em;">
99,300 (2016)<sup class="reference" id="cite_ref-2"><a href="#cite_note-2">[2]</a></sup></td></tr><tr><th scope="row" style="padding-right:0.5em;"><a href="/wiki/Subsidiary" title="Subsidiary">Subsidiaries</a></th><td style="line-height:1.35em;">
<a href="/wiki/Stiefel_Laboratories" title="Stiefel Laboratories">Stiefel Laboratories</a></td></tr><tr><th scope="row" style="padding-right:0.5em;">Website</th><td style="line-height:1.35em;">
<span class="url"><a class="external text" href="http://www.gsk.com/" rel="nofollow">www<wbr/>.gsk<wbr/>.com</a></span></td></tr></tbody></table>
<p><b> GlaxoSmithKline plc</b> (<b>GSK</b>) is a British <a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">pharmaceutical company</a> headquartered in <a href="/wiki/Brentford" title="Brentford">Brentford</a>, London.<sup class="reference" id="cite_ref-3"><a href="#cite_note-3">[3]</a></sup> Established in 2000 by a <a href="/wiki/Mergers_and_acquisitions" title="Mergers and acquisitions">merger</a> of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a>, <a href="/wiki/Novartis" title="Novartis">Novartis</a>, <a href="/wiki/Merck_%26_Co." title="Merck &amp; Co.">Merck</a>, <a href="/wiki/Hoffmann-La_Roche" title="Hoffmann-La Roche">Hoffmann-La Roche</a> and <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a>.<sup class="reference" id="cite_ref-4"><a href="#cite_note-4">[n 1]</a></sup><sup class="reference" id="cite_ref-5"><a href="#cite_note-5">[4]</a></sup> <a href="/wiki/Emma_Walmsley" title="Emma Walmsley">Emma Walmsley</a> became <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a> on 31 March 2017 and is the first female CEO of the company.<sup class="reference" id="cite_ref-6"><a href="#cite_note-6">[5]</a></sup>
</p><p>The company has a primary listing on the <a href="/wiki/London_Stock_Exchange" title="London Stock Exchange">London Stock Exchange</a> and is a constituent of the <a href="/wiki/FTSE_100_Index" title="FTSE 100 Index">FTSE 100 Index</a>. As of August 2016 it had a market capitalisation of £81 billion (around $107 billion), the fourth largest on the <a href="/wiki/London" title="London">London</a> Stock Exchange.<sup class="reference" id="cite_ref-7"><a href="#cite_note-7">[6]</a></sup> It has a secondary listing on the <a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">New York Stock Exchange</a>.
</p><p>GSK's drugs and vaccines earned £21.3 billion in 2013.<sup class="reference" id="cite_ref-AR2013_8-0"><a href="#cite_note-AR2013-8">[7]</a></sup> Its top-selling products that year were <a class="mw-redirect" href="/wiki/Advair" title="Advair">Advair</a>, <a class="mw-redirect" href="/wiki/Avodart" title="Avodart">Avodart</a>, <a class="mw-redirect" href="/wiki/Flovent" title="Flovent">Flovent</a>, <a class="mw-redirect" href="/wiki/Augmentin" title="Augmentin">Augmentin</a>, <a class="mw-redirect" href="/wiki/Lovaza" title="Lovaza">Lovaza</a> and <a class="mw-redirect" href="/wiki/Lamictal" title="Lamictal">Lamictal</a>. GSK's consumer products, which earned £5.2 billion in 2013, include <a href="/wiki/Sensodyne" title="Sensodyne">Sensodyne</a> and <a class="mw-redirect" href="/wiki/Aquafresh" title="Aquafresh">Aquafresh</a> toothpaste, the malted-milk drink <a href="/wiki/Horlicks" title="Horlicks">Horlicks</a>, <a href="/wiki/Docosanol" title="Docosanol">Abreva</a> for cold sores, Breathe Right <a href="/wiki/Nasal_strip" title="Nasal strip">nasal strips</a>, <a class="mw-redirect" href="/wiki/Nicoderm" title="Nicoderm">Nicoderm</a> and <a href="/wiki/Nicorette" title="Nicorette">Nicorette</a> nicotine replacements, and Night Nurse, a cold remedy.<sup class="reference" id="cite_ref-GSKproducts_9-0"><a href="#cite_note-GSKproducts-9">[8]</a></sup> The company developed the first <a href="/wiki/Malaria_vaccine" title="Malaria vaccine">malaria vaccine</a>, <a href="/wiki/RTS,S" title="RTS,S">RTS,S</a>, which it said in 2014 it would make available for five percent above cost.<sup class="reference" id="cite_ref-malariavaccine_10-0"><a href="#cite_note-malariavaccine-10">[9]</a></sup> Legacy products developed at GSK include several listed in the <a class="mw-redirect" href="/wiki/World_Health_Organization_Model_List_of_Essential_Medicines" title="World Health Organization Model List of Essential Medicines">World Health Organization Model List of Essential Medicines</a>, such as <a href="/wiki/Amoxicillin" title="Amoxicillin">amoxicillin</a>, <a href="/wiki/Mercaptopurine" title="Mercaptopurine">mercaptopurine</a>, <a href="/wiki/Pyrimethamine" title="Pyrimethamine">pyrimethamine</a> and <a href="/wiki/Zidovudine" title="Zidovudine">zidovudine</a>.
</p><p>In 2012 GSK pleaded guilty to promotion of drugs for unapproved uses, failure to report safety data, and kickbacks to physicians in the United States and agreed to pay a $3 billion (£1.9bn) settlement. It was the largest health-care fraud case to date in that country and the <a class="mw-redirect" href="/wiki/List_of_largest_pharmaceutical_settlements_in_the_United_States" title="List of largest pharmaceutical settlements in the United States">largest settlement</a> by a drug company.<sup class="reference" id="cite_ref-USDOJJuly2012_11-0"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup>
</p>
<div class="toc" id="toc"><input class="toctogglecheckbox" id="toctogglecheckbox" role="button" style="display:none" type="checkbox"/><div class="toctitle" dir="ltr" lang="en"><h2>Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Glaxo_Wellcome"><span class="tocnumber">1.1</span> <span class="toctext">Glaxo Wellcome</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#SmithKline_Beecham"><span class="tocnumber">1.2</span> <span class="toctext">SmithKline Beecham</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#2000:_Glaxo_Wellcome_and_SmithKline_Beecham_merger"><span class="tocnumber">1.3</span> <span class="toctext">2000: Glaxo Wellcome and SmithKline Beecham merger</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#2001–2010"><span class="tocnumber">1.4</span> <span class="toctext">2001–2010</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#2011–present"><span class="tocnumber">1.5</span> <span class="toctext">2011–present</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Venture_arms"><span class="tocnumber">1.6</span> <span class="toctext">Venture arms</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Research_areas_and_products"><span class="tocnumber">2</span> <span class="toctext">Research areas and products</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Pharmaceuticals"><span class="tocnumber">2.1</span> <span class="toctext">Pharmaceuticals</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Malaria_vaccine"><span class="tocnumber">2.2</span> <span class="toctext">Malaria vaccine</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Consumer_healthcare"><span class="tocnumber">2.3</span> <span class="toctext">Consumer healthcare</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Facilities"><span class="tocnumber">2.4</span> <span class="toctext">Facilities</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Recognition,_philanthropy_and_social_responsibility"><span class="tocnumber">3</span> <span class="toctext">Recognition, philanthropy and social responsibility</span></a>
<ul>
<li class="toclevel-2 tocsection-14"><a href="#Scientific_recognition"><span class="tocnumber">3.1</span> <span class="toctext">Scientific recognition</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Philanthropy_and_social_responsibility"><span class="tocnumber">3.2</span> <span class="toctext">Philanthropy and social responsibility</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#Controversies"><span class="tocnumber">4</span> <span class="toctext">Controversies</span></a>
<ul>
<li class="toclevel-2 tocsection-17"><a href="#2012_criminal_and_civil_settlement"><span class="tocnumber">4.1</span> <span class="toctext">2012 criminal and civil settlement</span></a>
<ul>
<li class="toclevel-3 tocsection-18"><a href="#Overview"><span class="tocnumber">4.1.1</span> <span class="toctext">Overview</span></a></li>
<li class="toclevel-3 tocsection-19"><a href="#Rosiglitazone_(Avandia)"><span class="tocnumber">4.1.2</span> <span class="toctext">Rosiglitazone (Avandia)</span></a></li>
<li class="toclevel-3 tocsection-20"><a href="#Paroxetine_(Paxil/Seroxat)"><span class="tocnumber">4.1.3</span> <span class="toctext">Paroxetine (Paxil/Seroxat)</span></a></li>
<li class="toclevel-3 tocsection-21"><a href="#Bupropion_(Wellbutrin)"><span class="tocnumber">4.1.4</span> <span class="toctext">Bupropion (Wellbutrin)</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-22"><a href="#Antitrust_case_over_griseofulvin"><span class="tocnumber">4.2</span> <span class="toctext">Antitrust case over griseofulvin</span></a></li>
<li class="toclevel-2 tocsection-23"><a href="#Ribena"><span class="tocnumber">4.3</span> <span class="toctext">Ribena</span></a></li>
<li class="toclevel-2 tocsection-24"><a href="#SB_Pharmco_Puerto_Rico"><span class="tocnumber">4.4</span> <span class="toctext">SB Pharmco Puerto Rico</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#China"><span class="tocnumber">4.5</span> <span class="toctext">China</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Market_manipulation_in_the_UK"><span class="tocnumber">4.6</span> <span class="toctext">Market manipulation in the UK</span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#Miscellaneous"><span class="tocnumber">4.7</span> <span class="toctext">Miscellaneous</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-28"><a href="#Acquisition-history_diagram"><span class="tocnumber">5</span> <span class="toctext">Acquisition-history diagram</span></a></li>
<li class="toclevel-1 tocsection-29"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-30"><a href="#Notes"><span class="tocnumber">7</span> <span class="toctext">Notes</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-32"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=1" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Glaxo_Wellcome">Glaxo Wellcome</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=2" title="Edit section: Glaxo Wellcome">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:Glaxo_Factory,_Bunnythorpe,_New_Zealand_03.JPG"><img alt="" class="thumbimage" data-file-height="3216" data-file-width="4288" height="165" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/df/Glaxo_Factory%2C_Bunnythorpe%2C_New_Zealand_03.JPG/220px-Glaxo_Factory%2C_Bunnythorpe%2C_New_Zealand_03.JPG" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/df/Glaxo_Factory%2C_Bunnythorpe%2C_New_Zealand_03.JPG/330px-Glaxo_Factory%2C_Bunnythorpe%2C_New_Zealand_03.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/df/Glaxo_Factory%2C_Bunnythorpe%2C_New_Zealand_03.JPG/440px-Glaxo_Factory%2C_Bunnythorpe%2C_New_Zealand_03.JPG 2x" width="220"/></a> <div class="thumbcaption"><div class="magnify"><a class="internal" href="/wiki/File:Glaxo_Factory,_Bunnythorpe,_New_Zealand_03.JPG" title="Enlarge"></a></div>The historic Glaxo factory in <a href="/wiki/Bunnythorpe" title="Bunnythorpe">Bunnythorpe, New Zealand</a>, with the Glaxo Laboratories sign still visible</div></div></div>
<p>Joseph Nathan and Co. was founded in 1873 as a general trading company in <a href="/wiki/Wellington" title="Wellington">Wellington</a>, New Zealand, by a Londoner, <a class="mw-redirect" href="/wiki/Joseph_Nathan_(businessman)" title="Joseph Nathan (businessman)">Joseph Edward Nathan</a>.<sup class="reference" id="cite_ref-12"><a href="#cite_note-12">[11]</a></sup> In 1904 it began producing a dried-milk baby food from excess milk produced on the family farms outside <a href="/wiki/Bunnythorpe" title="Bunnythorpe">Bunnythorpe</a>. The resulting product was first known as Defiance, then as Glaxo (from <i>lacto</i>), under the slogan "Glaxo builds bonny babies."<sup class="reference" id="cite_ref-13"><a href="#cite_note-13">[12]</a></sup><sup class="reference" id="cite_ref-Ravenscraft2000_14-0"><a href="#cite_note-Ravenscraft2000-14">[13]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>306</span></sup><sup class="reference" id="cite_ref-history_15-0"><a href="#cite_note-history-15">[14]</a></sup> The Glaxo Laboratories sign is still visible <i>(right)</i> on what is now a car repair shop on the main street of Bunnythorpe. The company's first pharmaceutical product, released in 1924, was vitamin D.<sup class="reference" id="cite_ref-Ravenscraft2000_14-1"><a href="#cite_note-Ravenscraft2000-14">[13]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>306</span></sup>
</p><p>Glaxo Laboratories was registered as a subsidiary company in London in 1935. Glaxo bought out its parent, Joseph Nathan in 1947 and acquired <a href="/wiki/Allen_%26_Hanburys" title="Allen &amp; Hanburys">Allen &amp; Hanburys</a> in 1958. The Scottish pharmacologist <a href="/wiki/David_Jack_(scientist)" title="David Jack (scientist)">David Jack</a> was hired as a researcher for Allen &amp; Hanburys a few years after Glaxo took it over; he went on to lead the company's R&amp;D until 1987.<sup class="reference" id="cite_ref-Ravenscraft2000_14-2"><a href="#cite_note-Ravenscraft2000-14">[13]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>306</span></sup> After the company bought Meyer Laboratories in 1978, it began to play an important role in the US market. In 1983 the American arm, Glaxo Inc., moved to <a href="/wiki/Research_Triangle_Park" title="Research Triangle Park">Research Triangle Park</a> (US headquarters/research) and Zebulon (US manufacturing) in North Carolina.<sup class="reference" id="cite_ref-history_15-1"><a href="#cite_note-history-15">[14]</a></sup>
</p><p>Burroughs Wellcome &amp; Company was founded in 1880 in London by the American pharmacists <a href="/wiki/Henry_Wellcome" title="Henry Wellcome">Henry Wellcome</a> and <a class="mw-redirect" href="/wiki/Silas_Mainville_Burroughs_(pharmacist)" title="Silas Mainville Burroughs (pharmacist)">Silas Burroughs</a>. The Wellcome Tropical Research Laboratories opened in 1902. In the 1920s Burroughs Wellcome established research and manufacturing facilities in <a href="/wiki/Tuckahoe_(village),_New_York" title="Tuckahoe (village), New York">Tuckahoe, New York</a>,<sup class="reference" id="cite_ref-TriCent_16-0"><a href="#cite_note-TriCent-16">[15]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>18</span></sup><sup class="reference" id="cite_ref-17"><a href="#cite_note-17">[16]</a></sup><sup class="reference" id="cite_ref-18"><a href="#cite_note-18">[17]</a></sup> which served as the US headquarters until the company moved to <a href="/wiki/Research_Triangle_Park" title="Research Triangle Park">Research Triangle Park</a> in North Carolina in 1971.<sup class="reference" id="cite_ref-19"><a href="#cite_note-19">[18]</a></sup> The Nobel Prize winning scientists <a href="/wiki/Gertrude_B._Elion" title="Gertrude B. Elion">Gertrude B. Elion</a> and <a href="/wiki/George_H._Hitchings" title="George H. Hitchings">George H. Hitchings</a> worked there and invented drugs still used many years later, such as <a href="/wiki/Mercaptopurine" title="Mercaptopurine">mercaptopurine</a>.<sup class="reference" id="cite_ref-20"><a href="#cite_note-20">[19]</a></sup> In 1959 the Wellcome Foundation bought <a href="/wiki/William_Cooper_(chemical_manufacturer)" title="William Cooper (chemical manufacturer)">Cooper, McDougall &amp; Robertson Inc</a> to become more active in animal health.<sup class="reference" id="cite_ref-history_15-2"><a href="#cite_note-history-15">[14]</a></sup> Glaxo and Wellcome merged in 1995 to form Glaxo Wellcome plc.<sup class="reference" id="cite_ref-21"><a href="#cite_note-21">[20]</a></sup><sup class="reference" id="cite_ref-Ravenscraft2000_14-3"><a href="#cite_note-Ravenscraft2000-14">[13]</a></sup> Glaxo Wellcome restructured its R&amp;D operation that year, cutting 10,000 jobs worldwide, closing its R&amp;D facility in Beckenham, Kent, and opening a Medicines Research Centre in Stevenage, Hertfordshire.<sup class="reference" id="cite_ref-22"><a href="#cite_note-22">[21]</a></sup><sup class="reference" id="cite_ref-23"><a href="#cite_note-23">[22]</a></sup><sup class="reference" id="cite_ref-24"><a href="#cite_note-24">[23]</a></sup> Also that year, Glaxo Wellcome acquired the California-based Affymax, a leader in the field of <a href="/wiki/Combinatorial_chemistry" title="Combinatorial chemistry">combinatorial chemistry</a>.<sup class="reference" id="cite_ref-25"><a href="#cite_note-25">[24]</a></sup>
</p><p>By 1999 Glaxo Wellcome had become the world's third-largest pharmaceutical company by revenues (behind <a href="/wiki/Novartis" title="Novartis">Novartis</a> and Merck), with a global market share of around 4 per cent.<sup class="reference" id="cite_ref-26"><a href="#cite_note-26">[25]</a></sup> Its products included <a class="mw-redirect" href="/wiki/Imigran" title="Imigran">Imigran</a> (for the treatment of migraine), <a href="/wiki/Salbutamol" title="Salbutamol">salbutamol</a> (Ventolin) (for the treatment of asthma), <a class="mw-redirect" href="/wiki/Zovirax" title="Zovirax">Zovirax</a> (for the treatment of coldsores), and <a class="mw-redirect" href="/wiki/Retrovir" title="Retrovir">Retrovir</a> and <a class="mw-redirect" href="/wiki/Epivir" title="Epivir">Epivir</a> (for the treatment of AIDS). In 1999 the company was the world's largest manufacturer of drugs for the treatment of asthma and HIV/AIDS.<sup class="reference" id="cite_ref-indep1899_27-0"><a href="#cite_note-indep1899-27">[26]</a></sup> It employed 59,000 people, including 13,400 in the UK, had 76 operating companies and 50 manufacturing facilities worldwide, and seven of its products were among the world's top 50 best-selling pharmaceuticals. The company had R&amp;D facilities in Hertfordshire, Kent, London and Verona (Italy), and manufacturing plants in Scotland and the north of England. It had R&amp;D centres in the US and Japan, and production facilities in the US, Europe and the Far East.<sup class="reference" id="cite_ref-bbc17100_28-0"><a href="#cite_note-bbc17100-28">[27]</a></sup>
</p>
<h3><span class="mw-headline" id="SmithKline_Beecham">SmithKline Beecham</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=3" title="Edit section: SmithKline Beecham">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:BeechamsBuilding.jpg"><img alt="" class="thumbimage" data-file-height="1212" data-file-width="1118" height="238" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/12/BeechamsBuilding.jpg/220px-BeechamsBuilding.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/12/BeechamsBuilding.jpg/330px-BeechamsBuilding.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/12/BeechamsBuilding.jpg/440px-BeechamsBuilding.jpg 2x" width="220"/></a> <div class="thumbcaption"><div class="magnify"><a class="internal" href="/wiki/File:BeechamsBuilding.jpg" title="Enlarge"></a></div>Beecham's Clock Tower, constructed 1877, part of the <a class="mw-redirect" href="/wiki/Beecham_(pharmaceutical_company)" title="Beecham (pharmaceutical company)">Beecham</a>'s factory, <a href="/wiki/St_Helens,_Merseyside" title="St Helens, Merseyside">St Helens</a></div></div></div>
<p>In 1848 <a href="/wiki/Thomas_Beecham_(chemist)" title="Thomas Beecham (chemist)">Thomas Beecham</a> launched his <a href="/wiki/Beecham%27s_Pills" title="Beecham's Pills">Beecham's Pills</a> laxative in England, giving birth to the <a href="/wiki/Beecham_Group" title="Beecham Group">Beecham Group</a>. In 1859 Beecham opened its first factory in <a href="/wiki/St_Helens,_Merseyside" title="St Helens, Merseyside">St Helens</a>, <a href="/wiki/Lancashire" title="Lancashire">Lancashire</a>. By the 1960s Beecham was extensively involved in pharmaceuticals and consumer products such as Macleans toothpaste, Lucozade and synthetic penicillin research.<sup class="reference" id="cite_ref-history_15-3"><a href="#cite_note-history-15">[14]</a></sup><sup class="reference" id="cite_ref-29"><a href="#cite_note-29">[28]</a></sup>
</p><p><a href="/wiki/John_K._Smith" title="John K. Smith">John K. Smith</a> opened his first pharmacy in Philadelphia in 1830. In 1865 <a href="/wiki/Mahlon_Kline" title="Mahlon Kline">Mahlon Kline</a> joined the business, which 10 years later became Smith, Kline &amp; Co. In 1891 it merged with French, Richard and Company, and in 1929 changed its name to <a class="mw-redirect" href="/wiki/SmithKline_%26_French" title="SmithKline &amp; French">Smith Kline &amp; French Laboratories</a> as it focused more on research. Years later it bought Norden Laboratories, a business doing research into animal health, and <a href="/wiki/Recherche_et_Industrie_Th%C3%A9rapeutiques" title="Recherche et Industrie Thérapeutiques">Recherche et Industrie Thérapeutiques</a> in Belgium in 1963 to focus on vaccines. The company began to expand globally, buying seven laboratories in Canada and the United States in 1969. In 1982 it bought <a href="/wiki/Allergan" title="Allergan">Allergan</a>, a manufacturer of eye and skincare products.<sup class="reference" id="cite_ref-history_15-4"><a href="#cite_note-history-15">[14]</a></sup>
</p><p>SmithKline &amp; French merged with Beckman Inc. in 1982 and changed its name to <i>SmithKline Beckman</i>. In 1988 it bought its biggest competitor, International Clinical Laboratories, and in 1989 merged with <a class="mw-redirect" href="/wiki/Beecham_(pharmaceutical_company)" title="Beecham (pharmaceutical company)">Beecham</a> to form <i>SmithKline Beecham plc</i>. The headquarters moved from the United States to England. To expand R&amp;D in the United States, the company bought a new research center in 1995; another opened in 1997 in England at New Frontiers Science Park, <a href="/wiki/Harlow" title="Harlow">Harlow</a>.<sup class="reference" id="cite_ref-history_15-5"><a href="#cite_note-history-15">[14]</a></sup>
</p>
<h3><span class="mw-headline" id="2000:_Glaxo_Wellcome_and_SmithKline_Beecham_merger">2000: Glaxo Wellcome and SmithKline Beecham merger</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=4" title="Edit section: 2000: Glaxo Wellcome and SmithKline Beecham merger">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Glaxo Wellcome and SmithKline Beecham announced their intention to merge in January 2000. The merger was completed in December that year, forming GlaxoSmithKline (GSK).<sup class="reference" id="cite_ref-30"><a href="#cite_note-30">[29]</a></sup><sup class="reference" id="cite_ref-31"><a href="#cite_note-31">[30]</a></sup> The company's global headquarters are at GSK House, <a href="/wiki/Brentford" title="Brentford">Brentford</a>, London, officially opened in 2002 by then-Prime Minister <a href="/wiki/Tony_Blair" title="Tony Blair">Tony Blair</a>. The building was erected at a cost of £300 million and as of 2002 was home to 3,000 administrative staff.<sup class="reference" id="cite_ref-tele15702_32-0"><a href="#cite_note-tele15702-32">[31]</a></sup>
</p>
<h3><span id="2001.E2.80.932010"></span><span class="mw-headline" id="2001–2010">2001–2010</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=5" title="Edit section: 2001–2010">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:Andrew_Witty_in_2015.jpg"><img alt="photograph" class="thumbimage" data-file-height="2592" data-file-width="3872" height="147" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Andrew_Witty_in_2015.jpg/220px-Andrew_Witty_in_2015.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Andrew_Witty_in_2015.jpg/330px-Andrew_Witty_in_2015.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Andrew_Witty_in_2015.jpg/440px-Andrew_Witty_in_2015.jpg 2x" width="220"/></a> <div class="thumbcaption"><div class="magnify"><a class="internal" href="/wiki/File:Andrew_Witty_in_2015.jpg" title="Enlarge"></a></div><a href="/wiki/Andrew_Witty" title="Andrew Witty">Andrew Witty</a>, GSK's CEO from May 2008 to April 2017</div></div></div>
<p>GSK completed the acquisition of New Jersey-based <a href="/wiki/Block_Drug" title="Block Drug">Block Drug</a> in 2001 for US$1.24 billion.<sup class="reference" id="cite_ref-33"><a href="#cite_note-33">[32]</a></sup> In 2006 GSK acquired the US-based consumer healthcare company CNS Inc., whose products included Breathe Right nasal strips and FiberChoice dietary supplements, for US$566 million in cash.<sup class="reference" id="cite_ref-34"><a href="#cite_note-34">[33]</a></sup>
</p><p><a href="/wiki/Chris_Gent" title="Chris Gent">Chris Gent</a>, previously CEO of <a href="/wiki/Vodafone" title="Vodafone">Vodafone</a>, was appointed chairman of the board in 2005.<sup class="reference" id="cite_ref-35"><a href="#cite_note-35">[34]</a></sup> GSK opened its first R&amp;D centre in China in 2007, in Shanghai, initially focused on neurodegenerative diseases.<sup class="reference" id="cite_ref-36"><a href="#cite_note-36">[35]</a></sup> <a href="/wiki/Andrew_Witty" title="Andrew Witty">Andrew Witty</a> became the chief executive officer in 2008.<sup class="reference" id="cite_ref-37"><a href="#cite_note-37">[36]</a></sup> Witty joined Glaxo in 1985 and had been president of GSK's Pharmaceuticals Europe since 2003.<sup class="reference" id="cite_ref-38"><a href="#cite_note-38">[37]</a></sup>
</p><p>In 2009 GSK acquired <a href="/wiki/Stiefel_Laboratories" title="Stiefel Laboratories">Stiefel Laboratories</a>, then the world's largest independent dermatology drug company, for US$3.6bn.<sup class="reference" id="cite_ref-39"><a href="#cite_note-39">[38]</a></sup> In November the FDA approved GSK's vaccine for 2009 H1N1 influenza protection, manufactured by the company's ID Biomedical Corp in Canada.<sup class="reference" id="cite_ref-40"><a href="#cite_note-40">[39]</a></sup> Also in November 2009 GSK formed a joint venture with <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a> to create <a href="/wiki/ViiV_Healthcare" title="ViiV Healthcare">ViiV Healthcare</a>, which specializes in HIV research.<sup class="reference" id="cite_ref-41"><a href="#cite_note-41">[40]</a></sup> In 2010 the company acquired Laboratorios Phoenix, an Argentine pharmaceutical company, for US$253m,<sup class="reference" id="cite_ref-42"><a href="#cite_note-42">[41]</a></sup> and the UK-based sports nutrition company Maxinutrition for £162 million (US$256 million).<sup class="reference" id="cite_ref-43"><a href="#cite_note-43">[42]</a></sup>
</p>
<h3><span id="2011.E2.80.93present"></span><span class="mw-headline" id="2011–present">2011–present</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=6" title="Edit section: 2011–present">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2011, in a $660-million deal, <a href="/wiki/Prestige_Brands" title="Prestige Brands">Prestige Brands Holdings</a> took over 17 GSK brands with sales of $210 million, including <a href="/wiki/BC_Powder" title="BC Powder">BC Powder</a>, <a href="/wiki/Beano_(dietary_supplement)" title="Beano (dietary supplement)">Beano</a>, <a class="mw-redirect" href="/wiki/Ecotrin" title="Ecotrin">Ecotrin</a>, Fiber Choice, <a href="/wiki/Goody%27s_Powder" title="Goody's Powder">Goody's Powder</a>, <a href="/wiki/Sominex" title="Sominex">Sominex</a> and <a class="mw-redirect" href="/wiki/Tagamet" title="Tagamet">Tagamet</a>.<sup class="reference" id="cite_ref-44"><a href="#cite_note-44">[43]</a></sup> In 2012 the company announced that it would invest £500 million in manufacturing facilities in <a href="/wiki/Ulverston" title="Ulverston">Ulverston</a>, northern England, designating it as the site for a previously announced biotech plant.<sup class="reference" id="cite_ref-45"><a href="#cite_note-45">[44]</a></sup> In May that year it acquired CellZome, a German biotech company, for US$98 million,<sup class="reference" id="cite_ref-46"><a href="#cite_note-46">[45]</a></sup> and in June worldwide rights to <a href="/wiki/Alitretinoin" title="Alitretinoin">alitretinoin</a> (Toctino), an <a class="mw-redirect" href="/wiki/Eczema" title="Eczema">eczema</a> drug, for $302 million.<sup class="reference" id="cite_ref-47"><a href="#cite_note-47">[46]</a></sup> In 2013 GSK acquired <a href="/wiki/Human_Genome_Sciences" title="Human Genome Sciences">Human Genome Sciences</a> (HGS) for $3 billion; the companies had collaborated on developing the <a class="mw-redirect" href="/wiki/Lupus" title="Lupus">lupus</a> drug <a href="/wiki/Belimumab" title="Belimumab">Belimumab</a> (Benlysta), <a href="/wiki/Albiglutide" title="Albiglutide">albiglutide</a> for <a class="mw-redirect" href="/wiki/Type_2_diabetes" title="Type 2 diabetes">type 2 diabetes</a>, and <a href="/wiki/Darapladib" title="Darapladib">darapladib</a> for <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>.<sup class="reference" id="cite_ref-3Lessons_48-0"><a href="#cite_note-3Lessons-48">[47]</a></sup>
</p><p>In March 2014, GSK paid $1 billion to raise its stake in its Indian pharmaceutical unit, GlaxoSmithKline Pharmaceuticals, to 75 percent as part of a move to focus on emerging markets.<sup class="reference" id="cite_ref-49"><a href="#cite_note-49">[48]</a></sup> In April 2014 Novartis and Glaxo agreed on more than $20 billion in deals, with Novartis selling its vaccine business to GSK and buying GSK's cancer business.<sup class="reference" id="cite_ref-50"><a href="#cite_note-50">[49]</a></sup><sup class="reference" id="cite_ref-wsj4222014_51-0"><a href="#cite_note-wsj4222014-51">[50]</a></sup> In February 2015 GSK announced that it would acquire GlycoVaxyn, a Swiss pharmaceutical company, for $190 million,<sup class="reference" id="cite_ref-52"><a href="#cite_note-52">[51]</a></sup> and in June that year that it would sell two <a href="/wiki/Meningitis" title="Meningitis">meningitis</a> drugs to <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a>, <a class="new" href="/w/index.php?title=Nimenrix&amp;action=edit&amp;redlink=1" title="Nimenrix (page does not exist)">Nimenrix</a> and <a class="mw-redirect" href="/wiki/Mencevax" title="Mencevax">Mencevax</a> for around $130 million.<sup class="reference" id="cite_ref-53"><a href="#cite_note-53">[52]</a></sup>
</p><p><a href="/wiki/Philip_Hampton" title="Philip Hampton">Philip Hampton</a>, at that time chair of the <a href="/wiki/Royal_Bank_of_Scotland" title="Royal Bank of Scotland">Royal Bank of Scotland</a>, became GSK chairman in September 2015.<sup class="reference" id="cite_ref-54"><a href="#cite_note-54">[53]</a></sup>
</p><p>In September 2016, the company announced that Witty would be succeeded as CEO by <a href="/wiki/Emma_Walmsley" title="Emma Walmsley">Emma Walmsley</a> in March 2017; Walmsley was a management professional originally from Lancashire with a background in marketing.<sup class="reference" id="cite_ref-successionAWtoEW_55-0"><a href="#cite_note-successionAWtoEW-55">[54]</a></sup>
</p><p>In December 2017, Reuters reported that Glaxo had increased its stake in its Saudi Arabian unit to 75% (from 49%) taking over control from its Saudi partner <a class="new" href="/w/index.php?title=Banaja_KSA_Holding_Company&amp;action=edit&amp;redlink=1" title="Banaja KSA Holding Company (page does not exist)">Banaja KSA Holding Company</a>.<sup class="reference" id="cite_ref-56"><a href="#cite_note-56">[55]</a></sup>
</p><p>In March 2018, GSK announced that it has reached an agreement with <a href="/wiki/Novartis" title="Novartis">Novartis</a> to acquire Novartis’ 36.5% stake in their Consumer Healthcare Joint Venture for $13 billion (£9.2 billion).<sup class="reference" id="cite_ref-57"><a href="#cite_note-57">[56]</a></sup> This acquisition is consistent with the notion prevalent by July 2018 that the company was seriously considering a breakup that would spin-off the company's Consumer division.<sup class="reference" id="cite_ref-:0_58-0"><a href="#cite_note-:0-58">[57]</a></sup>
</p><p>With respect to <a href="/wiki/Rare_disease" title="Rare disease">rare diseases</a>, the company divested its portfolio of <a href="/wiki/Gene_therapy" title="Gene therapy">gene therapy</a> drugs to Orchard Therapeutics in April 2018.<sup class="reference" id="cite_ref-:0_58-1"><a href="#cite_note-:0-58">[57]</a></sup>
</p>
<h3><span class="mw-headline" id="Venture_arms">Venture arms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=7" title="Edit section: Venture arms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>SR One was established in 1985 by SmithKline Beecham to invest in new biotechnology companies and continued operating after GSK was formed; by 2003 GSK had formed another subsidiary, GSK Ventures, to out-license or start new companies around drug candidates that it did not intend to develop further.<sup class="reference" id="cite_ref-JPE2003_59-0"><a href="#cite_note-JPE2003-59">[58]</a></sup>  As of 2003, SR One tended to invest only if the company aligned with GSK's business.<sup class="reference" id="cite_ref-JPE2003_59-1"><a href="#cite_note-JPE2003-59">[58]</a></sup>
</p>
<h2><span class="mw-headline" id="Research_areas_and_products">Research areas and products</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=8" title="Edit section: Research areas and products">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote navigation-not-searchable" role="note">Further information: <a href="/wiki/List_of_GlaxoSmithKline_products" title="List of GlaxoSmithKline products">List of GlaxoSmithKline products</a></div>
<h3><span class="mw-headline" id="Pharmaceuticals">Pharmaceuticals</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=9" title="Edit section: Pharmaceuticals">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes and mental health. Its biggest-selling products in 2013 were <a class="mw-redirect" href="/wiki/Seretide" title="Seretide">Advair</a>, <a class="mw-redirect" href="/wiki/Avodart" title="Avodart">Avodart</a>, <a class="mw-redirect" href="/wiki/Flixotide" title="Flixotide">Flovent</a>, <a class="mw-redirect" href="/wiki/Augmentin" title="Augmentin">Augmentin</a>, <a class="mw-redirect" href="/wiki/Lovaza" title="Lovaza">Lovaza</a>, and <a class="mw-redirect" href="/wiki/Lamictal" title="Lamictal">Lamictal</a>; its drugs and vaccines earned £21.3 billion that year. Other top-selling products include its <a href="/wiki/Asthma" title="Asthma">asthma</a>/<a class="mw-redirect" href="/wiki/COPD" title="COPD">COPD</a> inhalers Advair, Ventolin, and Flovent; its <a href="/wiki/Diphtheria" title="Diphtheria">diphtheria</a>/<a href="/wiki/Tetanus" title="Tetanus">tetanus</a>/<a class="mw-redirect" href="/wiki/Pertussis" title="Pertussis">pertussis</a> vaccine Infanrix and its <a href="/wiki/Hepatitis_B_vaccine" title="Hepatitis B vaccine">hepatitis B vaccine</a>; the epilepsy drug <a class="mw-redirect" href="/wiki/Lamictal" title="Lamictal">Lamictal</a>, and the antibacterial Augmentin.<sup class="reference" id="cite_ref-AR2013_8-1"><a href="#cite_note-AR2013-8">[7]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>220</span></sup>
</p><p>Medicines historically discovered or developed at GSK and its legacy companies and now sold as generics include <a href="/wiki/Amoxicillin" title="Amoxicillin">amoxicillin</a><sup class="reference" id="cite_ref-60"><a href="#cite_note-60">[59]</a></sup> and <a class="mw-redirect" href="/wiki/Amoxicillin-clavulanate" title="Amoxicillin-clavulanate">amoxicillin-clavulanate</a>,<sup class="reference" id="cite_ref-61"><a href="#cite_note-61">[60]</a></sup> <a href="/wiki/Ticarcillin/clavulanic_acid" title="Ticarcillin/clavulanic acid">ticarcillin-clavulanate</a>,<sup class="reference" id="cite_ref-62"><a href="#cite_note-62">[61]</a></sup> <a href="/wiki/Mupirocin" title="Mupirocin">mupirocin</a>,<sup class="reference" id="cite_ref-63"><a href="#cite_note-63">[62]</a></sup> and <a href="/wiki/Ceftazidime" title="Ceftazidime">ceftazidime</a><sup class="reference" id="cite_ref-64"><a href="#cite_note-64">[63]</a></sup> for bacterial infections, <a href="/wiki/Zidovudine" title="Zidovudine">zidovudine</a> for <a class="mw-redirect" href="/wiki/HIV_infection" title="HIV infection">HIV infection</a>, <a class="mw-redirect" href="/wiki/Valacyclovir" title="Valacyclovir">valacyclovir</a> for herpes virus infections, <a href="/wiki/Albendazole" title="Albendazole">albendazole</a> for parasitic infections, <a href="/wiki/Sumatriptan" title="Sumatriptan">sumatriptan</a> for <a href="/wiki/Migraine" title="Migraine">migraine</a>, <a href="/wiki/Lamotrigine" title="Lamotrigine">lamotrigine</a> for epilepsy, <a href="/wiki/Bupropion" title="Bupropion">bupropion</a> and <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> for <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depressive disorder</a>, <a href="/wiki/Cimetidine" title="Cimetidine">cimetidine</a> and <a href="/wiki/Ranitidine" title="Ranitidine">ranitidine</a> for <a class="mw-redirect" href="/wiki/Gastroesophageal_reflux_disorder" title="Gastroesophageal reflux disorder">gastroesophageal reflux disorder</a>, <a href="/wiki/Mercaptopurine" title="Mercaptopurine">mercaptopurine</a><sup class="reference" id="cite_ref-pubs.acs.org_65-0"><a href="#cite_note-pubs.acs.org-65">[64]</a></sup> and <a class="mw-redirect" href="/wiki/Thioguanine" title="Thioguanine">thioguanine</a><sup class="reference" id="cite_ref-ScienceHistory_66-0"><a href="#cite_note-ScienceHistory-66">[65]</a></sup> for the treatment of leukemia, <a href="/wiki/Allopurinol" title="Allopurinol">allopurinol</a> for <a href="/wiki/Gout" title="Gout">gout</a>,<sup class="reference" id="cite_ref-The_purine_path_to_chemotherapy_67-0"><a href="#cite_note-The_purine_path_to_chemotherapy-67">[66]</a></sup> <a href="/wiki/Pyrimethamine" title="Pyrimethamine">pyrimethamine</a> for <a href="/wiki/Malaria" title="Malaria">malaria</a>,<sup class="reference" id="cite_ref-nytimes.com_68-0"><a href="#cite_note-nytimes.com-68">[67]</a></sup> and the antibacterial <a href="/wiki/Trimethoprim" title="Trimethoprim">trimethoprim</a>.<sup class="reference" id="cite_ref-ScienceHistory_66-1"><a href="#cite_note-ScienceHistory-66">[65]</a></sup>
</p><p>Among these, albendazole, amoxicillin, amoxicillin-clavulanate, allopurinol, mercaptopurine, mupriocin, pyrimethamine, ranitidine, thioguanine, trimethoprim and zidovudine are listed on the World Health Organization's list of essential medications.<sup class="reference" id="cite_ref-69"><a href="#cite_note-69">[68]</a></sup>
</p>
<h3><span class="mw-headline" id="Malaria_vaccine">Malaria vaccine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=10" title="Edit section: Malaria vaccine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2014 GSK applied for regulatory approval for the first <a href="/wiki/Malaria_vaccine" title="Malaria vaccine">malaria vaccine</a>.<sup class="reference" id="cite_ref-70"><a href="#cite_note-70">[69]</a></sup> <a href="/wiki/Malaria" title="Malaria">Malaria</a> is responsible for over 650,000 deaths annually, mainly in Africa.<sup class="reference" id="cite_ref-71"><a href="#cite_note-71">[70]</a></sup> Known as <a href="/wiki/RTS,S" title="RTS,S">RTS,S</a>, the vaccine was developed as a joint project with the <a href="/wiki/PATH_(global_health_organization)" title="PATH (global health organization)">PATH</a> vaccines initiative and the <a class="mw-redirect" href="/wiki/Bill_and_Melinda_Gates_Foundation" title="Bill and Melinda Gates Foundation">Bill and Melinda Gates Foundation</a>. The company has committed to making the vaccine available in developing countries for five percent above the cost of production.<sup class="reference" id="cite_ref-malariavaccine_10-1"><a href="#cite_note-malariavaccine-10">[9]</a></sup>
</p><p>As of 2013 RTS,S, which uses GSK's proprietary AS01 adjuvant, was being examined in a Phase 3 trial in eight African countries. PATH reported that "[i]n the 12-month period following vaccination, RTS,S conferred approximately 50% protection from clinical Plasmodium falciparum disease in children aged 5-17 months, and approximately 30% protection in children aged 6-12 weeks when administered in conjunction with Expanded Program for Immunization (EPI) vaccines."<sup class="reference" id="cite_ref-72"><a href="#cite_note-72">[71]</a></sup> In 2014 Glaxo said it had spent more than $350 million and expected to spend an additional $260 million before seeking regulatory approval.<sup class="reference" id="cite_ref-73"><a href="#cite_note-73">[72]</a></sup><sup class="reference" id="cite_ref-74"><a href="#cite_note-74">[73]</a></sup> A second generation malaria vaccine is being evaluated in Phase 2 clinical trials.<sup class="reference" id="cite_ref-75"><a href="#cite_note-75">[74]</a></sup>
</p>
<h3><span class="mw-headline" id="Consumer_healthcare">Consumer healthcare</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=11" title="Edit section: Consumer healthcare">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>GSK's consumer healthcare division, which earned £5.2 billion in 2013, sells oral healthcare, including  <a class="mw-redirect" href="/wiki/Aquafresh" title="Aquafresh">Aquafresh</a>, Maclean's and <a href="/wiki/Sensodyne" title="Sensodyne">Sensodyne</a> toothpastes; and drinks such as <a href="/wiki/Horlicks" title="Horlicks">Horlicks</a>, Boost and a chocolate-flavoured malt drink sold in India. GSK also previously owned the <a href="/wiki/Lucozade" title="Lucozade">Lucozade</a> and <a href="/wiki/Ribena" title="Ribena">Ribena</a> brands of soft drinks, but they were sold in 2013 to <a href="/wiki/Suntory" title="Suntory">Suntory</a> for £1.35bn.<sup class="reference" id="cite_ref-Monaghan_76-0"><a href="#cite_note-Monaghan-76">[75]</a></sup> Other products include <a href="/wiki/Docosanol" title="Docosanol">Abreva</a> to treat cold sores; Night Nurse, a cold remedy; Breathe Right <a href="/wiki/Nasal_strip" title="Nasal strip">nasal strips</a>; and <a class="mw-redirect" href="/wiki/Nicoderm" title="Nicoderm">Nicoderm</a> and <a href="/wiki/Nicorette" title="Nicorette">Nicorette</a> nicotine replacements.<sup class="reference" id="cite_ref-Maj07_77-0"><a href="#cite_note-Maj07-77">[76]</a></sup> In March 2014 it recalled <a href="/wiki/Orlistat" title="Orlistat">Alli</a>, an over-the-counter weight-loss drug, in the United States and <a href="/wiki/Puerto_Rico" title="Puerto Rico">Puerto Rico</a> because of possible tampering, following customer complaints.<sup class="reference" id="cite_ref-78"><a href="#cite_note-78">[77]</a></sup>
</p>
<h3><span class="mw-headline" id="Facilities">Facilities</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=12" title="Edit section: Facilities">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>As of 2013 GSK had offices in over 115 countries and employed over 99,000 people, 12,500 in <a href="/wiki/Research_and_development" title="Research and development">R&amp;D</a>. The company's single largest market is the United States. Its US headquarters are in <a class="mw-redirect" href="/wiki/The_Navy_Yard" title="The Navy Yard">The Navy Yard</a>, Philadelphia, and <a href="/wiki/Research_Triangle_Park" title="Research Triangle Park">Research Triangle Park</a>, North Carolina; its consumer-products division is in <a class="mw-redirect" href="/wiki/Moon_Township,_Pennsylvania" title="Moon Township, Pennsylvania">Moon Township, Pennsylvania</a>.<sup class="reference" id="cite_ref-AR2013_8-2"><a href="#cite_note-AR2013-8">[7]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>7</span></sup><sup class="reference" id="cite_ref-achievements_79-0"><a href="#cite_note-achievements-79">[78]</a></sup>
</p>
<h2><span id="Recognition.2C_philanthropy_and_social_responsibility"></span><span class="mw-headline" id="Recognition,_philanthropy_and_social_responsibility">Recognition, philanthropy and social responsibility</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=13" title="Edit section: Recognition, philanthropy and social responsibility">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Scientific_recognition">Scientific recognition</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=14" title="Edit section: Scientific recognition">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Four GlaxoSmithKline scientists have been recognized by the Nobel Committee for their contributions to basic medical science and/or therapeutics development.
</p>
<ul><li><a href="/wiki/Henry_Hallett_Dale" title="Henry Hallett Dale">Henry Dale</a>, a former student of <a href="/wiki/Paul_Ehrlich" title="Paul Ehrlich">Paul Ehrlich</a>, received the 1936 <a class="mw-redirect" href="/wiki/Nobel_Prize_in_Medicine" title="Nobel Prize in Medicine">Nobel Prize in Medicine</a> for his work on the chemical transmission of neural impulses.  Dale served as a pharmacologist and then as Director of the Wellcome Physiological Research Laboratories from 1904 to 1914, and later served as Trustee and Chairman of the Board of the <a href="/wiki/Wellcome_Trust" title="Wellcome Trust">Wellcome Trust</a>.<sup class="reference" id="cite_ref-80"><a href="#cite_note-80">[79]</a></sup></li>
<li><a href="/wiki/John_Vane" title="John Vane">John Vane</a> of Wellcome Research Laboratories shared the 1982 Nobel Prize for Medicine for his work on prostaglandin biology and the discovery of <a href="/wiki/Prostacyclin" title="Prostacyclin">prostacyclin</a>.  Vane served as Group Research and Development Director for The Wellcome Foundation from 1973 to 1985.<sup class="reference" id="cite_ref-81"><a href="#cite_note-81">[80]</a></sup></li>
<li><a href="/wiki/Gertrude_B._Elion" title="Gertrude B. Elion">Gertrude B. Elion</a> and <a class="mw-redirect" href="/wiki/George_Hitchings" title="George Hitchings">George Hitchings</a>, both of the Wellcome Research Laboratories, shared the 1988 Nobel Prize in Medicine with <a class="mw-redirect" href="/wiki/Sir_James_W._Black" title="Sir James W. Black">Sir James W. Black</a> ""for their discoveries of important principles for drug treatment"." Elion and Hitchings were responsible for the discovery of a plethora of important drugs, including mercaptopurine<sup class="reference" id="cite_ref-pubs.acs.org_65-1"><a href="#cite_note-pubs.acs.org-65">[64]</a></sup> and thioguanine<sup class="reference" id="cite_ref-ScienceHistory_66-2"><a href="#cite_note-ScienceHistory-66">[65]</a></sup> for the treatment of leukemia, the immunosuppressant azothioprine,<sup class="reference" id="cite_ref-82"><a href="#cite_note-82">[81]</a></sup> allopurinol for gout,<sup class="reference" id="cite_ref-The_purine_path_to_chemotherapy_67-1"><a href="#cite_note-The_purine_path_to_chemotherapy-67">[66]</a></sup> pyrimethamine for malaria,<sup class="reference" id="cite_ref-nytimes.com_68-1"><a href="#cite_note-nytimes.com-68">[67]</a></sup> the antibacterial trimethoprim,<sup class="reference" id="cite_ref-ScienceHistory_66-3"><a href="#cite_note-ScienceHistory-66">[65]</a></sup> acyclovir for herpes virus infection,<sup class="reference" id="cite_ref-83"><a href="#cite_note-83">[82]</a></sup> and nelarabine for cancer treatment.<sup class="reference" id="cite_ref-84"><a href="#cite_note-84">[83]</a></sup></li></ul>
<h3><span class="mw-headline" id="Philanthropy_and_social_responsibility">Philanthropy and social responsibility</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=15" title="Edit section: Philanthropy and social responsibility">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg"><img alt="" class="thumbimage" data-file-height="1992" data-file-width="2744" height="160" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a3/GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg/220px-GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a3/GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg/330px-GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a3/GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg/440px-GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg 2x" width="220"/></a> <div class="thumbcaption"><div class="magnify"><a class="internal" href="/wiki/File:GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg" title="Enlarge"></a></div>GlaxoSmithKline, <a href="/wiki/Center_City,_Philadelphia" title="Center City, Philadelphia">Center City, Philadelphia</a></div></div></div>
<p>Since 2010, GlaxoSmithKline has several times ranked first among pharmaceutical companies on the Global Access to Medicines Index, which is funded by the <a class="mw-redirect" href="/wiki/Bill_and_Melinda_Gates_Foundation" title="Bill and Melinda Gates Foundation">Bill and Melinda Gates Foundation</a>.<sup class="reference" id="cite_ref-www.accesstomedicineindex.org_85-0"><a href="#cite_note-www.accesstomedicineindex.org-85">[84]</a></sup> In 2014 the <a href="/wiki/Human_Rights_Campaign" title="Human Rights Campaign">Human Rights Campaign</a>, an <a href="/wiki/LGBT" title="LGBT">LGBT</a>-rights advocacy group gave GSK a score of 100 percent in its <a href="/wiki/Corporate_Equality_Index" title="Corporate Equality Index">Corporate Equality Index</a>.<sup class="reference" id="cite_ref-86"><a href="#cite_note-86">[85]</a></sup>
</p><p>GSK has been active, with the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO), in the Global Alliance to Eliminate Lymphatic Filariasis (GAELF). Around 120 million people globally are believed to be infected with <a href="/wiki/Filariasis" title="Filariasis">lymphatic filariasis</a>.<sup class="reference" id="cite_ref-87"><a href="#cite_note-87">[86]</a></sup> In 2012 the company endorsed the <a href="/wiki/London_Declaration_on_Neglected_Tropical_Diseases" title="London Declaration on Neglected Tropical Diseases">London Declaration on Neglected Tropical Diseases</a>; it agreed to donate 400 million <a href="/wiki/Albendazole" title="Albendazole">albendazole</a> tablets to the WHO each year to fight <a href="/wiki/Soil-transmitted_helminthiasis" title="Soil-transmitted helminthiasis">soil-transmitted helminthiasis</a> and to provide 600 million albendazole tablets every year for lymphatic filariasis until the disease is eradicated.<sup class="reference" id="cite_ref-bill_88-0"><a href="#cite_note-bill-88">[87]</a></sup> As of 2014 over 5 billion treatments had been delivered, and 18 of 73 countries in which the disease is considered endemic had progressed to the surveillance stage.<sup class="reference" id="cite_ref-89"><a href="#cite_note-89">[88]</a></sup>
</p><p>In 2009 the company said it would cut drug prices by 25 percent in 50 of the poorest nations, release intellectual property rights for substances and processes relevant to neglected disease into a <a href="/wiki/Patent_pool" title="Patent pool">patent pool</a> to encourage new drug development, and invest 20 percent of profits from the least-developed countries in medical infrastructure for those countries.<sup class="reference" id="cite_ref-90"><a href="#cite_note-90">[89]</a></sup><sup class="reference" id="cite_ref-91"><a href="#cite_note-91">[90]</a></sup> <a href="/wiki/M%C3%A9decins_Sans_Fronti%C3%A8res" title="Médecins Sans Frontières">Médecins Sans Frontières</a> welcomed the decision, but criticized GSK for failing to include HIV patents in its patent pool and for not including middle-income countries in the initiative.<sup class="reference" id="cite_ref-92"><a href="#cite_note-92">[91]</a></sup>
</p><p>In 2013 GSK licensed its HIV portfolio to the Medicines Patent Pool for use in children, and agreed to negotiate a license for <a href="/wiki/Dolutegravir" title="Dolutegravir">dolutegravir</a>, an <a href="/wiki/Integrase_inhibitor" title="Integrase inhibitor">integrase inhibitor</a> then in clinical development.<sup class="reference" id="cite_ref-93"><a href="#cite_note-93">[92]</a></sup> In 2014 this license was extended to include dolutegravir and adults with HIV. The licenses include countries in which 93 percent of adults and 99 percent of children with HIV live.<sup class="reference" id="cite_ref-94"><a href="#cite_note-94">[93]</a></sup> Also in 2013 GSK joined <a href="/wiki/AllTrials" title="AllTrials">AllTrials</a>, a British campaign to ensure that all clinical trials are registered and the results reported. The company said it would make its past clinical-trial reports available and future ones within a year of the studies' end.<sup class="reference" id="cite_ref-95"><a href="#cite_note-95">[94]</a></sup>
</p>
<h2><span class="mw-headline" id="Controversies">Controversies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=16" title="Edit section: Controversies">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="2012_criminal_and_civil_settlement">2012 criminal and civil settlement</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=17" title="Edit section: 2012 criminal and civil settlement">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="Overview">Overview</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=18" title="Edit section: Overview">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>In July 2012 GSK pleaded guilty in the United States to criminal charges, and agreed to pay $3 billion, in what was the <a class="mw-redirect" href="/wiki/List_of_Largest_Pharmaceutical_Settlements" title="List of Largest Pharmaceutical Settlements">largest settlement</a> until then between the Justice Department and a drug company. The $3 billion included a criminal fine of $956,814,400 and forfeiture of $43,185,600. The remaining $2 billion covered a civil settlement with the government under the <a href="/wiki/False_Claims_Act" title="False Claims Act">False Claims Act</a>. The investigation was launched largely on the basis of information from four whistleblowers who filed <a href="/wiki/Qui_tam" title="Qui tam">qui tam</a> (whistleblower) lawsuits against the company under the False Claims Act.<sup class="reference" id="cite_ref-USDOJJuly2012_11-1"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup>
</p><p>The charges stemmed from GSK's promotion of the anti-depressants Paxil (<a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a>) and Wellbutrin (<a href="/wiki/Bupropion" title="Bupropion">bupropion</a>) for unapproved uses from 1998–2003, specifically as suitable for patients under the age of 18, and from its failure to report safety data about Avandia (<a href="/wiki/Rosiglitazone" title="Rosiglitazone">rosiglitazone</a>), both in violation of the <a href="/wiki/Federal_Food,_Drug,_and_Cosmetic_Act" title="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</a>. Other drugs promoted for unapproved uses were two inhalers, Advair (<a class="mw-redirect" href="/wiki/Fluticasone/salmeterol" title="Fluticasone/salmeterol">fluticasone/salmeterol</a>) and Flovent (<a href="/wiki/Fluticasone_propionate" title="Fluticasone propionate">fluticasone propionate</a>), as well as Zofran (<a href="/wiki/Ondansetron" title="Ondansetron">ondansetron</a>), Imitrex (<a href="/wiki/Sumatriptan" title="Sumatriptan">sumatriptan</a>), Lotronex (<a href="/wiki/Alosetron" title="Alosetron">alosetron</a>) and Valtrex (<a href="/wiki/Valaciclovir" title="Valaciclovir">valaciclovir</a>).<sup class="reference" id="cite_ref-USDOJJuly2012_11-2"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup>
</p><p>The settlement also covered reporting false best prices and underpaying rebates owed under the <a href="/wiki/Medicaid_Drug_Rebate_Program" title="Medicaid Drug Rebate Program">Medicaid Drug Rebate Program</a>, and kickbacks to physicians to prescribe GSK's drugs. There were all-expenses-paid spa treatments and hunting trips for doctors and their spouses, speakers' fees at conferences, and payment for articles <a href="/wiki/Medical_ghostwriter" title="Medical ghostwriter">ghostwritten</a> by the company and placed by physicians in medical journals.<sup class="reference" id="cite_ref-USDOJJuly2012_11-3"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup> The company set up a ghostwriting programme called CASPPER, initially to produce articles about Paxil but which was extended to cover Avandia.<sup class="reference" id="cite_ref-96"><a href="#cite_note-96">[95]</a></sup>
</p><p>As part of the settlement GSK signed a five-year <a href="/wiki/Corporate_integrity_agreement" title="Corporate integrity agreement">corporate integrity agreement</a> with the <a class="mw-redirect" href="/wiki/Department_of_Health_and_Human_Services" title="Department of Health and Human Services">Department of Health and Human Services</a>, which obliged the company to make major changes in the way it did business, including changing its compensation programmes for its sales force and executives, and to implement and maintain transparency in its research practices and publication policies.<sup class="reference" id="cite_ref-USDOJJuly2012_11-4"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup> It announced in 2013 that it would no longer pay doctors to promote its drugs or attend medical conferences, and that its sales staff would no longer have prescription targets.<sup class="reference" id="cite_ref-Reuters17Dec2013_97-0"><a href="#cite_note-Reuters17Dec2013-97">[96]</a></sup>
</p>
<h4><span id="Rosiglitazone_.28Avandia.29"></span><span class="mw-headline" id="Rosiglitazone_(Avandia)">Rosiglitazone (Avandia)</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=19" title="Edit section: Rosiglitazone (Avandia)">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="hatnote navigation-not-searchable" role="note">Further information: <a href="/wiki/Rosiglitazone#Adverse_effects" title="Rosiglitazone">Rosiglitazone § Adverse effects</a>, and <a href="/wiki/Rosiglitazone#Lawsuits" title="Rosiglitazone">Rosiglitazone § Lawsuits</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:Avandia_2mg_oral_tablet.jpg"><img alt="" class="thumbimage" data-file-height="600" data-file-width="840" height="157" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Avandia_2mg_oral_tablet.jpg/220px-Avandia_2mg_oral_tablet.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Avandia_2mg_oral_tablet.jpg/330px-Avandia_2mg_oral_tablet.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Avandia_2mg_oral_tablet.jpg/440px-Avandia_2mg_oral_tablet.jpg 2x" width="220"/></a> <div class="thumbcaption"><div class="magnify"><a class="internal" href="/wiki/File:Avandia_2mg_oral_tablet.jpg" title="Enlarge"></a></div><a href="/wiki/Rosiglitazone" title="Rosiglitazone">Rosiglitazone</a></div></div></div>
<p>The 2012 settlement included a criminal fine of $242,612,800 for failing to report safety data to the FDA about Avandia (<a href="/wiki/Rosiglitazone" title="Rosiglitazone">rosiglitazone</a>), a <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">diabetes</a> drug approved in 1999, and a civil settlement of $657 million for making false claims about it. The Justice Department said GSK had promoted rosiglitazone to physicians with misleading information, including that it conferred cardiovascular benefits despite an FDA-mandated label warning of cardiovascular risks.<sup class="reference" id="cite_ref-USDOJJuly2012_11-5"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup>
</p><p>In 1999 <a href="/wiki/John_Buse" title="John Buse">John Buse</a>, a diabetes specialist, told medical conferences that rosiglitazone might carry an increased risk of cardiovascular problems. GSK threatened to sue him, called his university head of department, and persuaded him to sign a retraction.<sup class="reference" id="cite_ref-98"><a href="#cite_note-98">[97]</a></sup> GSK raised questions internally about the drug's safety in 2000, and in 2002 the company <a href="/wiki/Medical_ghostwriter" title="Medical ghostwriter">ghostwrote</a> an article in <a href="/wiki/Circulation_(journal)" title="Circulation (journal)"><i>Circulation</i></a> describing a GSK funded clinical trial that suggested rosiglitazone might have a beneficial effect on cardiovascular risk.<sup class="reference" id="cite_ref-99"><a href="#cite_note-99">[98]</a></sup> From 2001 reports began to link the <a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a> (the class of drugs to which rosiglitazone belongs) to <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>.<sup class="reference" id="cite_ref-pmid20154334_100-0"><a href="#cite_note-pmid20154334-100">[99]</a></sup> In April that year GSK began a six-year, <a href="/wiki/Open-label_trial" title="Open-label trial">open-label</a>, <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized trial</a>, known as RECORD, to examine rosiglitazone and cardiovascular events.<sup class="reference" id="cite_ref-RECORDLancet_101-0"><a href="#cite_note-RECORDLancet-101">[100]</a></sup> Two GSK <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analyses</a> in 2005 and 2006 showed an increased risk of cardiovascular problems with rosiglitazone; the information was passed to the FDA and posted on the company website, but not otherwise published. By December 2006 rosiglitazone had become the top-selling diabetes drug, with annual sales of US$3.3 billion.<sup class="reference" id="cite_ref-pmid20154334_100-1"><a href="#cite_note-pmid20154334-100">[99]</a></sup>
</p><p>In June 2007 the <i>New England Journal of Medicine</i> published a meta-analysis that associated the drug with an increased risk of <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">heart attack</a>.<sup class="reference" id="cite_ref-102"><a href="#cite_note-102">[101]</a></sup> GSK had reportedly tried to persuade one of the authors, <a href="/wiki/Steven_Nissen" title="Steven Nissen">Steven Nissen</a>, not to publish it, after receiving an advance copy from one of the journal's peer reviewers, a GSK consultant.<sup class="reference" id="cite_ref-103"><a href="#cite_note-103">[102]</a></sup> In July 2007 FDA scientists suggested that rosiglitazone had caused 83,000 excess heart attacks between 1999 and 2007.<sup class="reference" id="cite_ref-Senatereport_104-0"><a href="#cite_note-Senatereport-104">[103]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>4</span></sup><sup class="reference" id="cite_ref-Graham_105-0"><a href="#cite_note-Graham-105">[104]</a></sup> The FDA placed restrictions on the drug, including adding a <a href="/wiki/Boxed_warning" title="Boxed warning">boxed warning</a>, but did not withdraw it.<sup class="reference" id="cite_ref-106"><a href="#cite_note-106">[105]</a></sup> (In 2013 the FDA rejected that the drug had caused excess heart attacks.)<sup class="reference" id="cite_ref-FDAheart_107-0"><a href="#cite_note-FDAheart-107">[106]</a></sup> A <a href="/wiki/United_States_Senate_Committee_on_Finance" title="United States Senate Committee on Finance">Senate Finance Committee</a> inquiry concluded in 2010 that GSK had sought to intimidate scientists who had concerns about rosiglitazone.<sup class="reference" id="cite_ref-Senatereport_104-1"><a href="#cite_note-Senatereport-104">[103]</a></sup> In February that year the company tried to halt publication of an editorial about the controversy by Nissen in the <i>European Heart Journal</i>.<sup class="reference" id="cite_ref-108"><a href="#cite_note-108">[107]</a></sup>
</p><p>The results of GSK's RECORD trial were published in June 2009. It confirmed an association between rosiglitazone and an increased risk of heart failure and fractures, but not of heart attack, and concluded that it "does not increase the risk of overall cardiovascular morbidity or mortality compared with standard glucose-lowering drugs."<sup class="reference" id="cite_ref-RECORDLancet_101-1"><a href="#cite_note-RECORDLancet-101">[100]</a></sup> Steven Nissan and Kathy Wolkski argued that the study's low event rates reduced its statistical power.<sup class="reference" id="cite_ref-109"><a href="#cite_note-109">[108]</a></sup> In September 2009 rosiglitazone was suspended in Europe.<sup class="reference" id="cite_ref-110"><a href="#cite_note-110">[109]</a></sup> The results of the RECORD study were confirmed in 2013 by the Duke Clinical Research Institute, in an independent review required by the FDA.<sup class="reference" id="cite_ref-111"><a href="#cite_note-111">[110]</a></sup> In November that year the FDA lifted the restrictions it had placed on the drug.<sup class="reference" id="cite_ref-112"><a href="#cite_note-112">[111]</a></sup> The boxed warning about heart attack was removed; the warning about heart failure remained in place.<sup class="reference" id="cite_ref-FDAheart_107-1"><a href="#cite_note-FDAheart-107">[106]</a></sup>
</p>
<h4><span id="Paroxetine_.28Paxil.2FSeroxat.29"></span><span class="mw-headline" id="Paroxetine_(Paxil/Seroxat)">Paroxetine (Paxil/Seroxat)</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=20" title="Edit section: Paroxetine (Paxil/Seroxat)">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="hatnote navigation-not-searchable" role="note">Main article: <a href="/wiki/Study_329" title="Study 329">Study 329</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:Paroxetine_pill.jpg"><img alt="" class="thumbimage" data-file-height="900" data-file-width="1200" height="165" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e9/Paroxetine_pill.jpg/220px-Paroxetine_pill.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e9/Paroxetine_pill.jpg/330px-Paroxetine_pill.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e9/Paroxetine_pill.jpg/440px-Paroxetine_pill.jpg 2x" width="220"/></a> <div class="thumbcaption"><div class="magnify"><a class="internal" href="/wiki/File:Paroxetine_pill.jpg" title="Enlarge"></a></div><a href="/wiki/Paroxetine" title="Paroxetine">Paroxetine</a>, known as Paxil and Seroxat</div></div></div>
<p>GSK was fined for promoting Paxil/Seroxat (<a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a>) for treating depression in the under-18s, although the drug had not been approved for pediatric use.<sup class="reference" id="cite_ref-USDOJJuly2012_11-6"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup>
Paxil had $4.97 billion worldwide sales in 2003.<sup class="reference" id="cite_ref-CMAJ2004_113-0"><a href="#cite_note-CMAJ2004-113">[112]</a></sup> The company conducted nine clinical trials between 1994 and 2002, none of which showed that Paxil helped children with depression.<sup class="reference" id="cite_ref-114"><a href="#cite_note-114">[113]</a></sup> From 1998 to 2003 it promoted the drug for the under-18s, paying physicians to go on all-expenses paid trips, five-star hotels and spas.<sup class="reference" id="cite_ref-USDOJJuly2012_11-7"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup> From 2004 Paxil's label, along with those of similar drugs, included an FDA-mandated boxed warning that it might increase the risk of suicidal ideation and behaviour in patients under 18.<sup class="reference" id="cite_ref-USDOJJuly2012_11-8"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup>
</p><p>An internal SmithKline Beecham document said in 1998, about withheld data from two GSK studies: "It would be commercially unacceptable to include a statement that [pediatric] efficacy had not been demonstrated, as this would undermine the profile of paroxetine."<sup class="reference" id="cite_ref-CMAJ2004_113-1"><a href="#cite_note-CMAJ2004-113">[112]</a></sup><sup class="reference" id="cite_ref-115"><a href="#cite_note-115">[114]</a></sup> The company <a href="/wiki/Medical_ghostwriter" title="Medical ghostwriter">ghostwrote</a> an article, published in 2001 in the <i>Journal of the American Academy of Child and Adolescent Psychiatry</i>, that misreported the results of one of its clinical trials, <a href="/wiki/Study_329" title="Study 329">Study 329</a>.<sup class="reference" id="cite_ref-USDOJJuly2012_11-9"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup><sup class="reference" id="cite_ref-116"><a href="#cite_note-116">[115]</a></sup> The article concluded that Paxil was "generally well tolerated and effective for major depression in adolescents."<sup class="reference" id="cite_ref-117"><a href="#cite_note-117">[116]</a></sup> The suppression of the research findings is the subject of <i><a href="/wiki/Side_Effects_(Bass_book)" title="Side Effects (Bass book)">Side Effects</a></i> (2008) by <a href="/wiki/Alison_Bass" title="Alison Bass">Alison Bass</a>.<sup class="reference" id="cite_ref-118"><a href="#cite_note-118">[117]</a></sup><sup class="reference" id="cite_ref-119"><a href="#cite_note-119">[118]</a></sup>
</p><p>For 10 years GSK marketed Paxil as non-habit forming. In 2001 35 patients filed a class-action suit alleging they had suffered withdrawal symptoms, and in 2002, a Los Angeles court issued an injunction preventing GSK from advertising that the drug was not habit forming.<sup class="reference" id="cite_ref-120"><a href="#cite_note-120">[119]</a></sup> The court withdrew the injunction after the FDA objected that the court had no jurisdiction over drug marketing that the FDA had approved.<sup class="reference" id="cite_ref-121"><a href="#cite_note-121">[120]</a></sup> In 2003, a World Health Organization committee reported that Paxil was among the top 30 drugs, and top three antidepressants, for which dependence had been reported.<sup class="reference" id="cite_ref-WHOdependence_122-0"><a href="#cite_note-WHOdependence-122">[121]</a></sup><sup class="reference" id="cite_ref-123"><a href="#cite_note-123">[n 2]</a></sup>
</p>
<h4><span id="Bupropion_.28Wellbutrin.29"></span><span class="mw-headline" id="Bupropion_(Wellbutrin)">Bupropion (Wellbutrin)</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=21" title="Edit section: Bupropion (Wellbutrin)">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The company was also fined for promoting Wellbutrin (<a href="/wiki/Bupropion" title="Bupropion">bupropion</a>) – approved at the time for <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depressive disorder</a> and also sold as a smoking-cessation aid, Zyban – for weight loss and the treatment of <a href="/wiki/Attention_deficit_hyperactivity_disorder" title="Attention deficit hyperactivity disorder">attention deficit hyperactivity disorder</a>, sexual dysfunction and substance addiction. GSK paid doctors to promote these off-label uses, and set up supposedly independent advisory boards and <a class="mw-redirect" href="/wiki/Continuing_Medical_Education" title="Continuing Medical Education">Continuing Medical Education</a> programmes.<sup class="reference" id="cite_ref-USDOJJuly2012_11-10"><a href="#cite_note-USDOJJuly2012-11">[10]</a></sup>
</p>
<h3><span class="mw-headline" id="Antitrust_case_over_griseofulvin">Antitrust case over griseofulvin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=22" title="Edit section: Antitrust case over griseofulvin">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In the 1960s Glaxo Group Ltd. (Glaxo) and Imperial Chemical Industries (ICI) each owned patents covering various aspects of the antifungal drug <a href="/wiki/Griseofulvin" title="Griseofulvin">griseofulvin</a>.<sup class="reference" id="cite_ref-GSKICI_124-0"><a href="#cite_note-GSKICI-124">[122]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>54, nn. 1–2</span></sup><sup class="reference" id="cite_ref-LaHatte_125-0"><a href="#cite_note-LaHatte-125">[123]</a></sup> They created a <a href="/wiki/Patent_pool" title="Patent pool">patent pool</a> by <a href="/wiki/Cross-licensing" title="Cross-licensing">cross-licensing</a> their patents, subject to express licensing restrictions that the chemical from which the "finished" form of the drug (tablets and capsules) was made must not be resold in bulk form, and they licensed other drug companies to sell the drug in finished form and subject to similar restrictions.<sup class="reference" id="cite_ref-GSKICI_124-1"><a href="#cite_note-GSKICI-124">[122]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>54–55</span></sup><sup class="reference" id="cite_ref-LaHatte_125-1"><a href="#cite_note-LaHatte-125">[123]</a></sup> The effect and intent of the bulk-sale restriction was to keep the drug chemical out of the hands of small companies that might act as price-cutters, and the effect was to maintain stable, uniform prices.<sup class="reference" id="cite_ref-Leslie_126-0"><a href="#cite_note-Leslie-126">[124]</a></sup><sup class="reference" id="cite_ref-127"><a href="#cite_note-127">[125]</a></sup><sup class="reference" id="cite_ref-Jacobson_128-0"><a href="#cite_note-Jacobson-128">[126]</a></sup>
</p><p>The United States brought an antitrust suit against the two companies—<i><a href="/wiki/United_States_v._Glaxo_Group_Ltd." title="United States v. Glaxo Group Ltd.">United States v. Glaxo Group Ltd.</a></i>—charging them with violation of the Sherman Act and also seeking to have the patents declared invalid.<sup class="reference" id="cite_ref-GSKICI_124-2"><a href="#cite_note-GSKICI-124">[122]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>55</span></sup><sup class="reference" id="cite_ref-LaHatte_125-2"><a href="#cite_note-LaHatte-125">[123]</a></sup> The trial court found that the defendants had engaged in several unlawful conspiracies, but dismissed the part of the suit seeking invalidation of patents and refused to grant as relief mandatory sales of the bulk drug chemical and compulsory licensing of the patents.<sup class="reference" id="cite_ref-GSKICI_124-3"><a href="#cite_note-GSKICI-124">[122]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>56</span></sup><sup class="reference" id="cite_ref-LaHatte_125-3"><a href="#cite_note-LaHatte-125">[123]</a></sup> The government appealed to the Supreme Court, which reversed, in <i><a href="/wiki/United_States_v._Glaxo_Group_Ltd." title="United States v. Glaxo Group Ltd.">United States v. Glaxo Group Ltd.</a></i>, 410 U.S. 52 (1973).<sup class="reference" id="cite_ref-LaHatte_125-4"><a href="#cite_note-LaHatte-125">[123]</a></sup>
</p>
<h3><span class="mw-headline" id="Ribena">Ribena</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=23" title="Edit section: Ribena">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<style data-mw-deduplicate="TemplateStyles:r856303569">@media all and (max-width:720px){.mw-parser-output .tmulti>.thumbinner{width:100%!important;max-width:none!important}.mw-parser-output .tmulti .tsingle{float:none!important;max-width:none!important;width:100%!important;text-align:center}}</style><div class="thumb tmulti tright"><div class="thumbinner" style="width:224px;max-width:224px"><div class="tsingle" style="margin:1px;width:222px;max-width:222px"><div class="thumbimage"><a class="image" href="/wiki/File:Ribena_bottle_(front_label_closeup).jpg"><img alt="photograph" data-file-height="3000" data-file-width="4000" height="165" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/26/Ribena_bottle_%28front_label_closeup%29.jpg/220px-Ribena_bottle_%28front_label_closeup%29.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/26/Ribena_bottle_%28front_label_closeup%29.jpg/330px-Ribena_bottle_%28front_label_closeup%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/26/Ribena_bottle_%28front_label_closeup%29.jpg/440px-Ribena_bottle_%28front_label_closeup%29.jpg 2x" width="220"/></a></div></div><div class="tsingle" style="margin:1px;width:222px;max-width:222px"><div class="thumbimage"><a class="image" href="/wiki/File:Ribena_bottle_(back_label_closeup).jpg"><img alt="photograph" data-file-height="3000" data-file-width="4000" height="165" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Ribena_bottle_%28back_label_closeup%29.jpg/220px-Ribena_bottle_%28back_label_closeup%29.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Ribena_bottle_%28back_label_closeup%29.jpg/330px-Ribena_bottle_%28back_label_closeup%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Ribena_bottle_%28back_label_closeup%29.jpg/440px-Ribena_bottle_%28back_label_closeup%29.jpg 2x" width="220"/></a></div><div class="thumbcaption" style="clear:left">Old Ribena bottle, year unknown, made by Beecham Products, Brentford, Middlesex; the label states: "widely used in hospitals and clinics."</div></div></div></div>
<p>There were concerns in the 2000s about the sugar and vitamin content of <a href="/wiki/Ribena" title="Ribena">Ribena</a>, a <a href="/wiki/Blackcurrant" title="Blackcurrant">blackcurrant</a>-based <a href="/wiki/Syrup" title="Syrup">syrup</a> and <a href="/wiki/Soft_drink" title="Soft drink">soft drink</a> owned by GSK until 2013. Produced in England by H.W. Carter &amp; Co from the 1930s, the company's unbranded syrup was distributed to children as a source of <a href="/wiki/Vitamin_C" title="Vitamin C">vitamin C</a> during World War II, which gave the drink a reputation as good for health. <a href="/wiki/Beecham_Group" title="Beecham Group">Beecham</a> bought H. W. Carter in 1955.<sup class="reference" id="cite_ref-129"><a href="#cite_note-129">[127]</a></sup>
</p><p>In 2001 the British <a href="/wiki/Advertising_Standards_Authority_(United_Kingdom)" title="Advertising Standards Authority (United Kingdom)">Advertising Standards Authority</a> (ASA) required GSK to withdraw its claim that Ribena Toothkind, a lower-sugar variety, did not encourage tooth decay. A company poster showed bottles of Toothkind in place of the bristles on a toothbrush. The ASA's ruling was upheld by the High Court.<sup class="reference" id="cite_ref-130"><a href="#cite_note-130">[128]</a></sup> In 2007 GSK was fined $217,000 in New Zealand over its claim that ready-to-drink Ribena contained high levels of vitamin C, after it was found to contain no detectable vitamin C.<sup class="reference" id="cite_ref-131"><a href="#cite_note-131">[129]</a></sup> In 2013 GSK sold Ribena and another drink, <a href="/wiki/Lucozade" title="Lucozade">Lucozade</a>, to the Japanese multinational <a href="/wiki/Suntory" title="Suntory">Suntory</a> for £1.35 billion.<sup class="reference" id="cite_ref-Monaghan_76-1"><a href="#cite_note-Monaghan-76">[75]</a></sup>
</p>
<h3><span class="mw-headline" id="SB_Pharmco_Puerto_Rico">SB Pharmco Puerto Rico</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=24" title="Edit section: SB Pharmco Puerto Rico">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2010 the US Department of Justice announced that GSK would pay a $150 million criminal fine and forfeiture, and a civil settlement of $600 million under the False Claims Act. The fines stemmed from production of improperly made and adulterated drugs from 2001 to 2005 at GSK's subsidiary, SB Pharmco Puerto Rico Inc., in Cidra, Puerto Rico, which at the time produced $5.5 billion of products each year. The drugs involved were <a class="mw-redirect" href="/wiki/Kytril" title="Kytril">Kytril</a>, an antiemetic; <a class="mw-redirect" href="/wiki/Bactroban" title="Bactroban">Bactroban</a>, used to treat skin infections; Paxil, the anti-depressant; and <a class="mw-redirect" href="/wiki/Avandamet" title="Avandamet">Avandamet</a>, a diabetes drug.<sup class="reference" id="cite_ref-132"><a href="#cite_note-132">[130]</a></sup> GSK closed the factory in 2009.<sup class="reference" id="cite_ref-NYTPuerto_133-0"><a href="#cite_note-NYTPuerto-133">[131]</a></sup>
</p><p>According to the <i>New York Times</i>, the case began in 2002 when GSK sent experts to fix problems cited by the FDA. The lead inspector recommended recalls of defective products, but they were not authorised; she was fired in 2003 and filed a whistleblower lawsuit. In 2005 federal marshals seized $2 billion worth of products, the largest such seizure in history. In the 2010 settlement SB Pharmco plead guilty to criminal charges, and agreed to pay $150 million in a criminal fine and forfeiture, at that time the largest such payment ever by a manufacturer of adulterated drugs, and $600 million in civil penalties to settle the civil lawsuit.<sup class="reference" id="cite_ref-NYTPuerto_133-1"><a href="#cite_note-NYTPuerto-133">[131]</a></sup>
</p>
<h3><span class="mw-headline" id="China">China</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=25" title="Edit section: China">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2013 Chinese authorities announced that, since 2007, GSK had funnelled HK$3.8 billion in kickbacks to GSK managers, doctors, hospitals and others who prescribed their drugs, using over 700 travel agencies and consulting firms.<sup class="reference" id="cite_ref-134"><a href="#cite_note-134">[132]</a></sup> Chinese authorities arrested four GSK executives as part of a four-month investigation into claims that doctors were bribed with cash and sexual favours.<sup class="reference" id="cite_ref-135"><a href="#cite_note-135">[133]</a></sup> In 2014 a Chinese court found the company guilty of bribery and imposed a fine of $490 million. Mark Reilly, the British head of GSK's Chinese operations, received a three-year suspended prison sentence after a one-day trial held in secret.<sup class="reference" id="cite_ref-136"><a href="#cite_note-136">[134]</a></sup> Reilly was reportedly deported from China and dismissed by the company.<sup class="reference" id="cite_ref-137"><a href="#cite_note-137">[135]</a></sup>
</p>
<h3><span class="mw-headline" id="Market_manipulation_in_the_UK">Market manipulation in the UK</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=26" title="Edit section: Market manipulation in the UK">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In February 2016 the company was fined over £37 million in the UK by the <a href="/wiki/Competition_and_Markets_Authority" title="Competition and Markets Authority">Competition and Markets Authority</a> for paying <a class="new" href="/w/index.php?title=Generics_UK&amp;action=edit&amp;redlink=1" title="Generics UK (page does not exist)">Generics UK</a>, <a class="mw-redirect" href="/wiki/Alpharma" title="Alpharma">Alpharma</a> and <a href="/wiki/Norton_Healthcare" title="Norton Healthcare">Norton Healthcare</a> more than £50m between 2001 and 2004 to keep generic varieties of <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> out of the UK market. The generics companies were fined a further £8 million. At the end of 2003, when generics became available in the UK, the price of paroxetine dropped by 70 percent.<sup class="reference" id="cite_ref-138"><a href="#cite_note-138">[136]</a></sup>
</p>
<h3><span class="mw-headline" id="Miscellaneous">Miscellaneous</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=27" title="Edit section: Miscellaneous">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Italian police sought bribery charges in May 2004 against 4,400 doctors and 273 GSK employees. GSK and its predecessor were accused of having spent £152m on physicians, pharmacists and others, giving them cameras, computers, holidays and cash. Doctors were alleged to have received cash based on the number of patients they treated with a cancer drug, <a href="/wiki/Topotecan" title="Topotecan">topotecan</a> (Hycamtin).<sup class="reference" id="cite_ref-139"><a href="#cite_note-139">[137]</a></sup> The following month prosecutors in Munich accused 70–100 doctors of having accepted bribes from SmithKline Beecham between 1997 and 1999. The inquiry was opened over allegations that the company had given over 4,000 hospital doctors money and free trips.<sup class="reference" id="cite_ref-140"><a href="#cite_note-140">[138]</a></sup> All charges were dismissed by the Verona court in January 2009.<sup class="reference" id="cite_ref-141"><a href="#cite_note-141">[139]</a></sup>
</p><p>In 2006 in the United States GSK settled the largest tax dispute in IRS history, agreeing to pay $3.1 billion. At issue were Zantac and other products sold in 1989–2005. The case revolved around intracompany <a href="/wiki/Transfer_pricing" title="Transfer pricing">transfer pricing</a>—determining the share of profit attributable to the US subsidiaries of GSK and subject to tax by the IRS.<sup class="reference" id="cite_ref-142"><a href="#cite_note-142">[140]</a></sup>
</p><p>The UK's <a href="/wiki/Serious_Fraud_Office_(United_Kingdom)" title="Serious Fraud Office (United Kingdom)">Serious Fraud Office</a> (SFO) opened a criminal inquiry in 2014 into GSK's sales practices, using powers granted by the <a href="/wiki/Bribery_Act_2010" title="Bribery Act 2010">Bribery Act 2010</a>.<sup class="reference" id="cite_ref-143"><a href="#cite_note-143">[141]</a></sup> The SFO said it was collaborating with Chinese authorities to investigate bringing charges in the UK related to GSK's activities in China, Europe and the Middle East.<sup class="reference" id="cite_ref-144"><a href="#cite_note-144">[142]</a></sup> Also as of 2014 the US Department of Justice was investigating GSK with reference to the <a href="/wiki/Foreign_Corrupt_Practices_Act" title="Foreign Corrupt Practices Act">Foreign Corrupt Practices Act</a>.<sup class="reference" id="cite_ref-145"><a href="#cite_note-145">[143]</a></sup>
</p>
<h2><span class="mw-headline" id="Acquisition-history_diagram">Acquisition-history diagram</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=28" title="Edit section: Acquisition-history diagram">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list):
</p>
<style data-mw-deduplicate="TemplateStyles:r853264556">.mw-parser-output table.clade{border-spacing:0;margin:0;font-size:100%;line-height:100%;border-collapse:separate;width:auto}.mw-parser-output table.clade table.clade{width:100%}.mw-parser-output table.clade td{border:0;padding:0;vertical-align:middle;text-align:center}.mw-parser-output table.clade td.clade-label{width:0.8em;border:0;padding:0 0.2em;vertical-align:bottom;text-align:center}.mw-parser-output table.clade td.clade-slabel{border:0;padding:0 0.2em;vertical-align:top;text-align:center}.mw-parser-output table.clade td.clade-bar{vertical-align:middle;text-align:left;padding:0 0.5em}.mw-parser-output table.clade td.clade-leaf{border:0;padding:0;text-align:left;vertical-align:middle}.mw-parser-output table.clade td.clade-leafR{border:0;padding:0;text-align:right}</style>
<table class="clade" style="font-size:90%;line-height:110%">
<tbody><tr>
<td class="clade-label" style="border-bottom:0px solid;"><span class="nowrap"><span style="font-size:100%;"><b>GlaxoSmithKline</b></span></span>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;">SmithKline Beecham plc<br/><small>(renamed 1989)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;">SmithKline Beckman<br/><small>(renamed 1982)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;">SmithKline-RIT<br/><small>(renamed 1968)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"><a href="/wiki/Smith,_Kline_%26_French" title="Smith, Kline &amp; French">Smith, Kline &amp; French</a><br/><small>(reorganized 1929 into <br/>Smith Kline and French Laboratories)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>French, Richards and Company<br/><small>(Acq 1891)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>Smith, Kline and Company<br/><small>(Founded 1830)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a href="/wiki/Recherche_et_Industrie_Th%C3%A9rapeutiques" title="Recherche et Industrie Thérapeutiques">Recherche et Industrie Thérapeutiques</a><br/><small>(Acq 1968)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"><a class="mw-redirect" href="/wiki/Beckman_Instruments,_Inc." title="Beckman Instruments, Inc.">Beckman Instruments, Inc.</a><br/><small>(Merged 1982, Sold 1989)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>Specialized Instruments Corp.<br/><small>(Acq 1954)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>Offner Electronics<br/><small>(Acq 1961)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px dashed;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><span style="color:red;"><a href="/wiki/Allergan" title="Allergan">Allergan</a><br/><small>(Acq 1982, Sold 1989)</small></span>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>International Clinical Laboratories<br/><small>(Acq 1989)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a href="/wiki/Reckitt_Benckiser" title="Reckitt Benckiser">Reckitt &amp; Colman</a><br/><small>(Acq 1999)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a class="mw-redirect" href="/wiki/Sanofi-Synthelabo" title="Sanofi-Synthelabo">Sanofi-Synthelabo</a><br/><small>(Acq 2001)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"><a href="/wiki/Beecham_Group" title="Beecham Group">Beecham Group</a> Plc<br/><small>(merged 1989)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>Norcliff Thayer<br/><small>(Acq 1986)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;">Beecham Group Ltd
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a href="/wiki/S._E._Massengill_Company" title="S. E. Massengill Company">S. E. Massengill Company</a><br/><small>(Acq 1971)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;">Beecham Group Ltd<br/><small>(Founded 1848, Renamed 1945)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>C.L. Bencard<br/><small>(Acq 1953)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>County Chemicals<br/><small>(Acq 1929)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;">Glaxo Wellcome<br/><small>(Renamed 1995)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;">Glaxo<br/><small>(Founded as Joseph Nathan &amp; Co 1873, <br/>Merged 1995)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a href="/wiki/Allen_%26_Hanburys" title="Allen &amp; Hanburys">Allen &amp; Hanburys</a><br/><small>(Founded 1715, Acq 1958)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>Meyer Laboratories<br/><small>(Acq 1978)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>Affymax<br/><small>(Acq 1995)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;">Wellcome Foundation<br/><small>(Name changed 1924, <br/>Merged 1995)</small>
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>McDougall &amp; Robertson Inc<br/><small>(Acq 1959)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>Burroughs Wellcome &amp; Company<br/><small>(Founded 1880)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a href="/wiki/Block_Drug" title="Block Drug">Block Drug</a><br/><small>(Acq 2001)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>CNS Inc.<br/><small>(Acq 2006)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a href="/wiki/Stiefel_Laboratories" title="Stiefel Laboratories">Stiefel Laboratories</a><br/><small>(Acq 2009)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>Laboratorios Phoenix<br/><small>(Acq 2010)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a class="new" href="/w/index.php?title=Maxinutrition&amp;action=edit&amp;redlink=1" title="Maxinutrition (page does not exist)">Maxinutrition</a><br/><small>(Acq 2010)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>CellZome<br/><small>(Acq 2011)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a href="/wiki/Human_Genome_Sciences" title="Human Genome Sciences">Human Genome Sciences</a><br/><small>(Acq 2013)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><a href="/wiki/Novartis" title="Novartis">Novartis</a><br/><small>(Vaccine div; Acq 2014)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px dashed;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p><span style="color:red;">GSK Cancer division<br/><small>(Sold 2014 to Novartis)</small></span>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel" style="border-left:1px solid;"> 
</td></tr>
<tr>
<td class="clade-label" style="border-left:1px solid;border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<link href="mw-data:TemplateStyles:r853264556" rel="mw-deduplicated-inline-style"/>
<table class="clade">
<tbody><tr>
<td class="clade-label" style="border-bottom:1px solid;"> 
</td>
<td class="clade-leaf" rowspan="2">
<p>GlycoVaxyn <br/><small>(Acq 2015)</small>
</p>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
</td></tr>
<tr>
<td class="clade-slabel"> 
</td></tr></tbody></table>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=29" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div aria-label="Portals" class="noprint portal plainlist tright" role="navigation" style="margin:0.5em 0 0.5em 1em;border:solid #aaa 1px">
<ul style="display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold">
<li style="display:table-row"><span style="display:table-cell;padding:0.2em;vertical-align:middle;text-align:center"><img alt="" class="noviewer" data-file-height="512" data-file-width="512" height="28" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/28px-Industry5.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/42px-Industry5.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/56px-Industry5.svg.png 2x" width="28"/></span><span style="display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle"><a href="/wiki/Portal:Companies" title="Portal:Companies">Companies portal</a></span></li></ul></div>
<ul><li><a href="/wiki/List_of_toothpaste_brands" title="List of toothpaste brands">List of toothpaste brands</a></li>
<li><a href="/wiki/Galvani_Bioelectronics" title="Galvani Bioelectronics">Galvani Bioelectronics</a></li>
<li><a href="/wiki/Index_of_oral_health_and_dental_articles" title="Index of oral health and dental articles">Index of oral health and dental articles</a></li>
<li><a href="/wiki/Recherche_et_Industrie_Th%C3%A9rapeutiques" title="Recherche et Industrie Thérapeutiques">Recherche et Industrie Thérapeutiques</a> (R.I.T.)</li></ul>
<h2><span class="mw-headline" id="Notes">Notes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=30" title="Edit section: Notes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist" style="list-style-type: decimal;">
<div class="mw-references-wrap"><ol class="references">
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text">Glaxo Wellcome was formed from Glaxo's 1995 acquisition of The Wellcome Foundation and SmithKline Beecham from the 1989 merger of the <a href="/wiki/Beecham_Group" title="Beecham Group">Beecham Group</a> and the <a href="/wiki/Smith,_Kline_%26_French" title="Smith, Kline &amp; French">SmithKline Beckman Corporation</a>.</span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> Expert Committee on Drug Dependence, 2003: "The Committee noted the striking number of reports on paroxetine and 'withdrawal syndrome' ... The representative of Consumers International reported that a number of patients had experienced difficulty in withdrawing from SSRIs in general. It was agreed that withdrawal was indeed a problem in some patients, but there was a difference of opinion on the degree of dependence that was involved, given the possibility that the need for treatment of resistant or relapsing disease could make these drugs indispensable for patient care. The Committee expressed concern about the possibility of inappropriate prescribing resulting in the risk of problems of withdrawal outweighing the benefits of treatment with SSRIs."<sup class="reference" id="cite_ref-WHOdependence_122-1"><a href="#cite_note-WHOdependence-122">[121]</a></sup></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=31" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 26em; -webkit-column-width: 26em; column-width: 26em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-prelims-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-prelims_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-prelims_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-prelims_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf" rel="nofollow">"Preliminary Results 2017"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">9 March</span> 2018</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Preliminary+Results+2017&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fmedia%2F4629%2Ffy-2017-results-announcement.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><style data-mw-deduplicate="TemplateStyles:r861714446">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"\"""\"""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.statista.com/statistics/266299/number-of-employees-at-glaxosmithkline-by-region/" rel="nofollow">"GlaxoSmithKline"</a>. Statista<span class="reference-accessdate">. Retrieved <span class="nowrap">7 April</span> 2017</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GlaxoSmithKline&amp;rft.pub=Statista&amp;rft_id=https%3A%2F%2Fwww.statista.com%2Fstatistics%2F266299%2Fnumber-of-employees-at-glaxosmithkline-by-region%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="https://www.forbes.com/companies/glaxosmithkline/" rel="nofollow">"GlaxoSmithKline on the Forbes Top Multinational Performers List"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 December</span> 2017</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=GlaxoSmithKline+on+the+Forbes+Top+Multinational+Performers+List&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fcompanies%2Fglaxosmithkline%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><a class="external text" href="https://www.forbes.com/global2000/#industry:Pharmaceuticals" rel="nofollow">"The World's Biggest Public Companies"</a>, 2015 ranking, <i>Forbes</i>.</span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation news">Herper, Matthew. <a class="external text" href="https://www.forbes.com/sites/matthewherper/2016/09/20/glaxosmithkline-appoints-big-pharmas-first-woman-chief-executive/#7f8a02ca3276" rel="nofollow">"GlaxoSmithKline Appoints Big Pharma's First Woman Chief Executive"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 December</span> 2017</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=GlaxoSmithKline+Appoints+Big+Pharma%27s+First+Woman+Chief+Executive&amp;rft.aulast=Herper&amp;rft.aufirst=Matthew&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2016%2F09%2F20%2Fglaxosmithkline-appoints-big-pharmas-first-woman-chief-executive%2F%237f8a02ca3276&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.stockchallenge.co.uk/ftse.php" rel="nofollow">"FTSE All-Share Index Ranking"</a>. stockchallenge.co.uk.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FTSE+All-Share+Index+Ranking&amp;rft.pub=stockchallenge.co.uk&amp;rft_id=http%3A%2F%2Fwww.stockchallenge.co.uk%2Fftse.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-AR2013-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-AR2013_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AR2013_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AR2013_8-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Annual-Report-2013.pdf" rel="nofollow">"Annual Report 2013"</a> <span class="cs1-format">(PDF)</span>. GlaxoSmithKline<span class="reference-accessdate">. Retrieved <span class="nowrap">26 May</span> 2014</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Annual+Report+2013&amp;rft.pub=GlaxoSmithKline&amp;rft_id=http%3A%2F%2Fwww.gsk.com%2Fcontent%2Fdam%2Fgsk%2Fglobals%2Fdocuments%2Fpdf%2FAnnual-Report-2013.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-GSKproducts-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-GSKproducts_9-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.gsk.com/products.html" rel="nofollow">"Products"</a>. GlaxoSmithKline plc<span class="reference-accessdate">. Retrieved <span class="nowrap">16 November</span> 2013</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Products&amp;rft.pub=GlaxoSmithKline+plc&amp;rft_id=http%3A%2F%2Fwww.gsk.com%2Fproducts.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-malariavaccine-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-malariavaccine_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-malariavaccine_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Hester Plumridge (24 July 2014). <a class="external text" href="https://www.wsj.com/articles/glaxo-files-its-entry-in-race-for-a-malaria-vaccine-1406218538" rel="nofollow">"Glaxo Files Its Entry in Race for a Malaria Vaccine"</a>. <i>Wall Street Journal</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Glaxo+Files+Its+Entry+in+Race+for+a+Malaria+Vaccine&amp;rft.date=2014-07-24&amp;rft.au=Hester+Plumridge&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fglaxo-files-its-entry-in-race-for-a-malaria-vaccine-1406218538&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><div class="paragraphbreak" style="margin-top:0.5em"></div>
<p><cite class="citation web">Laura Lorenzetti (24 July 2014). <a class="external text" href="http://fortune.com/2014/07/24/glaxosmithkline-seeks-approval-for-first-ever-malaria-vaccine/" rel="nofollow">"GlaxoSmithKline seeks approval on first-ever malaria vaccine"</a>. <i>Fortune</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=GlaxoSmithKline+seeks+approval+on+first-ever+malaria+vaccine&amp;rft.date=2014-07-24&amp;rft.au=Laura+Lorenzetti&amp;rft_id=http%3A%2F%2Ffortune.com%2F2014%2F07%2F24%2Fglaxosmithkline-seeks-approval-for-first-ever-malaria-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/>
</p>
</span></li>
<li id="cite_note-USDOJJuly2012-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-USDOJJuly2012_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-USDOJJuly2012_11-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><a class="external text" href="http://www.justice.gov/opa/pr/2012/July/12-civ-842.html" rel="nofollow">"GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data"</a>, United States Department of Justice, 2 July 2012.<div class="paragraphbreak" style="margin-top:0.5em"></div>
Katie Thomas and Michael S. Schmidt, <a class="external text" href="https://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html" rel="nofollow">"Glaxo Agrees to Pay $3 Billion in Fraud Settlement"</a>, <i>The New York Times</i>, 2 July 2012.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<p>Simon Neville, <a class="external text" href="https://www.theguardian.com/business/2012/jul/03/glaxosmithkline-fined-bribing-doctors-pharmaceuticals" rel="nofollow">"GlaxoSmithKline fined $3bn after bribing doctors to increase drugs sales"</a>, <i>The Guardian</i>, 3 July 2012.
</p>
</span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text">R. P. T. Davenport-Hines, Judy Slinn, <i>Glaxo: A History to 1962</i>, Cambridge University Press, 1992, pp. 7–13.</span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text">David Newton, <i>Trademarked: A History of Well-Known Brands, from Airtex to Wright's Coal Tar</i>, The History Press, 2012, p. 435.</span>
</li>
<li id="cite_note-Ravenscraft2000-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ravenscraft2000_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ravenscraft2000_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ravenscraft2000_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Ravenscraft2000_14-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">David J. Ravenscraft, William F. Long, <a class="external text" href="https://www.nber.org/chapters/c8653.pdf" rel="nofollow">"Paths to Creating Value in Pharmaceutical Mergers,"</a> in Steven N. Kaplan (ed.), <i>Mergers and Productivity</i>, University of Chicago Press, 2000.</span>
</li>
<li id="cite_note-history-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-history_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-history_15-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-history_15-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-history_15-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-history_15-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-history_15-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20110608203248/http://www.gsk.com/about/history-noflash.htm" rel="nofollow">"GSK History"</a>. GlaxoSmithKline. Archived from <a class="external text" href="http://www.gsk.com/about/history-noflash.htm" rel="nofollow">the original</a> on 8 June 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">18 April</span> 2011</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GSK+History&amp;rft.pub=GlaxoSmithKline&amp;rft_id=http%3A%2F%2Fwww.gsk.com%2Fabout%2Fhistory-noflash.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-TriCent-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-TriCent_16-0">^</a></b></span> <span class="reference-text"><a class="external text" href="http://eastchester350.org/350/wp-content/uploads/2014/04/History-of-the-town-1964.pdf" rel="nofollow">1664-1964 "The Story of a Town"</a>, Tricentennial Committee.</span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><a class="external text" href="http://news.hrvh.org/veridian/cgi-bin/senylrc?a=d&amp;d=theeastchester19241119.1.2" rel="nofollow">"Addition to Factory"</a>, <i>The Eastchester Citizen-Bulletin</i>, 19 November 1924</span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text">Peter Pennoyer, Anne Walker, <i>The Architecture of Delano &amp; Aldrich</i>, W. W. Norton &amp; Company, 2003, p. <a class="external text" href="https://books.google.com/books?id=PfsvwzwaQqUC&amp;pg=PA188" rel="nofollow">188</a>.</span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><a class="external text" href="http://recentpast.org/iconic-burroughs-wellcome-headquarters-open-for-rare-public-tour/" rel="nofollow">"Iconic Burroughs Wellcome Headquarters Open for Rare Public Tour"</a>, Triangle Modernist Houses, press release, 8 October 2012.</span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text">Katherine Bouton, <a class="external text" href="https://www.nytimes.com/1989/01/29/magazine/the-nobel-pair.html?pagewanted=all" rel="nofollow">"The Nobel Pair"</a>, <i>The New York Times</i>, 29 January 1989.</span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text">Mark S. Lesney, <a class="external text" href="http://pubs.acs.org/subscribe/journals/mdd/v07/i01/pdf/104timeline.pdf" rel="nofollow">"The ghosts of pharma past"</a>, <i>Modern Drug Discovery</i>, January 2004, pp. 25–26.</span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="https://www.independent.co.uk/news/business/10000-face-glaxos-axe-at-wellcome-1586547.html" rel="nofollow">"10,000 face Glaxo's axe at Wellcome"</a>. <i>The Independent</i>. 15 June 1995.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Independent&amp;rft.atitle=10%2C000+face+Glaxo%27s+axe+at+Wellcome&amp;rft.date=1995-06-15&amp;rft_id=https%3A%2F%2Fwww.independent.co.uk%2Fnews%2Fbusiness%2F10000-face-glaxos-axe-at-wellcome-1586547.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text">
<cite class="citation news">Magnus Grimond (21 June 1995). <a class="external text" href="https://www.independent.co.uk/news/business/glaxo-warns-of-redundancies-1587568.html" rel="nofollow">"Glaxo warns of redundancies"</a>. <i>The Independent</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Independent&amp;rft.atitle=Glaxo+warns+of+redundancies&amp;rft.date=1995-06-21&amp;rft.au=Magnus+Grimond&amp;rft_id=https%3A%2F%2Fwww.independent.co.uk%2Fnews%2Fbusiness%2Fglaxo-warns-of-redundancies-1587568.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><cite class="citation news">Magnus Grimond (7 September 1995). <a class="external text" href="https://www.independent.co.uk/news/business/glaxo-wellcome-plans-to-axe-7500-jobs-1600042.html" rel="nofollow">"Glaxo Wellcome plans to axe 7,500 jobs"</a>. <i>The Independent</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Independent&amp;rft.atitle=Glaxo+Wellcome+plans+to+axe+7%2C500+jobs&amp;rft.date=1995-09-07&amp;rft.au=Magnus+Grimond&amp;rft_id=https%3A%2F%2Fwww.independent.co.uk%2Fnews%2Fbusiness%2Fglaxo-wellcome-plans-to-axe-7500-jobs-1600042.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><a class="external text" href="https://www.nytimes.com/1995/01/27/business/glaxo-to-acquire-affymax.html" rel="nofollow">"Glaxo to Acquire Affymax"</a>, <i>The New York Times</i>, 27 January 1995.</span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="https://www.independent.co.uk/news/business/outlook-glaxo-wellcome-1084036.html" rel="nofollow">"Outlook: Glaxo Wellcome"</a>. <i>The Independent</i>. 30 March 1999.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Independent&amp;rft.atitle=Outlook%3A+Glaxo+Wellcome&amp;rft.date=1999-03-30&amp;rft_id=https%3A%2F%2Fwww.independent.co.uk%2Fnews%2Fbusiness%2Foutlook-glaxo-wellcome-1084036.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-indep1899-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-indep1899_27-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="https://www.independent.co.uk/news/business/company-of-the-week-glaxo-wellcome-1109929.html" rel="nofollow">"Company of the week: Glaxo Wellcome"</a>. <i>The Independent</i>. 1 August 1999.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Independent&amp;rft.atitle=Company+of+the+week%3A+Glaxo+Wellcome&amp;rft.date=1999-08-01&amp;rft_id=https%3A%2F%2Fwww.independent.co.uk%2Fnews%2Fbusiness%2Fcompany-of-the-week-glaxo-wellcome-1109929.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-bbc17100-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-bbc17100_28-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://news.bbc.co.uk/1/hi/business/606752.stm" rel="nofollow">"Profile: Glaxo Wellcome"</a>. BBC News. 17 January 2000.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Profile%3A+Glaxo+Wellcome&amp;rft.date=2000-01-17&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F1%2Fhi%2Fbusiness%2F606752.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><cite class="citation book">Corely, T.A.B. (2011). <i>Beechams, 1848-2000: from Pills to Pharmaceuticals</i>. Crucible Books. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/1905472145" title="Special:BookSources/1905472145">1905472145</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Beechams%2C+1848-2000%3A+from+Pills+to+Pharmaceuticals&amp;rft.pub=Crucible+Books&amp;rft.date=2011&amp;rft.isbn=1905472145&amp;rft.aulast=Corely&amp;rft.aufirst=T.A.B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://www.economist.com/node/275655" rel="nofollow">"The new alchemy – The drug industry's flurry of mergers is based on a big gamble"</a>. <i>The Economist</i>. 20 January 2000.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Economist&amp;rft.atitle=The+new+alchemy+%E2%80%93+The+drug+industry%E2%80%99s+flurry+of+mergers+is+based+on+a+big+gamble&amp;rft.date=2000-01-20&amp;rft_id=http%3A%2F%2Fwww.economist.com%2Fnode%2F275655&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gershon Diane (11 May 2000). <a class="external text" href="http://www.nature.com/nature/journal/v405/n6783/full/405258b0.html" rel="nofollow">"Partners resolve their differences and unite at the second attempt"</a>. <i>Nature</i>. <b>405</b>: 258. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1038%2F35012210" rel="nofollow">10.1038/35012210</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Partners+resolve+their+differences+and+unite+at+the+second+attempt&amp;rft.volume=405&amp;rft.pages=258&amp;rft.date=2000-05-11&amp;rft_id=info%3Adoi%2F10.1038%2F35012210&amp;rft.au=Gershon+Diane&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fnature%2Fjournal%2Fv405%2Fn6783%2Ffull%2F405258b0.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-tele15702-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-tele15702_32-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="https://www.telegraph.co.uk/finance/2767982/Hall-that-glitters-isnt-shareholder-gold.html" rel="nofollow">"Hall that glitters isn't shareholder gold"</a>. <i>The Daily Telegraph</i>. 15 July 2002.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Daily+Telegraph&amp;rft.atitle=Hall+that+glitters+isn%27t+shareholder+gold&amp;rft.date=2002-07-15&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Ffinance%2F2767982%2FHall-that-glitters-isnt-shareholder-gold.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.prnewswire.com/news-releases/glaxosmithkline-completes-the-purchase-of-block-drug-for-124-billion-71032672.html" rel="nofollow">"GlaxoSmithKline Completes the Purchase of Block Drug for $1.24 Billion"</a>. PR Newswire<span class="reference-accessdate">. Retrieved <span class="nowrap">1 August</span> 2010</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GlaxoSmithKline+Completes+the+Purchase+of+Block+Drug+for+%241.24+Billion&amp;rft.pub=PR+Newswire&amp;rft_id=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fglaxosmithkline-completes-the-purchase-of-block-drug-for-124-billion-71032672.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><cite class="citation news">Rick Stouffer (9 October 2006). <a class="external text" href="http://triblive.com/x/pittsburghtrib/business/s_474181.html" rel="nofollow">"Glaxo unit buys Breathe Right maker"</a>. <i>Trib Live</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trib+Live&amp;rft.atitle=Glaxo+unit+buys+Breathe+Right+maker&amp;rft.date=2006-10-09&amp;rft.au=Rick+Stouffer&amp;rft_id=http%3A%2F%2Ftriblive.com%2Fx%2Fpittsburghtrib%2Fbusiness%2Fs_474181.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><a class="external text" href="https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9639020/Sir-Christopher-Gent-to-exit-GlaxoSmithKline.html" rel="nofollow">"Sir Christopher Gent to exit GlaxoSmithKline"</a>, <i>The Daily Telegraph</i>, 28 October 2012.</span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><cite class="citation news">Ben Hirschler (24 May 2007). <a class="external text" href="https://www.reuters.com/article/2007/05/24/idUSL2452000720070524" rel="nofollow">"Glaxo China R&amp;D centre to target neurodegeneration"</a>. Reuters.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Glaxo+China+R%26D+centre+to+target+neurodegeneration&amp;rft.date=2007-05-24&amp;rft.au=Ben+Hirschler&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2007%2F05%2F24%2FidUSL2452000720070524&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><p>
<cite class="citation news">David Cyranoski (29 October 2008). <a class="external text" href="http://www.nature.com/news/2008/081029/full/4551168a.html" rel="nofollow">"Pharmaceutical futures: Made in China?"</a>. <i>Nature</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Pharmaceutical+futures%3A+Made+in+China%3F&amp;rft.date=2008-10-29&amp;rft.au=David+Cyranoski&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fnews%2F2008%2F081029%2Ffull%2F4551168a.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/>
</p></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.gsk.com/about-us/corporate-executive-team.html" rel="nofollow">"Corporate Executive Team"</a>, GlaxoSmithKline. Retrieved 16 November 2013. <a class="external text" href="https://web.archive.org/web/20121014041607/http://www.gsk.com/about-us/corporate-executive-team.html" rel="nofollow">Archived</a> 14 October 2012 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>.</span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><a class="external text" href="https://www.youtube.com/watch?v=FHkj9dJ6aNE" rel="nofollow">"Andrew Witty's journey from Graduate to GSK CEO"</a>, GlaxoSmithKline, 12 August 2008; <a class="external text" href="https://www.bloomberg.com/research/stocks/people/person.asp?personId=3027345&amp;ticker=GSK" rel="nofollow">"Andrew Philip Witty"</a>, <i>Bloomberg</i>.</span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite class="citation news">Graham Ruddick (20 April 2009). <a class="external text" href="https://www.telegraph.co.uk/finance/newsbysector/epic/gsk/5186751/GlaxoSmithKline-buys-Stiefel-for-3.6bn.html" rel="nofollow">"GlaxoSmithKline buys Stiefel for $3.6bn"</a>. <i>The Daily Telegraph</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Daily+Telegraph&amp;rft.atitle=GlaxoSmithKline+buys+Stiefel+for+%243.6bn&amp;rft.date=2009-04-20&amp;rft.au=Graham+Ruddick&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Ffinance%2Fnewsbysector%2Fepic%2Fgsk%2F5186751%2FGlaxoSmithKline-buys-Stiefel-for-3.6bn.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm190783.htm" rel="nofollow">"FDA Approves Additional Vaccine for 2009 H1N1 Influenza Virus"</a>. <a class="mw-redirect" href="/wiki/Food_and_Drug_Administration_(United_States)" title="Food and Drug Administration (United States)">US Food and Drug Administration (FDA)</a>. 16 November 2009.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approves+Additional+Vaccine+for+2009+H1N1+Influenza+Virus&amp;rft.pub=US+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2009-11-16&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm190783.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite class="citation web">Andrew Jack (16 April 2009). <a class="external text" href="http://www.ft.com/cms/s/0/5327ff12-2aaa-11de-8415-00144feabdc0.html" rel="nofollow">"Companies / Pharmaceuticals – GSK and Pfizer to merge HIV portfolios"</a>. <i>Financial Times</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Financial+Times&amp;rft.atitle=Companies+%2F+Pharmaceuticals+%E2%80%93+GSK+and+Pfizer+to+merge+HIV+portfolios&amp;rft.date=2009-04-16&amp;rft.au=Andrew+Jack&amp;rft_id=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F5327ff12-2aaa-11de-8415-00144feabdc0.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><a class="external text" href="https://web.archive.org/web/20100614180626/http://www.infogrok.com/index.php/pharma-companies/gsk-acquires-laboratorios-phoenix.html" rel="nofollow">GSK Acquires Laboratorios Phoenix for $253m</a>, InfoGrok.</span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><cite class="citation news">Paul Sandle (13 December 2010). <a class="external text" href="https://www.reuters.com/article/idUSLDE6BC0XO20101213" rel="nofollow">"UPDATE 2-Glaxo buys protein-drinks firm Maxinutrition"</a>. Reuters.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=UPDATE+2-Glaxo+buys+protein-drinks+firm+Maxinutrition&amp;rft.date=2010-12-13&amp;rft.au=Paul+Sandle&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSLDE6BC0XO20101213&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation news">David Ranii (21 December 2011). <a class="external text" href="https://web.archive.org/web/20120415192244/http://blogs.newsobserver.com/business/gsk-sells-bc-goodys-and-other-brands" rel="nofollow">"GSK sells BC, Goody's and other brands"</a>. <i>News &amp; Observer</i>. Archived from <a class="external text" href="http://blogs.newsobserver.com/business/gsk-sells-bc-goodys-and-other-brands" rel="nofollow">the original</a> on 15 April 2012.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=News+%26+Observer&amp;rft.atitle=GSK+sells+BC%2C+Goody%27s+and+other+brands&amp;rft.date=2011-12-21&amp;rft.au=David+Ranii&amp;rft_id=http%3A%2F%2Fblogs.newsobserver.com%2Fbusiness%2Fgsk-sells-bc-goodys-and-other-brands&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><a class="external text" href="https://www.reuters.com/article/2012/03/22/glaxosmithkline-britain-idUSWLA506520120322" rel="nofollow">"GSK confirms 500 mln stg UK investment plans"</a>, Reuters, 22 March 2012.</span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text">European Biotechnology News 16 May 2012. <a class="external text" href="http://www.european-biotechnology-news.com/news/news/2012-02/gsk-acquires-cellzome-100.html" rel="nofollow">GSK acquires Cellzome 100%: Britain's largest drugmaker GlaxoSmithKline will pay about €75m in cash to acquire Cellzome AG completely</a>; John Carroll for FierceBiotech 15 May 2012 <a class="external text" href="http://www.fiercebiotech.com/story/gsk-snags-proteomics-platform-tech-98m-cellzome-buyout/2012-05-15" rel="nofollow">GSK snags proteomics platform tech in $98M Cellzome buyout</a></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text">John Carroll for FiercePharma. 12 June 2012 <a class="external text" href="http://www.fiercebiotech.com/story/gsk-continues-deal-spree-302m-deal-eczema-drug/2012-06-12" rel="nofollow">GSK continues deal spree with $302M pact for Basilea eczema drug</a>; Basilea Pharmaceutica Press Release.  11 June 2012 <a class="external text" href="http://hugin.info/134390/R/1618919/516985.pdf" rel="nofollow">Basilea enters into global agreement with Stiefel, a GSK company, for Toctino® (alitretinoin)</a></span>
</li>
<li id="cite_note-3Lessons-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-3Lessons_48-0">^</a></b></span> <span class="reference-text">Matthew Herper, <a class="external text" href="https://www.forbes.com/sites/matthewherper/2012/07/16/three-lessons-from-glaxosmithklines-purchase-of-human-genome-sciences/" rel="nofollow">"Three Lessons From GlaxoSmithKline's Purchase Of Human Genome Sciences"</a>, <i>Forbes</i>, 16 July 2012.</span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation news">Hirschler, Ben (10 March 2014). <a class="external text" href="https://www.reuters.com/article/2014/03/10/us-glaxosmithkline-india-idUSBREA2909U20140310" rel="nofollow">"GSK pays $1 billion to lift Indian unit stake to 75 percent"</a>. <i>Reuters</i><span class="reference-accessdate">. Retrieved <span class="nowrap">10 March</span> 2014</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=GSK+pays+%241+billion+to+lift+Indian+unit+stake+to+75+percent&amp;rft.date=2014-03-10&amp;rft.aulast=Hirschler&amp;rft.aufirst=Ben&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2014%2F03%2F10%2Fus-glaxosmithkline-india-idUSBREA2909U20140310&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text">Chad Bray, David Jolly, <a class="external text" href="https://dealbook.nytimes.com/2014/04/22/novartis-announces-major-restructuring/?_php=true&amp;_type=blogs&amp;_r=0" rel="nofollow">"Novartis and Glaxo Agree to Trade $20 Billion in Assets"</a>, <i>The New York Times', 22 April 2014.</i></span>
</li>
<li id="cite_note-wsj4222014-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-wsj4222014_51-0">^</a></b></span> <span class="reference-text">Jonathan D. Rockoff, Jeanne Whalen, Marta Falconi, <a class="external text" href="https://www.wsj.com/news/articles/SB10001424052702303825604579518054271953092" rel="nofollow">"Deal Flurry Shows Drug Makers' Swing Toward Specialization"</a>, <i>The Wall Street Journal</i>, 22 April 2014.</span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.genengnews.com/gen-news-highlights/gsk-acquires-glycovaxyn-for-190m/81250916/" rel="nofollow">"GEN - News Highlights:GSK Acquires GlycoVaxyn for $190M"</a>. <i>GEN</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=GEN+-+News+Highlights%3AGSK+Acquires+GlycoVaxyn+for+%24190M&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fgsk-acquires-glycovaxyn-for-190m%2F81250916%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-buys-two-gsk-meningitis-vaccines-for-130m/81251415/" rel="nofollow">"Pfizer Buys Two GSK Meningitis Vaccines for $130M"</a>. <i>GEN</i><span class="reference-accessdate">. Retrieved <span class="nowrap">25 March</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Pfizer+Buys+Two+GSK+Meningitis+Vaccines+for+%24130M&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-buys-two-gsk-meningitis-vaccines-for-130m%2F81251415%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text">James Quinn, <a class="external text" href="https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/11120385/Sir-Philip-Hampton-to-chair-Glaxo.html" rel="nofollow">"Sir Philip Hampton to chair Glaxo"</a>, <i>The Daily Telegraph</i>, 25 September 2014.</span>
</li>
<li id="cite_note-successionAWtoEW-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-successionAWtoEW_55-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Jon Yeomans (20 September 2016). <a class="external text" href="https://www.telegraph.co.uk/business/2016/09/20/glaxosmithkline-names-emma-walmsley-to-replace-sir-andrew-witty/" rel="nofollow">"Emma Walmsley becomes latest female CEO in FTSE 100 as she replaces Sir Andrew Witty at GSK"</a>. <a class="mw-redirect" href="/wiki/Daily_Telegraph" title="Daily Telegraph">Daily Telegraph</a>, London<span class="reference-accessdate">. Retrieved <span class="nowrap">20 September</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Emma+Walmsley+becomes+latest+female+CEO+in+FTSE+100+as+she+replaces+Sir+Andrew+Witty+at+GSK&amp;rft.pub=Daily+Telegraph%2C+London&amp;rft.date=2016-09-20&amp;rft.au=Jon+Yeomans&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Fbusiness%2F2016%2F09%2F20%2Fglaxosmithkline-names-emma-walmsley-to-replace-sir-andrew-witty%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.reuters.com/article/gsk-saudi/glaxosmithkline-boosts-stake-in-saudi-arabia-unit-idUSL8N1OI1Q4" rel="nofollow">"GlaxoSmithKline boosts stake in Saudi Arabia unit"</a>. 18 December 2017  – via Reuters.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GlaxoSmithKline+boosts+stake+in+Saudi+Arabia+unit&amp;rft.date=2017-12-18&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fgsk-saudi%2Fglaxosmithkline-boosts-stake-in-saudi-arabia-unit-idUSL8N1OI1Q4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://uk.reuters.com/article/us-novartis-gsk/gsk-buys-out-novartis-in-13-billion-consumer-healthcare-shake-up-idUKKBN1H30FK" rel="nofollow">"GSK buys out Novartis in $13 billion consumer healthcare shake-up"</a>. Reuters. 27 March 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">27 March</span> 2018</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GSK+buys+out+Novartis+in+%2413+billion+consumer+healthcare+shake-up&amp;rft.pub=Reuters&amp;rft.date=2018-03-27&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-novartis-gsk%2Fgsk-buys-out-novartis-in-13-billion-consumer-healthcare-shake-up-idUKKBN1H30FK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-:0-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="https://in.reuters.com/article/gsk-divestiture/glaxosmithkline-considers-splitting-up-the-group-ft-idINKBN1KB07N" rel="nofollow">"GlaxoSmithKline considers splitting up the group - FT"</a>. Reuters. 21 July 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">23 July</span> 2018</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=GlaxoSmithKline+considers+splitting+up+the+group+-+FT&amp;rft.date=2018-07-21&amp;rft_id=https%3A%2F%2Fin.reuters.com%2Farticle%2Fgsk-divestiture%2Fglaxosmithkline-considers-splitting-up-the-group-ft-idINKBN1KB07N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-JPE2003-59"><span class="mw-cite-backlink">^ <a href="#cite_ref-JPE2003_59-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-JPE2003_59-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Reaume, Andrew (1 January 2003). "Is Corporate Venture Capital a Prescription for Success in the Pharmaceutical Industry?". <i>The Journal of Private Equity</i>. <b>6</b> (4): 77–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.3905%2Fjpe.2003.320058" rel="nofollow">10.3905/jpe.2003.320058</a>. <a href="/wiki/JSTOR" title="JSTOR">JSTOR</a> <a class="external text" href="//www.jstor.org/stable/43503355" rel="nofollow">43503355</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Private+Equity&amp;rft.atitle=Is+Corporate+Venture+Capital+a+Prescription+for+Success+in+the+Pharmaceutical+Industry%3F&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=77-87&amp;rft.date=2003-01-01&amp;rft_id=info%3Adoi%2F10.3905%2Fjpe.2003.320058&amp;rft_id=%2F%2Fwww.jstor.org%2Fstable%2F43503355&amp;rft.aulast=Reaume&amp;rft.aufirst=Andrew&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.drugs.com/news/most-recognized-brands-anti-infectives-december-2013-49719.html" rel="nofollow">"Most-recognized brands: Anti-infectives, December 2013"</a>. Drugs.com.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Most-recognized+brands%3A+Anti-infectives%2C+December+2013&amp;rft.pub=Drugs.com&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fnews%2Fmost-recognized-brands-anti-infectives-december-2013-49719.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><cite class="citation journal">Geddes AM,  et al. (Dec 2007). "Introduction: historical perspective and development of amoxicillin/clavulanate". <i>Int J Antimicrob Agents</i>. <b>30</b> (Suppl 2): S109–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1016%2Fj.ijantimicag.2007.07.015" rel="nofollow">10.1016/j.ijantimicag.2007.07.015</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17900874" rel="nofollow">17900874</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int+J+Antimicrob+Agents&amp;rft.atitle=Introduction%3A+historical+perspective+and+development+of+amoxicillin%2Fclavulanate&amp;rft.volume=30&amp;rft.issue=Suppl+2&amp;rft.pages=S109-12&amp;rft.date=2007-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ijantimicag.2007.07.015&amp;rft_id=info%3Apmid%2F17900874&amp;rft.aulast=Geddes&amp;rft.aufirst=AM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><cite class="citation journal">Brown AG (Aug 1986). "Clavulanic acid, a novel beta-lactamase inhibitor--a case study in drug discovery and development". <i>Drug Des Deliv</i>. <b>1</b> (1): 1–21. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3334541" rel="nofollow">3334541</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Des+Deliv&amp;rft.atitle=Clavulanic+acid%2C+a+novel+beta-lactamase+inhibitor--a+case+study+in+drug+discovery+and+development&amp;rft.volume=1&amp;rft.issue=1&amp;rft.pages=1-21&amp;rft.date=1986-08&amp;rft_id=info%3Apmid%2F3334541&amp;rft.aulast=Brown&amp;rft.aufirst=AG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.accessdata.fda.gov/Scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails" rel="nofollow">"Search"</a>. Food and Drug Administration.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Search&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2FScripts%2Fcder%2Fdrugsatfda%2Findex.cfm%3Ffuseaction%3DSearch.DrugDetails&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><cite class="citation journal">D. M. Richards; R. N. Brogden (February 1985). "Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use". <i>Drugs</i>. <b>29</b> (2): 105–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.2165%2F00003495-198529020-00002" rel="nofollow">10.2165/00003495-198529020-00002</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3884319" rel="nofollow">3884319</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs&amp;rft.atitle=Ceftazidime.+A+review+of+its+antibacterial+activity%2C+pharmacokinetic+properties+and+therapeutic+use&amp;rft.volume=29&amp;rft.issue=2&amp;rft.pages=105-61&amp;rft.date=1985-02&amp;rft_id=info%3Adoi%2F10.2165%2F00003495-198529020-00002&amp;rft_id=info%3Apmid%2F3884319&amp;rft.au=D.+M.+Richards&amp;rft.au=R.+N.+Brogden&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-pubs.acs.org-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-pubs.acs.org_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pubs.acs.org_65-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://pubs.acs.org/cen/coverstory/83/8325/83256-mercaptopurine.html" rel="nofollow">"6-Mercaptopurine"</a>. Chemical &amp; Engineering News.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=6-Mercaptopurine&amp;rft.pub=Chemical+%26+Engineering+News&amp;rft_id=http%3A%2F%2Fpubs.acs.org%2Fcen%2Fcoverstory%2F83%2F8325%2F83256-mercaptopurine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-ScienceHistory-66"><span class="mw-cite-backlink">^ <a href="#cite_ref-ScienceHistory_66-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ScienceHistory_66-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ScienceHistory_66-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-ScienceHistory_66-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.sciencehistory.org/historical-profile/george-hitchings-and-gertrude-elion" rel="nofollow">"George Hitchings and Gertrude Elion"</a>. Science History Institute.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=George+Hitchings+and+Gertrude+Elion&amp;rft.pub=Science+History+Institute&amp;rft_id=https%3A%2F%2Fwww.sciencehistory.org%2Fhistorical-profile%2Fgeorge-hitchings-and-gertrude-elion&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-The_purine_path_to_chemotherapy-67"><span class="mw-cite-backlink">^ <a href="#cite_ref-The_purine_path_to_chemotherapy_67-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-The_purine_path_to_chemotherapy_67-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Elion GB (1989). "The purine path to chemotherapy". <i>Science</i>. <b>244</b> (4900): 41–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1126%2Fscience.2649979" rel="nofollow">10.1126/science.2649979</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2649979" rel="nofollow">2649979</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=The+purine+path+to+chemotherapy&amp;rft.volume=244&amp;rft.issue=4900&amp;rft.pages=41-7&amp;rft.date=1989&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.2649979&amp;rft_id=info%3Apmid%2F2649979&amp;rft.aulast=Elion&amp;rft.aufirst=GB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-nytimes.com-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-nytimes.com_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nytimes.com_68-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Lawrence K. Altman (23 February 1999). <a class="external text" href="https://www.nytimes.com/1999/02/23/us/gertrude-elion-drug-developer-dies-at-81.html" rel="nofollow">"Gertrude Elion, Drug Developer, Dies at 81"</a>. <i>The New York Times</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Gertrude+Elion%2C+Drug+Developer%2C+Dies+at+81&amp;rft.date=1999-02-23&amp;rft.au=Lawrence+K.+Altman&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1999%2F02%2F23%2Fus%2Fgertrude-elion-drug-developer-dies-at-81.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf" rel="nofollow">"WHO Model List of Essential Medicines. 18th list"</a> <span class="cs1-format">(PDF)</span>. World Health Organization. October 2013.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=WHO+Model+List+of+Essential+Medicines.+18th+list&amp;rft.pub=World+Health+Organization&amp;rft.date=2013-10&amp;rft_id=http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2F10665%2F93142%2F1%2FEML_18_eng.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.wsj.com/articles/glaxo-files-its-entry-in-race-for-a-malaria-vaccine-1406218538" rel="nofollow">"Glaxo Files Its Entry in Race for a Malaria Vaccine"</a>. <i>Wall Street Journal</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Glaxo+Files+Its+Entry+in+Race+for+a+Malaria+Vaccine&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fglaxo-files-its-entry-in-race-for-a-malaria-vaccine-1406218538&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.path.org/news/press-room/651/" rel="nofollow">"Press release: Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children"</a>. PATH.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Press+release%3A+Malaria+vaccine+candidate+reduces+disease+over+18+months+of+follow-up+in+late-stage+study+of+more+than+15%2C000+infants+and+young+children&amp;rft.pub=PATH&amp;rft_id=http%3A%2F%2Fwww.path.org%2Fnews%2Fpress-room%2F651%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><cite class="citation journal">Birkett, A. J.;  et al. (April 2013). "Malaria vaccine R&amp;D in the Decade of Vaccines: breakthroughs, challenges and opportunities". <i>Vaccine</i>. <b>31</b> (Supplement 2): B233–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1016%2Fj.vaccine.2013.02.040" rel="nofollow">10.1016/j.vaccine.2013.02.040</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23598488" rel="nofollow">23598488</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Malaria+vaccine+R%26D+in+the+Decade+of+Vaccines%3A+breakthroughs%2C+challenges+and+opportunities&amp;rft.volume=31&amp;rft.issue=Supplement+2&amp;rft.pages=B233-43&amp;rft.date=2013-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2013.02.040&amp;rft_id=info%3Apmid%2F23598488&amp;rft.aulast=Birkett&amp;rft.aufirst=A.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20140407081405/http://www.gsk.com/media/press-releases/2013/malaria-vaccine-candidate-reduces-disease-over-18-months-of-foll.html" rel="nofollow">"Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children"</a>. GlaxoSmithKline. Archived from <a class="external text" href="http://www.gsk.com/media/press-releases/2013/malaria-vaccine-candidate-reduces-disease-over-18-months-of-foll.html" rel="nofollow">the original</a> on 7 April 2014.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Malaria+vaccine+candidate+reduces+disease+over+18+months+of+follow-up+in+late-stage+study+of+more+than+15%2C000+infants+and+young+children&amp;rft.pub=GlaxoSmithKline&amp;rft_id=http%3A%2F%2Fwww.gsk.com%2Fmedia%2Fpress-releases%2F2013%2Fmalaria-vaccine-candidate-reduces-disease-over-18-months-of-foll.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><cite class="citation news">Donald G. McNeil Jr (18 October 2011). <a class="external text" href="https://www.nytimes.com/2011/10/19/health/19malaria.html" rel="nofollow">"Glaxo's RTS,S Malaria Vaccine Shows Promise, Scientists Say"</a>. <i>The New York Times</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Glaxo%27s+RTS%2CS+Malaria+Vaccine+Shows+Promise%2C+Scientists+Say&amp;rft.date=2011-10-18&amp;rft.au=Donald+G.+McNeil+Jr&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2011%2F10%2F19%2Fhealth%2F19malaria.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.gsk.com/en-gb/research/what-we-are-working-on/product-pipeline/" rel="nofollow">"Product pipeline | GSK"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Product+pipeline+%26%23124%3B+GSK&amp;rft_id=http%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fresearch%2Fwhat-we-are-working-on%2Fproduct-pipeline%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Monaghan-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-Monaghan_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Monaghan_76-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Angela Monaghan <a class="external text" href="https://www.theguardian.com/business/2013/sep/09/ribena-lucozade-sold-japan-glaxosmithkline" rel="nofollow">"Ribena and Lucozade sold to Japanese drinks giant"</a>, <i>The Guardian</i>, 9 September 2013</span>
</li>
<li id="cite_note-Maj07-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-Maj07_77-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Majumdar, Ramanuj (2007). <a class="external text" href="https://books.google.com/books?id=vI9vE7_LJX4C&amp;pg=PT242&amp;" rel="nofollow"><i>Product management in India</i></a> (3rd ed.). PHI Learning. p. 242. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-81-203-3383-3" title="Special:BookSources/978-81-203-3383-3">978-81-203-3383-3</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Product+management+in+India&amp;rft.pages=242&amp;rft.edition=3rd&amp;rft.pub=PHI+Learning&amp;rft.date=2007&amp;rft.isbn=978-81-203-3383-3&amp;rft.aulast=Majumdar&amp;rft.aufirst=Ramanuj&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DvI9vE7_LJX4C%26pg%3DPT242%26&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text">Aaron Smith, <a class="external text" href="http://money.cnn.com/2014/03/27/news/companies/glaxosmithkline-alli-recall" rel="nofollow">"Alli weight-loss drug recalled for tampering"</a>, CNN, 27 March 2014.</span>
</li>
<li id="cite_note-achievements-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-achievements_79-0">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.gsk.com/about-us/what-we-do.html" rel="nofollow">"About us: what we do"</a>, GlaxoSmithKline, accessed 16 November 2013 <a class="external text" href="https://web.archive.org/web/20131013192519/http://www.gsk.com/about-us/what-we-do.html" rel="nofollow">Archived</a> 13 October 2013 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>.</span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.nobelprize.org/nobel_prizes/medicine/laureates/1936/dale-bio.html" rel="nofollow">"Sir Henry Dale - Biographical"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Sir+Henry+Dale+-+Biographical&amp;rft_id=https%3A%2F%2Fwww.nobelprize.org%2Fnobel_prizes%2Fmedicine%2Flaureates%2F1936%2Fdale-bio.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.nobelprize.org/nobel_prizes/medicine/laureates/1982/vane-bio.html" rel="nofollow">"John R. Vane - Biographical"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=John+R.+Vane+-+Biographical&amp;rft_id=https%3A%2F%2Fwww.nobelprize.org%2Fnobel_prizes%2Fmedicine%2Flaureates%2F1982%2Fvane-bio.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite class="citation journal">Maltzman JS, Koretzky GA (April 2003). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC152947" rel="nofollow">"Azathioprine: old drug, new actions"</a>. <i>J. Clin. Invest</i>. <b>111</b>: 1122–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1172%2FJCI18384" rel="nofollow">10.1172/JCI18384</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC152947" rel="nofollow">152947</a></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12697731" rel="nofollow">12697731</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.atitle=Azathioprine%3A+old+drug%2C+new+actions&amp;rft.volume=111&amp;rft.pages=1122-4&amp;rft.date=2003-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC152947&amp;rft_id=info%3Apmid%2F12697731&amp;rft_id=info%3Adoi%2F10.1172%2FJCI18384&amp;rft.aulast=Maltzman&amp;rft.aufirst=JS&amp;rft.au=Koretzky%2C+GA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC152947&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><cite class="citation journal">Elion GB (1993). "Acyclovir: discovery, mechanism of action, and selectivity". <i>J. Med. Virol</i>. Suppl 1: 2–6. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8245887" rel="nofollow">8245887</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Med.+Virol.&amp;rft.atitle=Acyclovir%3A+discovery%2C+mechanism+of+action%2C+and+selectivity&amp;rft.volume=Suppl+1&amp;rft.pages=2-6&amp;rft.date=1993&amp;rft_id=info%3Apmid%2F8245887&amp;rft.aulast=Elion&amp;rft.aufirst=GB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><cite class="citation journal">Koenig R (2006). "The legacy of great science: the work of Nobel Laureate Gertrude Elion lives on". <i>Oncologist</i>. <b>11</b> (9): 961–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1634%2Ftheoncologist.11-9-961" rel="nofollow">10.1634/theoncologist.11-9-961</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17030634" rel="nofollow">17030634</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncologist&amp;rft.atitle=The+legacy+of+great+science%3A+the+work+of+Nobel+Laureate+Gertrude+Elion+lives+on&amp;rft.volume=11&amp;rft.issue=9&amp;rft.pages=961-5&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1634%2Ftheoncologist.11-9-961&amp;rft_id=info%3Apmid%2F17030634&amp;rft.aulast=Koenig&amp;rft.aufirst=R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-www.accesstomedicineindex.org-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-www.accesstomedicineindex.org_85-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20140207165041/http://www.accesstomedicineindex.org/sites/www.accesstomedicineindex.org/files/longitudinal_analysis_2010-2012_access_to_medicine_index.pdf" rel="nofollow">"Access to medicine"</a> <span class="cs1-format">(PDF)</span>. Archived from <a class="external text" href="http://www.accesstomedicineindex.org/sites/www.accesstomedicineindex.org/files/longitudinal_analysis_2010-2012_access_to_medicine_index.pdf" rel="nofollow">the original</a> <span class="cs1-format">(PDF)</span> on 7 February 2014.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Access+to+medicine&amp;rft_id=http%3A%2F%2Fwww.accesstomedicineindex.org%2Fsites%2Fwww.accesstomedicineindex.org%2Ffiles%2Flongitudinal_analysis_2010-2012_access_to_medicine_index.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text">Human Rights Campaign. <a class="external text" href="http://www.hrc.org/apps/buyersguide/profile.php?orgid=1563#.UUMVCzdF8zI" rel="nofollow">Profle: Buyers Guide entry for GlaxoSmithKline</a>. Accessed 16 May 2014</span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20081227072400/http://www.ifpma.org/index.php?id=588" rel="nofollow">"Global alliance to eliminate Lymphatic Filariasis"</a>. Ifpma.org. Archived from <a class="external text" href="http://www.ifpma.org/index.php?id=588" rel="nofollow">the original</a> on 27 December 2008.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Global+alliance+to+eliminate+Lymphatic+Filariasis&amp;rft.pub=Ifpma.org&amp;rft_id=http%3A%2F%2Fwww.ifpma.org%2Findex.php%3Fid%3D588&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-bill-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-bill_88-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.gatesfoundation.org/media-center/press-releases/2012/01/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020" rel="nofollow">"Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020"</a>. Bill &amp; Melinda Gates Foundation. 30 January 2012.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Private+and+Public+Partners+Unite+to+Combat+10+Neglected+Tropical+Diseases+by+2020&amp;rft.pub=Bill+%26+Melinda+Gates+Foundation&amp;rft.date=2012-01-30&amp;rft_id=http%3A%2F%2Fwww.gatesfoundation.org%2Fmedia-center%2Fpress-releases%2F2012%2F01%2Fprivate-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><div class="paragraphbreak" style="margin-top:0.5em"></div>
<p><cite class="citation web"><a class="external text" href="http://www.thepharmaletter.com/file/110665/research-based-pharma-pledges-on-neglected-tropical-diseases.html" rel="nofollow">"Research-based pharma pledges on neglected tropical diseases"</a>. <i>The Pharma Letter</i>. 31 January 2012.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Pharma+Letter&amp;rft.atitle=Research-based+pharma+pledges+on+neglected+tropical+diseases&amp;rft.date=2012-01-31&amp;rft_id=http%3A%2F%2Fwww.thepharmaletter.com%2Ffile%2F110665%2Fresearch-based-pharma-pledges-on-neglected-tropical-diseases.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/>
</p>
</span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.who.int/wer/2015/wer9038.pdf" rel="nofollow">"Global programme to eliminate lymphatic filariasis: progress report, 2014"</a> <span class="cs1-format">(PDF)</span>. World Health Organization. 18 September 2015. p. 490.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Global+programme+to+eliminate+lymphatic+filariasis%3A+progress+report%2C+2014&amp;rft.pages=490&amp;rft.pub=World+Health+Organization&amp;rft.date=2015-09-18&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fwer%2F2015%2Fwer9038.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text">Sarah Boseley, <a class="external text" href="https://www.theguardian.com/business/2009/feb/13/glaxo-smith-kline-cheap-medicine" rel="nofollow">"Drug giant GlaxoSmithKline pledges cheap medicine for world's poor"</a>, <i>The Guardian</i>, 13 February 2009.</span>
</li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text">UNITAID 16 February 2009. <a class="external text" href="http://www.unitaid.eu/en/resources/press-centre/news/158-unitaid-statement-on-gsk-patent-pool-for-neglected-diseases" rel="nofollow">UNITAID Statement on GSK Patent Pool For Neglected Diseases</a></span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text">Tido von Schoen-Angerer, <a class="external text" href="http://www.msfaccess.org/content/guardian-letter-response-gsks-patent-pool-proposal" rel="nofollow">Letter to the editor</a>, <i>The Guardian</i>, 16 February 2009.]</span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.reuters.com/article/2013/02/27/us-aids-drugs-patents-idUSBRE91Q0P520130227" rel="nofollow">"GlaxoSmithKline unit joins patent pool for AIDS drugs | Reuters"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GlaxoSmithKline+unit+joins+patent+pool+for+AIDS+drugs+%26%23124%3B+Reuters&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2013%2F02%2F27%2Fus-aids-drugs-patents-idUSBRE91Q0P520130227&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.medicinespatentpool.org/medicines-patent-pool-viiv-healthcare-sign-licence-for-the-most-recent-hiv-medicine-to-have-received-regulatory-approval/" rel="nofollow">"Medicines Patent Pool, ViiV Healthcare Sign Licence for the Most Recent HIV Medicine to Have Received Regulatory Approval | Medicines Patent Pool"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Medicines+Patent+Pool%2C+ViiV+Healthcare+Sign+Licence+for+the+Most+Recent+HIV+Medicine+to+Have+Received+Regulatory+Approval+%26%23124%3B+Medicines+Patent+Pool&amp;rft_id=http%3A%2F%2Fwww.medicinespatentpool.org%2Fmedicines-patent-pool-viiv-healthcare-sign-licence-for-the-most-recent-hiv-medicine-to-have-received-regulatory-approval%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><a href="/wiki/Ben_Goldacre" title="Ben Goldacre">Ben Goldacre</a>, <i><a href="/wiki/Bad_Pharma" title="Bad Pharma">Bad Pharma</a></i>, Fourth Estate, 2013 [2012], p. 387.</span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><a href="/wiki/Max_Baucus" title="Max Baucus">Max Baucus</a>, <a href="/wiki/Chuck_Grassley" title="Chuck Grassley">Chuck Grassley</a>, <a class="external text" href="http://finance.senate.gov/newsroom/chairman/download/?id=a5c07780-6351-4905-8c63-52e4a7a7a66b" rel="nofollow">"Finance Committee Letter to the FDA Regarding Avandia"</a>, United States Senate Finance Committee, 12 July 2010.<p>
Jim Edwards, <a class="external text" href="http://www.cbsnews.com/news/inside-gsks-cassper-ghostwriting-program/" rel="nofollow">"Inside GSK's CASSPER Ghostwriting Program"</a>, CBS News, 21 August 2009.
</p></span></li>
<li id="cite_note-Reuters17Dec2013-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-Reuters17Dec2013_97-0">^</a></b></span> <span class="reference-text"><a class="external text" href="http://sustainability.thomsonreuters.com/2013/12/17/gsk-stop-paying-doctors-major-marketing-overhaul" rel="nofollow">"GSK to stop paying doctors in major marketing overhaul"</a>, Thomson/Reuters, 17 December 2013.</span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.finance.senate.gov/download/?id=883E903D-F973-4A74-8432-3C651C71B4B4" rel="nofollow">"The Intimidation of Dr. John Buse and the Diabetes Drug Avandia"</a>, Committee on Finance, United States Senate, November 2007, pp. 2–4.</span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><a href="/wiki/Max_Baucus" title="Max Baucus">Max Baucus</a>, <a href="/wiki/Chuck_Grassley" title="Chuck Grassley">Chuck Grassley</a>, <a class="external text" href="http://finance.senate.gov/newsroom/chairman/download/?id=a5c07780-6351-4905-8c63-52e4a7a7a66b" rel="nofollow">"Finance Committee Letter to the FDA Regarding Avandia"</a>, United States Senate Finance Committee, 12 July 2010; for internal concerns, p. 2 and attachment E, pp. 20–35; for ghostwriting, p. 3 and attachment H, pp. 58–109; for the ghostwriting, attachment I, p. 110ff; for cover letter to <i>Circulation</i>, attachment I, p. 143; for the ghostwritten article, attachment I, pp. 152–158.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<p><cite class="citation journal">Haffner SM,  et al. (2002). "<span class="cs1-kern-left">"</span>, 2002 "Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus". <i>Circulation</i>. <b>106</b> (6): 679–684. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1161%2F01.CIR.0000025403.20953.23" rel="nofollow">10.1161/01.CIR.0000025403.20953.23</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12163427" rel="nofollow">12163427</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=%22%2C+2002+%22Effect+of+Rosiglitazone+Treatment+on+Nontraditional+Markers+of+Cardiovascular+Disease+in+Patients+With+Type+2+Diabetes+Mellitus&amp;rft.volume=106&amp;rft.issue=6&amp;rft.pages=679-684&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.0000025403.20953.23&amp;rft_id=info%3Apmid%2F12163427&amp;rft.aulast=Haffner&amp;rft.aufirst=SM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/>
</p>
</span></li>
<li id="cite_note-pmid20154334-100"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20154334_100-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20154334_100-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Nissen SE (2010). "The rise and fall of rosiglitazone". <i>European Heart Journal</i>. <b>31</b> (7): 773–776. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1093%2Feurheartj%2Fehq016" rel="nofollow">10.1093/eurheartj/ehq016</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20154334" rel="nofollow">20154334</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Heart+Journal&amp;rft.atitle=The+rise+and+fall+of+rosiglitazone&amp;rft.volume=31&amp;rft.issue=7&amp;rft.pages=773-776&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1093%2Feurheartj%2Fehq016&amp;rft_id=info%3Apmid%2F20154334&amp;rft.aulast=Nissen&amp;rft.aufirst=SE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/> see table 1 for timeline.</span>
</li>
<li id="cite_note-RECORDLancet-101"><span class="mw-cite-backlink">^ <a href="#cite_ref-RECORDLancet_101-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RECORDLancet_101-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Philip D. Home, et al., "Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial," <i>The Lancet</i>, 373(9681), 20 June 2009, pp. 2125–2135 <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.1016%2FS0140-6736%2809%2960953-3" rel="nofollow">10.1016/S0140-6736(09)60953-3</a> <link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19501900" rel="nofollow">19501900</a><div class="paragraphbreak" style="margin-top:0.5em"></div>
Philip D. Home, et al., "Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol," <i>Diabetologia</i>, 48(9), September 2005, pp. 1726–1735. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.1007%2Fs00125-005-1869-1" rel="nofollow">10.1007/s00125-005-1869-1</a> <link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16025252" rel="nofollow">16025252</a><div class="paragraphbreak" style="margin-top:0.5em"></div>
<p><a class="external text" href="https://clinicaltrials.gov/show/NCT00379769" rel="nofollow">"RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes"</a>, clinicaltrials.gov.
</p>
</span></li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><cite class="citation journal">Nissen SE, Wolski K (2007). "Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes". <i>New England Journal of Medicine</i>. <b>356</b> (24): 2457–2471. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1056%2FNEJMoa072761" rel="nofollow">10.1056/NEJMoa072761</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17517853" rel="nofollow">17517853</a>. <q>Rosiglitazone was associated with a significant increase in the risk of myocardial infarction and with an increase in the risk of death from cardiovascular causes that had borderline significance.</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Effect+of+Rosiglitazone+on+the+Risk+of+Myocardial+Infarction+and+Death+from+Cardiovascular+Causes&amp;rft.volume=356&amp;rft.issue=24&amp;rft.pages=2457-2471&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa072761&amp;rft_id=info%3Apmid%2F17517853&amp;rft.aulast=Nissen&amp;rft.aufirst=SE&amp;rft.au=Wolski%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text">Stephanie Saul, <a class="external text" href="https://www.nytimes.com/2008/01/30/business/30cnd-censure.html" rel="nofollow">"Doctor Accused of Leak to Drug Maker"</a>, <i>The New York Times</i>, 30 January 2008.<p>
Gardiner Harris, <a class="external text" href="https://www.nytimes.com/2010/02/23/health/23niss.html" rel="nofollow">"A Face-Off on the Safety of a Drug for Diabetes"</a>, <i>The New York Times</i>, 22 February 2010.
</p></span></li>
<li id="cite_note-Senatereport-104"><span class="mw-cite-backlink">^ <a href="#cite_ref-Senatereport_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Senatereport_104-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a class="external text" href="http://www.finance.senate.gov/newsroom/chairman/download/?id=9e4b091f-de21-4df1-b65e-b227d74bec12" rel="nofollow">"Staff report on GlaxoSmithKline and the diabetes drug Avandia"</a>, Committee on Finance, United States Senate, January 2010.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<a class="external text" href="http://www.finance.senate.gov/newsroom/chairman/release/?id=bc56b552-efc5-4706-968d-f7032d5cd2e4" rel="nofollow">"Grassley, Baucus Release Committee Report on Avandia"</a>, The United States Senate Committee on Finance, 20 February 2010.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<p>Andrew Clark, <a class="external text" href="https://www.theguardian.com/business/2010/feb/22/glaxosmithkline-avandia-concerns-senate" rel="nofollow">"Glaxo's handling of Avandia concerns damned by US Senate committee"</a>, <i>The Guardian</i>, 22 February 2010.
</p>
</span></li>
<li id="cite_note-Graham-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-Graham_105-0">^</a></b></span> <span class="reference-text"><a href="/wiki/David_Graham_(epidemiologist)" title="David Graham (epidemiologist)">David Graham</a>, <a class="external text" href="http://www.fda.gov/ohrms/dockets/ac/07/slides/2007-4308s1-08-fda-graham_files/frame.htm" rel="nofollow">"Assessment of the cardiovascular risks and health benefits of rosiglitazone"</a>, Office of Surveillance and Epidemiology, Food and Drug Administration, 30 July 2007.</span>
</li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109026.htm" rel="nofollow">"FDA Adds Boxed Warning for Heart-related Risks to Anti-Diabetes Drug Avandia. Agency says drug to remain on market, while safety assessment continues"</a>, Food and Drug Administration, 14 November 2007.</span>
</li>
<li id="cite_note-FDAheart-107"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDAheart_107-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDAheart_107-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.fda.gov/Drugs/DrugSafety/ucm376389.htm" rel="nofollow">"FDA Drug Safety Communication: FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines"</a>. Food and Drug Administration. 25 November 2013.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Drug+Safety+Communication%3A+FDA+requires+removal+of+some+prescribing+and+dispensing+restrictions+for+rosiglitazone-containing+diabetes+medicines&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2013-11-25&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDrugSafety%2Fucm376389.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><p>
<a class="external text" href="http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM143413.pdf" rel="nofollow">Avandia. Prescribing information"</a>, Food and Drug Administration.
</p></span></li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><cite class="citation journal">Thomas F. Lüscher; Ulf Landmesser; Frank Ruschitzka (23 April 2010). "Standing firm—the European Heart Journal, scientific controversies and the industry". <i>European Heart Journal</i>. <b>31</b> (10): 1157–1158. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1093%2Feurheartj%2Fehq127" rel="nofollow">10.1093/eurheartj/ehq127</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Heart+Journal&amp;rft.atitle=Standing+firm%E2%80%94the+European+Heart+Journal%2C+scientific+controversies+and+the+industry&amp;rft.volume=31&amp;rft.issue=10&amp;rft.pages=1157-1158&amp;rft.date=2010-04-23&amp;rft_id=info%3Adoi%2F10.1093%2Feurheartj%2Fehq127&amp;rft.au=Thomas+F.+L%C3%BCscher&amp;rft.au=Ulf+Landmesser&amp;rft.au=Frank+Ruschitzka&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><div class="paragraphbreak" style="margin-top:0.5em"></div>
Steven E. Nissen, "The rise and fall of rosiglitazone," <i>European Heart Journal</i>, 31(7), April 2010, pp. 773–776. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.1093%2Feurheartj%2Fehq016" rel="nofollow">10.1093/eurheartj/ehq016</a> <link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20154334" rel="nofollow">20154334</a><div class="paragraphbreak" style="margin-top:0.5em"></div>
Moncef Slaoui, "The rise and fall of rosiglitazone: reply," <i>European Heart Journal</i>, 31(7), April 2010, pp. 1282–1284. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.1093%2Feurheartj%2Fehq118" rel="nofollow">10.1093/eurheartj/ehq118</a> <link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20499440" rel="nofollow">20499440</a><div class="paragraphbreak" style="margin-top:0.5em"></div>
<p>Michel Komajda, et al, "Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial," <i>European Heart Journal</i>, 31(7), April 2010, pp. 824–831. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.1093%2Feurheartj%2Fehp604" rel="nofollow">10.1093/eurheartj/ehp604</a> <link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20118174" rel="nofollow">20118174</a>
</p>
</span></li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text">Steven E. Nissen, Kathy Wolski, "Rosiglitazone RevisitedAn Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality," <i>Archives of Internal Medicine</i>, 170(14), July 2010, pp. 1191–1202: "That study was limited by low event rates, which resulted in insufficient statistical power to confirm or refute evidence of an increased risk for ischemic myocardial events." <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.1001%2Farchinternmed.2010.207" rel="nofollow">10.1001/archinternmed.2010.207</a> <link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20656674" rel="nofollow">20656674</a></span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/09/news_detail_001119.jsp&amp;murl=menus/news_and_events/news_and_events.jsp&amp;mid=WC0b01ac058004d5c1&amp;jsenabled=false" rel="nofollow">"European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim"</a>, European Medicines Agency, 23 September 2010.</span>
</li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text">Kenneth W. McHaffey, et al., "Results of a reevaluation of cardiovascular outcomes in the RECORD trial," <i>American Heart Journal</i>, 166(2), August 2013, pp. 240–249. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.1016%2Fj.ahj.2013.05.004" rel="nofollow">10.1016/j.ahj.2013.05.004</a> <link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23895806" rel="nofollow">23895806</a></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376516.htm" rel="nofollow">"FDA requires removal of certain restrictions on the diabetes drug Avandia"</a>, Food and Drug Administration, 25 November 2013.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<a class="external text" href="http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354859.pdf" rel="nofollow">"Readjudication of the Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycemia in Diabetes Trial (RECORD)"</a>, Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Food and Drug Administration, 5–6 June 2013.<div class="paragraphbreak" style="margin-top:0.5em"></div>
Steven Nissen, <a class="external text" href="https://www.forbes.com/sites/matthewherper/2013/05/23/steven-nissen-the-hidden-agenda-behind-the-fdas-avandia-hearings/" rel="nofollow">"Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings"</a>, <i>Forbes</i>, 23 May 2013.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<p><a class="external text" href="https://www.forbes.com/sites/matthewherper/2013/05/23/the-fda-responds-to-steve-nissens-criticism-of-upcoming-avandia-meeting/" rel="nofollow">"The FDA Responds To Steve Nissen's Criticism Of Upcoming Avandia Meeting"</a>, <i>Forbes</i>, 23 May 2013.
</p>
</span></li>
<li id="cite_note-CMAJ2004-113"><span class="mw-cite-backlink">^ <a href="#cite_ref-CMAJ2004_113-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CMAJ2004_113-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">W. Kondro; B. Sibbald (March 2004). <a class="external text" href="http://www.cmaj.ca/content/170/5/783.long" rel="nofollow">"Drug company experts advised staff to withhold data about SSRI use in children"</a>. <i>Canadian Medical Association Journal</i>. <b>170</b> (5): 783. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1503%2Fcmaj.1040213" rel="nofollow">10.1503/cmaj.1040213</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC343848" rel="nofollow">343848</a></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14993169" rel="nofollow">14993169</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Canadian+Medical+Association+Journal&amp;rft.atitle=Drug+company+experts+advised+staff+to+withhold+data+about+SSRI+use+in+children&amp;rft.volume=170&amp;rft.issue=5&amp;rft.pages=783&amp;rft.date=2004-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC343848&amp;rft_id=info%3Apmid%2F14993169&amp;rft_id=info%3Adoi%2F10.1503%2Fcmaj.1040213&amp;rft.au=W.+Kondro&amp;rft.au=B.+Sibbald&amp;rft_id=http%3A%2F%2Fwww.cmaj.ca%2Fcontent%2F170%2F5%2F783.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text">Goldacre 2013, p. 58.</span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kurt Samson (December 2008). "Senate probe seeks industry payment data on individual academic researchers". <i>Annals of Neurology</i>. <b>64</b> (6): A7–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//doi.org/10.1002%2Fana.21271" rel="nofollow">10.1002/ana.21271</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19107985" rel="nofollow">19107985</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Senate+probe+seeks+industry+payment+data+on+individual+academic+researchers&amp;rft.volume=64&amp;rft.issue=6&amp;rft.pages=A7-9&amp;rft.date=2008-12&amp;rft_id=info%3Adoi%2F10.1002%2Fana.21271&amp;rft_id=info%3Apmid%2F19107985&amp;rft.au=Kurt+Samson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><a class="external text" href="http://dida.library.ucsf.edu/pdf/otu38h10" rel="nofollow">Letter showing authorship of Study 239</a>, Drug Industry Document Archive, University of California, San Francisco.<div class="paragraphbreak" style="margin-top:0.5em"></div>
Isabel Heck, <a class="external text" href="http://www.browndailyherald.com/2014/04/02/controversial-paxil-paper-still-fire-13-years-later/" rel="nofollow">"Controversial Paxil paper still under fire 13 years later"</a>, <i>The Brown Daily Herald</i>, 2 April 2014.<div class="paragraphbreak" style="margin-top:0.5em"></div>
Jon N. Jureidini, Leemon B. McHenry, Peter R. Mansfield, "Clinical trials and drug promotion: Selective reporting of study 329", <i>International Journal of Risk &amp; Safety in Medicine</i>, 20, 2008, pp. 73–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.3233%2FJRS-2008-0426" rel="nofollow">10.3233/JRS-2008-0426</a><div class="paragraphbreak" style="margin-top:0.5em"></div>
<p><a class="external text" href="http://news.bbc.co.uk/2/hi/health/6308871.stm" rel="nofollow">"Company hid suicide link"</a>, BBC News, 29 January 2007; "Secrets of the Drug Trials," BBC Panorama, 29 January 2007; Goldacre 2013, pp. 296–297.
</p>
</span></li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><a href="/wiki/Martin_Keller_(psychiatrist)" title="Martin Keller (psychiatrist)">Martin Keller</a>, et al., <a class="external text" href="http://www.justice.gov/sites/default/files/opa/legacy/2012/07/02/complaint-ex2.pdf" rel="nofollow">"Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial"</a>, <i>Journal of the American Academy of Child and Adolescent Psychiatry</i>, 40(7), July 2001, pp. 762–772. <link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11437014" rel="nofollow">11437014</a> <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="https://doi.org/10.1097%2F00004583-200107000-00010" rel="nofollow">10.1097/00004583-200107000-00010</a></span>
</li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text">Alison Bass (2008). <i>Side Effects: A Prosecutor, a Whistleblower, and a Bestselling Antidepressant on Trial</i>. Algonquin Books of Chapel Hill.</span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><cite class="citation news"><a href="/wiki/Marcia_Angell" title="Marcia Angell">Marcia Angell</a> (15 January 2009). <a class="external text" href="http://www.nybooks.com/articles/archives/2009/jan/15/drug-companies-doctorsa-story-of-corruption/" rel="nofollow">"Drug Companies &amp; Doctors: A Story of Corruption"</a>. <i>The New York Review of Books</i>. <b>56</b> (1).</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Review+of+Books&amp;rft.atitle=Drug+Companies+%26+Doctors%3A+A+Story+of+Corruption&amp;rft.volume=56&amp;rft.issue=1&amp;rft.date=2009-01-15&amp;rft.au=Marcia+Angell&amp;rft_id=http%3A%2F%2Fwww.nybooks.com%2Farticles%2Farchives%2F2009%2Fjan%2F15%2Fdrug-companies-doctorsa-story-of-corruption%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="https://www.usatoday.com/news/health/2002-08-20-paxil-ads_x.htm" rel="nofollow">"Judge: Paxil ads can't say it isn't habit-forming"</a>. Associated Press. 20 August 2002.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Judge%3A+Paxil+ads+can%27t+say+it+isn%27t+habit-forming&amp;rft.date=2002-08-20&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fnews%2Fhealth%2F2002-08-20-paxil-ads_x.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text">Drug and Device Law. 14 December 2006 <a class="external text" href="http://druganddevicelaw.blogspot.com/2006/12/fdas-amicus-briefs-on-preemption.html" rel="nofollow">The FDA's Amicus Briefs on Preemption</a><div class="paragraphbreak" style="margin-top:0.5em"></div>
<p>Ronald D. White for the Los Angeles Times. 21 August 2002 <a class="external text" href="http://articles.latimes.com/2002/aug/21/business/fi-paxil21" rel="nofollow">U.S. Opposes Order to Pull Paxil TV Ads</a>
</p>
</span></li>
<li id="cite_note-WHOdependence-122"><span class="mw-cite-backlink">^ <a href="#cite_ref-WHOdependence_122-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHOdependence_122-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a class="external text" href="https://web.archive.org/web/20150418195400/http://apps.who.int/medicinedocs/collect/medicinedocs/pdf/s4896e/s4896e.pdf" rel="nofollow">"WHO Expert Committee on Drug Dependence"</a>, Thirty-third Report, World Health Organization, 2003, pp. 20, 25.</span>
</li>
<li id="cite_note-GSKICI-124"><span class="mw-cite-backlink">^ <a href="#cite_ref-GSKICI_124-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-GSKICI_124-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-GSKICI_124-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-GSKICI_124-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><a class="external text" href="https://caselaw.findlaw.com/us-supreme-court/410/52.html" rel="nofollow"><i>United States v. Glaxo Group Ltd</i>.</a>, 410 U.S. 52 (1973).</span>
</li>
<li id="cite_note-LaHatte-125"><span class="mw-cite-backlink">^ <a href="#cite_ref-LaHatte_125-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-LaHatte_125-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-LaHatte_125-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-LaHatte_125-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-LaHatte_125-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">LaHatte, Gabrielle (2011). <a class="external text" href="http://scholarlycommons.law.case.edu/cgi/viewcontent.cgi?article=1051&amp;context=jolti" rel="nofollow">"Reverse Payments: When the Federal Trade Commission can Attack the Validity of Underlying Patents"</a>. <i>Case Western Reserve Journal of Law, Technology &amp; the Internet</i>. <b>2</b>: 37–73<span class="reference-accessdate">. Retrieved <span class="nowrap">19 June</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Case+Western+Reserve+Journal+of+Law%2C+Technology+%26+the+Internet&amp;rft.atitle=Reverse+Payments%3A+When+the+Federal+Trade+Commission+can+Attack+the+Validity+of+Underlying+Patents&amp;rft.volume=2&amp;rft.pages=37-73&amp;rft.date=2011&amp;rft.aulast=LaHatte&amp;rft.aufirst=Gabrielle&amp;rft_id=http%3A%2F%2Fscholarlycommons.law.case.edu%2Fcgi%2Fviewcontent.cgi%3Farticle%3D1051%26context%3Djolti&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Leslie-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-Leslie_126-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Leslie, Christopher R. (2011). <i>Antitrust Law and Intellectual Property Rights: Cases and Materials</i>. Oxford University Press. pp. 574–75. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9780195337198" title="Special:BookSources/9780195337198">9780195337198</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Antitrust+Law+and+Intellectual+Property+Rights%3A+Cases+and+Materials&amp;rft.pages=574-75&amp;rft.pub=Oxford+University+Press&amp;rft.date=2011&amp;rft.isbn=9780195337198&amp;rft.aulast=Leslie&amp;rft.aufirst=Christopher+R.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><a class="external text" href="https://caselaw.findlaw.com/us-supreme-court/410/52.html" rel="nofollow"><i>United States v. Glaxo Group Ltd</i>.</a> at 62-63.</span>
</li>
<li id="cite_note-Jacobson-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jacobson_128-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Jacobson, Jonathan M. (2007). <i>Antitrust Law Developments</i>. American Bar Association. p. 1162. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9781590318676" title="Special:BookSources/9781590318676">9781590318676</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Antitrust+Law+Developments&amp;rft.pages=1162&amp;rft.pub=American+Bar+Association&amp;rft.date=2007&amp;rft.isbn=9781590318676&amp;rft.aulast=Jacobson&amp;rft.aufirst=Jonathan+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-129">^</a></b></span> <span class="reference-text">Oliver Thring, <a class="external text" href="https://www.theguardian.com/lifeandstyle/wordofmouth/2010/sep/07/consider-squash-cordial" rel="nofollow">"Consider squash and cordial"</a>, <i>The Guardian</i>, 7 September 2010.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<p><a class="external text" href="http://www.bristolpost.co.uk/Frank-Vernon-thank-Ribena/story-19804329-detail/story.html" rel="nofollow">"We have Frank and Vernon to thank for Ribena"</a>, <i>The Bristol Post</i>, 17 September 2013.
</p>
</span></li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text">Linus Gregoriadis, <a class="external text" href="https://www.telegraph.co.uk/news/uknews/1318417/Makers-of-Ribena-lose-fight-over-anti-decay-claims.html" rel="nofollow">"Makers of Ribena lose fight over anti-decay claims"</a>, <i>The Daily Telegraph</i>, 18 January 2001.</span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><cite class="citation news">David Eames (28 March 2007). <a class="external text" href="http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&amp;objectid=10431253" rel="nofollow">"Judge orders Ribena to fess up"</a>. <i><a href="/wiki/The_New_Zealand_Herald" title="The New Zealand Herald">The New Zealand Herald</a></i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+Zealand+Herald&amp;rft.atitle=Judge+orders+Ribena+to+fess+up&amp;rft.date=2007-03-28&amp;rft.au=David+Eames&amp;rft_id=http%3A%2F%2Fwww.nzherald.co.nz%2Fnz%2Fnews%2Farticle.cfm%3Fc_id%3D1%26objectid%3D10431253&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><div class="paragraphbreak" style="margin-top:0.5em"></div>
Tony Jaques, <a class="external text" href="http://issueoutcomes.publishpath.com/Websites/issueoutcomes/Images/Ribena%20icon%20stumbles%20CCIJ.pdf" rel="nofollow">"When an Icon Stumbles – The Ribena Issue Mismanaged"</a>, <i>Corporate Communications: An International Journal</i>, 13(4), 2008, pp. 394–406.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<p>Michael Regester, Judy Larkin, <i>Risk Issues and Crisis Management in Public Relations</i>, Kogan Page Publishers, 2008, p. <a class="external text" href="https://books.google.com/books?id=MIIx4NVTz6EC&amp;pg=PA67" rel="nofollow">67ff</a>.
</p>
</span></li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.justice.gov/opa/pr/2010/October/10-civ-1205.html" rel="nofollow">"GlaxoSmithKline to Plead Guilty &amp; Pay $750 Million to Resolve Criminal and Civil Liability Regarding Manufacturing Deficiencies at Puerto Rico Plant"</a>, U.S. Department of Justice, 26 October 2010.</span>
</li>
<li id="cite_note-NYTPuerto-133"><span class="mw-cite-backlink">^ <a href="#cite_ref-NYTPuerto_133-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NYTPuerto_133-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="https://www.nytimes.com/2010/10/27/business/27drug.html" rel="nofollow">"Glaxo to Pay $750 Million for Sale of Bad Products"</a>. <i>The New York Times</i>. 27 October 2010.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Glaxo+to+Pay+%24750+Million+for+Sale+of+Bad+Products&amp;rft.date=2010-10-27&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F10%2F27%2Fbusiness%2F27drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-134">^</a></b></span> <span class="reference-text"><cite class="citation web">Alice Yan; Toh Han Shih (16 July 2013). <a class="external text" href="http://www.scmp.com/news/china/article/1283207/glaxosmithkline-suspects-drug-bribery-probe-identified" rel="nofollow">"Shanghai travel agent's revenue surge led to arrests in GSK bribery case"</a>. <i>South China Morning Post</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=South+China+Morning+Post&amp;rft.atitle=Shanghai+travel+agent%27s+revenue+surge+led+to+arrests+in+GSK+bribery+case&amp;rft.date=2013-07-16&amp;rft.au=Alice+Yan&amp;rft.au=Toh+Han+Shih&amp;rft_id=http%3A%2F%2Fwww.scmp.com%2Fnews%2Fchina%2Farticle%2F1283207%2Fglaxosmithkline-suspects-drug-bribery-probe-identified&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/><p>
<cite class="citation news"><a class="external text" href="https://www.bbc.co.uk/news/business-23265958" rel="nofollow">"GlaxoSmithKline executives face China bribery probe"</a>. BBC News. 11 July 2013.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=GlaxoSmithKline+executives+face+China+bribery+probe&amp;rft.date=2013-07-11&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-23265958&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/>
</p></span></li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text">Rupert Neate and Angela Monaghan, <a class="external text" href="https://www.theguardian.com/business/2013/jul/22/glaxosmithkline-admits-bribery-china" rel="nofollow">"GlaxoSmithKline admits some staff in China involved in bribery"</a>, <i>The Guardian</i>, 22 July 2013.<div class="paragraphbreak" style="margin-top:0.5em"></div>
Rupert Neate, <a class="external text" href="https://www.theguardian.com/business/2013/jul/24/gsk-china-crisis-ceo-andrew-witty-live" rel="nofollow">"GSK’s China crisis: chief executive Andrew Witty speaks - as it happened"</a>, <i>The Guardian</i>, 24 July 2013.<div class="paragraphbreak" style="margin-top:0.5em"></div>
<p><cite class="citation news">Tom Philips (26 July 2013). <a class="external text" href="https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10204304/Chinese-police-allege-Glaxo-sales-reps-trained-to-offer-sexual-bribes.html" rel="nofollow">"Chinese police allege Glaxo sales reps trained to offer sexual bribes"</a>. <i>The Daily Telegraph</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Daily+Telegraph&amp;rft.atitle=Chinese+police+allege+Glaxo+sales+reps+trained+to+offer+sexual+bribes&amp;rft.date=2013-07-26&amp;rft.au=Tom+Philips&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Ffinance%2Fnewsbysector%2Fpharmaceuticalsandchemicals%2F10204304%2FChinese-police-allege-Glaxo-sales-reps-trained-to-offer-sexual-bribes.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/>
</p>
</span></li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.nytimes.com/2014/09/20/business/international/gsk-china-fines.html" rel="nofollow">"China Fines GlaxoSmithKline Nearly $500 Million in Bribery Case - The New York Times"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=China+Fines+GlaxoSmithKline+Nearly+%24500+Million+in+Bribery+Case+-+The+New+York+Times&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2014%2F09%2F20%2Fbusiness%2Finternational%2Fgsk-china-fines.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text">Malcolm Moore, Denise Roland, <a class="external text" href="https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/11108376/China-fines-Glaxo-297m-for-bribery-Mark-Reilly-sentenced.html" rel="nofollow">"China fines Glaxo £297m for bribery, Mark Reilly sentenced"</a>, <i>The Daily Telegraph</i>, 19 September 2014.</span>
</li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><cite class="citation news">Julia Bradshaw (12 February 2016). <a class="external text" href="https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/12153450/Watchdog-fines-GSK-37m-for-paying-to-keep-generic-drugs-out-of-UK-market.html" rel="nofollow">"Watchdog fines GSK £37m for paying to keep generic drugs out of UK market"</a>. <i>The Daily Telegraph</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Daily+Telegraph&amp;rft.atitle=Watchdog+fines+GSK+%C2%A337m+for+paying+to+keep+generic+drugs+out+of+UK+market&amp;rft.date=2016-02-12&amp;rft.au=Julia+Bradshaw&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Ffinance%2Fnewsbysector%2Fpharmaceuticalsandchemicals%2F12153450%2FWatchdog-fines-GSK-37m-for-paying-to-keep-generic-drugs-out-of-UK-market.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text">John Hooper, Heather Stewart, <a class="external text" href="https://www.theguardian.com/world/2004/may/27/italy.heatherstewart" rel="nofollow">"Over 4,000 doctors face charges in Italian drugs scandal"</a>, <i>The Guardian</i>, 27 May 2004.</span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text">Jane Burgermeister, <a class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420312/pdf/bmj3281333a.pdf" rel="nofollow">"German prosecutors probe again into bribes by drug companies"</a>, <i>BMJ</i>, 328, 5 June 2004; <a class="external text" href="http://news.bbc.co.uk/2/hi/business/1869162.stm" rel="nofollow">"Glaxo probed over doctor freebies"</a>, BBC News, 12 March 2002.</span>
</li>
<li id="cite_note-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-141">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.gsk.com/media/2684/annual-report-2008.pdf" rel="nofollow">"GlaxoSmithKline Annual Report pg 177"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">8 October</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GlaxoSmithKline+Annual+Report+pg+177&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fmedia%2F2684%2Fannual-report-2008.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><a class="external text" href="https://www.nytimes.com/2006/09/12/business/worldbusiness/12glaxo.html" rel="nofollow">"GlaxoSmithKline to Settle Tax Dispute With U.S."</a>, Reuters, 12 September 2006; <a class="external text" href="https://www.irs.gov/uac/IRS-Accepts-Settlement-Offer-in-Largest-Transfer-Pricing-Dispute" rel="nofollow">"IRS Accepts Settlement Offer in Largest Transfer Pricing Dispute"</a>, IRS, 11 September 2006.</span>
</li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><cite class="citation news">Julia Kollewe (28 May 2014). <a class="external text" href="https://www.theguardian.com/business/2014/may/28/serious-fraud-office-investigates-glaxosmithkline" rel="nofollow">"GlaxoSmithKline faces criminal investigation by Serious Fraud Office"</a>. <i>The Guardian</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=GlaxoSmithKline+faces+criminal+investigation+by+Serious+Fraud+Office&amp;rft.date=2014-05-28&amp;rft.au=Julia+Kollewe&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2014%2Fmay%2F28%2Fserious-fraud-office-investigates-glaxosmithkline&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlaxoSmithKline"></span><link href="mw-data:TemplateStyles:r861714446" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text">Kirsten Ridley, <a class="external text" href="https://www.reuters.com/article/2014/07/23/us-britain-fraud-sfo-gsk-idUSKBN0FS1U320140723" rel="nofollow">"UK fraud office liaising with China on GSK bribery case"</a>, Reuters, 23 July 2014.</span>
</li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text"><a class="external text" href="https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/11027538/Serious-Fraud-Office-opens-criminal-investigation-into-GlaxoSmithKline.html" rel="nofollow">"GlaxoSmithKline faces bribery claims in Syria"</a>, Reuters, 12 August 2014.</span>
</li>
</ol></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=GlaxoSmithKline&amp;action=edit&amp;section=32" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><span class="official-website"><span class="url"><a class="external text" href="http://www.gsk.com/" rel="nofollow">Official website</a></span></span></li>
<li><a class="external text" href="https://opencorporates.com/corporate_groupings/GlaxoSmithKline" rel="nofollow">GlaxoSmithKline companies</a> grouped at <a href="/wiki/OpenCorporates" title="OpenCorporates">OpenCorporates</a></li>
<li><a href="/wiki/Financial_Times" title="Financial Times">Financial Times</a> <a class="external text" href="http://briefings.ft.com/company/news.html?extelID=00044814&amp;query=UK:GSK&amp;region=&amp;industry=" rel="nofollow">Quote, profile, and news</a></li>
<li><a href="/wiki/London_Stock_Exchange" title="London Stock Exchange">London Stock Exchange</a> <a class="external text" href="https://web.archive.org/web/20070617040743/http://www.londonstockexchange.com/en-gb/pricesnews/prices/system/detailedprices.htm?sym=GB0009252882GBGBXSET10925288GSK" rel="nofollow">Quote, regulatory filings, and news</a></li>
<li><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">New York Stock Exchange</a> <a class="external text" href="https://www.nyse.com/about/listed/lcddata.html?ticker=GSK" rel="nofollow">Quote, profile, regulatory filings, and news</a></li></ul>
<div aria-labelledby="GlaxoSmithKline" class="navbox" role="navigation" style="padding:3px"><table class="nowraplinks hlist collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th class="navbox-title" colspan="2" scope="col"><div class="plainlinks hlist navbar mini"><ul><li class="nv-view"><a href="/wiki/Template:GlaxoSmithKline" title="Template:GlaxoSmithKline"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:GlaxoSmithKline" title="Template talk:GlaxoSmithKline"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:GlaxoSmithKline&amp;action=edit"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="Edit this template">e</abbr></a></li></ul></div><div id="GlaxoSmithKline" style="font-size:114%;margin:0 4em"><a class="mw-selflink selflink">GlaxoSmithKline</a></div></th></tr><tr><th class="navbox-group" scope="row" style="width:1%">Subsidiaries</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/GlaxoSmithKline_Pakistan" title="GlaxoSmithKline Pakistan">GlaxoSmithKline Pakistan</a></li>
<li><a href="/wiki/GlaxoSmithKline_Pharmaceuticals_Ltd" title="GlaxoSmithKline Pharmaceuticals Ltd">GlaxoSmithKline Pharmaceuticals Ltd</a></li>
<li><a href="/wiki/Stiefel_Laboratories" title="Stiefel Laboratories">Stiefel Laboratories</a></li>
<li><a href="/wiki/ViiV_Healthcare" title="ViiV Healthcare">ViiV Healthcare</a> (85%)</li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">Predecessors,<br/>acquisitions</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Allen_%26_Hanburys" title="Allen &amp; Hanburys">Allen &amp; Hanburys</a></li>
<li><a href="/wiki/Beecham_Group" title="Beecham Group">Beecham Group</a></li>
<li><a href="/wiki/Block_Drug" title="Block Drug">Block Drug</a></li>
<li><a href="/wiki/GlaxoSmithKline#Glaxo_Wellcome" title="GlaxoSmithKline">Burroughs Wellcome</a></li>
<li><a href="/wiki/GlaxoSmithKline#Glaxo_Wellcome" title="GlaxoSmithKline">Glaxo</a></li>
<li><a href="/wiki/GlaxoSmithKline#Glaxo_Wellcome" title="GlaxoSmithKline">Glaxo Wellcome</a></li>
<li><a href="/wiki/Human_Genome_Sciences" title="Human Genome Sciences">Human Genome Sciences</a></li>
<li><a href="/wiki/Recherche_et_Industrie_Th%C3%A9rapeutiques" title="Recherche et Industrie Thérapeutiques">Recherche et Industrie Thérapeutiques</a></li>
<li><a href="/wiki/Reliant_Pharmaceuticals" title="Reliant Pharmaceuticals">Reliant Pharmaceuticals</a></li>
<li><a href="/wiki/S._E._Massengill_Company" title="S. E. Massengill Company">S. E. Massengill Company</a></li>
<li><a href="/wiki/GlaxoSmithKline#SmithKline_Beecham" title="GlaxoSmithKline">SmithKline Beecham</a></li>
<li><a href="/wiki/Smith,_Kline_%26_French" title="Smith, Kline &amp; French">Smith, Kline &amp; French</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">Products</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th class="navbox-group" scope="row" style="width:1%">Current</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th class="navbox-group" scope="row" style="width:1%">Pharmaceuticals</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a class="mw-redirect" href="/wiki/Fluticasone/salmeterol" title="Fluticasone/salmeterol">Advair</a></li>
<li><a href="/wiki/Orlistat" title="Orlistat">Alli</a></li>
<li><a href="/wiki/Amoxicillin/clavulanic_acid" title="Amoxicillin/clavulanic acid">Augmentin</a></li>
<li><a href="/wiki/Rosiglitazone" title="Rosiglitazone">Avandia</a></li>
<li><a href="/wiki/Beclometasone_dipropionate" title="Beclometasone dipropionate">Beconase</a></li>
<li><a href="/wiki/Ibandronic_acid" title="Ibandronic acid">Boniva</a></li>
<li><a href="/wiki/Fluticasone" title="Fluticasone">Flixonase</a></li>
<li><a href="/wiki/Topotecan" title="Topotecan">Hycamtin</a></li>
<li><a href="/wiki/Lamotrigine" title="Lamotrigine">Lamictal</a></li>
<li><a href="/wiki/Paroxetine" title="Paroxetine">Paxil/Seroxat</a></li>
<li><a href="/wiki/Piboserod" title="Piboserod">Serlipet</a></li>
<li><a href="/wiki/Cimetidine" title="Cimetidine">Tagamet</a></li>
<li><a href="/wiki/Salbutamol" title="Salbutamol">Ventolin</a></li>
<li><a href="/wiki/Bupropion" title="Bupropion">Wellbutrin/Zyban</a></li>
<li><a href="/wiki/Ranitidine" title="Ranitidine">Zantac</a> … <a href="/wiki/List_of_GlaxoSmithKline_products" title="List of GlaxoSmithKline products"><b>more</b></a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">Vaccines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a class="mw-redirect" href="/wiki/Hepatyrix" title="Hepatyrix">Hepatyrix</a></li>
<li><a href="/wiki/Pandemrix" title="Pandemrix">Pandemrix</a></li>
<li><a class="mw-redirect" href="/wiki/Twinrix" title="Twinrix">Twinrix</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a class="mw-redirect" href="/wiki/Aquafresh" title="Aquafresh">Aquafresh</a></li>
<li><a href="/wiki/Horlicks" title="Horlicks">Horlicks</a></li>
<li><a class="mw-redirect" href="/wiki/Nicoderm" title="Nicoderm">Nicoderm</a></li>
<li><a href="/wiki/Nicorette" title="Nicorette">Nicorette</a></li>
<li><a href="/wiki/Niquitin" title="Niquitin">NiQuitin</a></li>
<li><a href="/wiki/Sensodyne" title="Sensodyne">Sensodyne</a></li>
<li><a href="/wiki/Tums" title="Tums">Tums</a> … <a href="/wiki/List_of_GlaxoSmithKline_products" title="List of GlaxoSmithKline products"><b>more</b></a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">Former</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/BC_Powder" title="BC Powder">BC Powder</a></li>
<li><a href="/wiki/Geritol" title="Geritol">Geritol</a></li>
<li><a href="/wiki/Goody%27s_Powder" title="Goody's Powder">Goody's Powder</a></li>
<li><a href="/wiki/Lucozade" title="Lucozade">Lucozade</a></li>
<li><a href="/wiki/Ribena" title="Ribena">Ribena</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">People</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th class="navbox-group" scope="row" style="width:1%">Board of Directors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Philip_Hampton" title="Philip Hampton">Philip Hampton</a></li>
<li><a href="/wiki/Emma_Walmsley" title="Emma Walmsley">Emma Walmsley</a></li>
<li>Simon Dingemans</li>
<li><a href="/wiki/Roy_M._Anderson" title="Roy M. Anderson">Roy M. Anderson</a></li>
<li><a href="/wiki/M._S._Banga" title="M. S. Banga">Manvinder Banga </a></li>
<li><a href="/wiki/Patrick_Vallance" title="Patrick Vallance">Patrick Vallance</a></li>
<li><a href="/wiki/Vivienne_Cox" title="Vivienne Cox">Vivienne Cox</a></li>
<li><a href="/wiki/Lynn_Elsenhans" title="Lynn Elsenhans">Lynn Elsenhans</a></li>
<li>Jesse Goodman</li>
<li><a href="/wiki/Judy_Lewent" title="Judy Lewent">Judy Lewent</a></li>
<li><a href="/wiki/Urs_Rohner" title="Urs Rohner">Urs Rohner</a></li>
<li><a href="/wiki/Laurie_Glimcher" title="Laurie Glimcher">Laurie Glimcher</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Thomas_Beecham_(chemist)" title="Thomas Beecham (chemist)">Thomas Beecham</a></li>
<li><a href="/wiki/Silas_M._Burroughs_(pharmacist)" title="Silas M. Burroughs (pharmacist)">Silas M. Burroughs</a></li>
<li><a href="/wiki/Mahlon_Kline" title="Mahlon Kline">Mahlon Kline</a></li>
<li><a href="/wiki/John_K._Smith" title="John K. Smith">John K. Smith</a></li>
<li><a href="/wiki/Henry_Wellcome" title="Henry Wellcome">Henry Wellcome</a></li>
<li><a href="/wiki/Andrew_Witty" title="Andrew Witty">Andrew Witty</a></li>
<li><a href="/wiki/Chris_Gent" title="Chris Gent">Chris Gent</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">Litigation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><a class="mw-redirect" href="/wiki/Canada_v._GlaxoSmithKline_Inc." title="Canada v. GlaxoSmithKline Inc.">Canada v. GlaxoSmithKline Inc.</a></i></li>
<li><i><a href="/wiki/Christopher_v._SmithKline_Beecham_Corp." title="Christopher v. SmithKline Beecham Corp.">Christopher v. SmithKline Beecham Corp.</a></i></li>
<li><i><a href="/wiki/GlaxoSmithKline_Services_Unlimited_v_Commission" title="GlaxoSmithKline Services Unlimited v Commission">GlaxoSmithKline Services Unlimited v Commission</a></i></li>
<li><i><a href="/wiki/United_States_v._Glaxo_Group_Ltd." title="United States v. Glaxo Group Ltd.">United States v. Glaxo Group Ltd.</a></i></li>
<li><i><a href="/wiki/United_States_v._GlaxoSmithKline" title="United States v. GlaxoSmithKline">United States v. GlaxoSmithKline</a></i></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a class="mw-redirect" href="/wiki/Drug_Industry_Document_Archive" title="Drug Industry Document Archive">Drug Industry Document Archive</a></li>
<li><a href="/wiki/GlaxoSmithKline_Prize" title="GlaxoSmithKline Prize">GlaxoSmithKline Prize</a></li>
<li><i><a href="/wiki/Side_Effects_(Bass_book)" title="Side Effects (Bass book)">Side Effects</a></i></li>
<li><a href="/wiki/Study_329" title="Study 329">Study 329</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><img alt="Category" data-file-height="31" data-file-width="36" height="14" src="//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x" title="Category" width="16"/> <a href="/wiki/Category:GlaxoSmithKline" title="Category:GlaxoSmithKline"><b>Category</b></a></li></ul>
</div></td></tr></tbody></table></div>
<div aria-labelledby="23x15px&amp;#124;border_&amp;#124;alt=United_Kingdom&amp;#124;link=United_Kingdom_Pharmaceutical_and_biotechnology_industry_in_the_United_Kingdom" class="navbox" role="navigation" style="padding:3px"><table class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th class="navbox-title" colspan="2" scope="col"><div class="plainlinks hlist navbar mini"><ul><li class="nv-view"><a href="/wiki/Template:Pharmaceutical_and_biotechnology_industry_in_the_United_Kingdom" title="Template:Pharmaceutical and biotechnology industry in the United Kingdom"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Pharmaceutical_and_biotechnology_industry_in_the_United_Kingdom" title="Template talk:Pharmaceutical and biotechnology industry in the United Kingdom"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Pharmaceutical_and_biotechnology_industry_in_the_United_Kingdom&amp;action=edit"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="Edit this template">e</abbr></a></li></ul></div><div id="23x15px&amp;#124;border_&amp;#124;alt=United_Kingdom&amp;#124;link=United_Kingdom_Pharmaceutical_and_biotechnology_industry_in_the_United_Kingdom" style="font-size:114%;margin:0 4em"><span class="flagicon"><a href="/wiki/United_Kingdom" title="United Kingdom"><img alt="United Kingdom" class="thumbborder" data-file-height="600" data-file-width="1200" height="12" src="//upload.wikimedia.org/wikipedia/en/thumb/a/ae/Flag_of_the_United_Kingdom.svg/23px-Flag_of_the_United_Kingdom.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/a/ae/Flag_of_the_United_Kingdom.svg/35px-Flag_of_the_United_Kingdom.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/a/ae/Flag_of_the_United_Kingdom.svg/46px-Flag_of_the_United_Kingdom.svg.png 2x" width="23"/></a></span> <a href="/wiki/Pharmaceutical_industry_in_the_United_Kingdom" title="Pharmaceutical industry in the United Kingdom">Pharmaceutical and biotechnology industry in the United Kingdom</a></div></th></tr><tr><td class="navbox-abovebelow" colspan="2"><div id="*Manufacturing_in_the_United_Kingdom&amp;#10;*Economy_of_the_United_Kingdom">
<ul><li><a href="/wiki/Manufacturing_in_the_United_Kingdom" title="Manufacturing in the United Kingdom">Manufacturing in the United Kingdom</a></li>
<li><a href="/wiki/Economy_of_the_United_Kingdom" title="Economy of the United Kingdom">Economy of the United Kingdom</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%"><a href="/wiki/List_of_pharmaceutical_manufacturers_in_the_United_Kingdom" title="List of pharmaceutical manufacturers in the United Kingdom">companies</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th class="navbox-group" scope="row" style="width:1%">current</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/AAH_Pharmaceuticals" title="AAH Pharmaceuticals">AAH Pharmaceuticals</a></li>
<li><a href="/wiki/Alliance_Boots" title="Alliance Boots">Alliance Boots</a></li>
<li><a href="/wiki/Astex" title="Astex">Astex</a></li>
<li><a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a> <small>(<a href="/wiki/MedImmune" title="MedImmune">MedImmune</a>)</small></li>
<li><a href="/wiki/BTG_plc" title="BTG plc">BTG</a></li>
<li><a href="/wiki/Cyclacel" title="Cyclacel">Cyclacel</a></li>
<li><a href="/wiki/Dechra_Pharmaceuticals" title="Dechra Pharmaceuticals">Dechra Pharmaceuticals</a></li>
<li><a href="/wiki/GE_Healthcare" title="GE Healthcare">GE Healthcare</a></li>
<li><a href="/wiki/Genus_plc" title="Genus plc">Genus</a></li>
<li><a class="mw-selflink selflink">GlaxoSmithKline</a></li>
<li><a href="/wiki/Hikma_Pharmaceuticals" title="Hikma Pharmaceuticals">Hikma Pharmaceuticals</a></li>
<li><a href="/wiki/Indivior" title="Indivior">Indivior</a></li>
<li><a href="/wiki/MacFarlan_Smith" title="MacFarlan Smith">MacFarlan Smith</a></li>
<li><a href="/wiki/Norbrook_Group" title="Norbrook Group">Norbrook Group</a></li>
<li><a href="/wiki/Oxford_BioMedica" title="Oxford BioMedica">Oxford BioMedica</a></li>
<li><a href="/wiki/Pfizer_UK" title="Pfizer UK">Pfizer UK</a></li>
<li><a href="/wiki/Phytopharm" title="Phytopharm">Phytopharm</a></li>
<li><a href="/wiki/Upsher-Smith_Laboratories" title="Upsher-Smith Laboratories">Proximagen</a></li>
<li><a class="mw-redirect" href="/wiki/Shire_plc" title="Shire plc">Shire</a></li>
<li><a href="/wiki/Silence_Therapeutics" title="Silence Therapeutics">Silence Therapeutics</a></li>
<li><a href="/wiki/TBS_GB" title="TBS GB">TBS GB</a></li>
<li><a href="/wiki/Unipath" title="Unipath">Unipath</a></li>
<li><a href="/wiki/Vectura_Group" title="Vectura Group">Vectura Group</a></li>
<li><a href="/wiki/Vernalis_plc" title="Vernalis plc">Vernalis</a></li>
<li><a href="/wiki/ViiV_Healthcare" title="ViiV Healthcare">ViiV Healthcare</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">defunct</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Allen_%26_Hanburys" title="Allen &amp; Hanburys">Allen &amp; Hanburys</a></li>
<li><a href="/wiki/Amersham_plc" title="Amersham plc">Amersham</a></li>
<li><a href="/wiki/Beecham_Group" title="Beecham Group">Beecham Group</a></li>
<li><a href="/wiki/Cambridge_Antibody_Technology" title="Cambridge Antibody Technology">Cambridge Antibody Technology</a></li>
<li><a href="/wiki/Celltech" title="Celltech">Celltech</a></li>
<li><a href="/wiki/Chiroscience" title="Chiroscience">Chiroscience</a></li>
<li><a class="mw-redirect" href="/wiki/Distillers_Company" title="Distillers Company">Distillers Company</a></li>
<li><a href="/wiki/Fisons" title="Fisons">Fisons</a></li>
<li><a class="mw-redirect" href="/wiki/Glaxo_Wellcome" title="Glaxo Wellcome">Glaxo Wellcome</a></li>
<li><a href="/wiki/Imperial_Chemical_Industries" title="Imperial Chemical Industries">ICI</a></li>
<li><a href="/wiki/Reliant_Pharmaceuticals" title="Reliant Pharmaceuticals">Reliant Pharmaceuticals</a></li>
<li><a href="/wiki/Renovo_plc" title="Renovo plc">Renovo</a></li>
<li><a href="/wiki/Zeneca" title="Zeneca">Zeneca</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">government and<br/>regulatory bodies</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Commission_on_Human_Medicines" title="Commission on Human Medicines">Commission on Human Medicines</a></li>
<li><a class="mw-redirect" href="/wiki/Department_of_Health_(United_Kingdom)" title="Department of Health (United Kingdom)">Department of Health</a></li>
<li><a href="/wiki/European_Directorate_for_the_Quality_of_Medicines" title="European Directorate for the Quality of Medicines">European Directorate for the Quality of Medicines</a></li>
<li><a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a></li>
<li><a class="mw-redirect" href="/wiki/Medicines_and_Healthcare_Products_Regulatory_Agency" title="Medicines and Healthcare Products Regulatory Agency">Medicines and Healthcare Products Regulatory Agency</a></li>
<li><a href="/wiki/National_Collaborating_Centre_for_Mental_Health" title="National Collaborating Centre for Mental Health">National Collaborating Centre for Mental Health</a></li>
<li><a href="/wiki/National_Patient_Safety_Agency" title="National Patient Safety Agency">National Patient Safety Agency</a></li>
<li><a href="/wiki/Pharmaceutical_Price_Regulation_Scheme" title="Pharmaceutical Price Regulation Scheme">Pharmaceutical Price Regulation Scheme</a></li>
<li><a href="/wiki/Pharmaceutical_Society_of_Northern_Ireland" title="Pharmaceutical Society of Northern Ireland">Pharmaceutical Society of Northern Ireland</a></li>
<li><a href="/wiki/General_Pharmaceutical_Council" title="General Pharmaceutical Council">General Pharmaceutical Council</a></li>
<li><a class="mw-redirect" href="/wiki/Scottish_Medicines_Consortium" title="Scottish Medicines Consortium">Scottish Medicines Consortium</a></li>
<li><a href="/wiki/Veterinary_Medicines_Directorate" title="Veterinary Medicines Directorate">Veterinary Medicines Directorate</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">industry and<br/>professional bodies</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Association_of_the_British_Pharmaceutical_Industry" title="Association of the British Pharmaceutical Industry">Association of the British Pharmaceutical Industry</a></li>
<li><a href="/wiki/Chemical_Industries_Association" title="Chemical Industries Association">Chemical Industries Association</a></li>
<li><a href="/wiki/European_Federation_of_Biotechnology" title="European Federation of Biotechnology">European Federation of Biotechnology</a></li>
<li><a href="/wiki/European_Federation_of_Pharmaceutical_Industries_and_Associations" title="European Federation of Pharmaceutical Industries and Associations">European Federation of Pharmaceutical Industries and Associations</a></li>
<li><a href="/wiki/Faculty_of_Pharmaceutical_Medicine" title="Faculty of Pharmaceutical Medicine">Faculty of Pharmaceutical Medicine</a></li>
<li><a href="/wiki/Pharmacists%27_Defence_Association" title="Pharmacists' Defence Association">Pharmacists' Defence Association</a></li>
<li><a href="/wiki/Royal_Pharmaceutical_Society_of_Great_Britain" title="Royal Pharmaceutical Society of Great Britain">Royal Pharmaceutical Society of Great Britain</a></li>
<li><a href="/wiki/Worshipful_Society_of_Apothecaries" title="Worshipful Society of Apothecaries">Worshipful Society of Apothecaries</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">books and journals</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><a href="/wiki/Bandolier_(journal)" title="Bandolier (journal)">Bandolier</a></i></li>
<li><i><a href="/wiki/Bad_Pharma" title="Bad Pharma">Bad Pharma</a></i> (2012)</li>
<li><i><a href="/wiki/British_National_Formulary" title="British National Formulary">British National Formulary</a></i></li>
<li><i><a href="/wiki/British_National_Formulary_for_Children" title="British National Formulary for Children">British National Formulary for Children</a></i></li>
<li><i><a href="/wiki/Monthly_Index_of_Medical_Specialities" title="Monthly Index of Medical Specialities">Monthly Index of Medical Specialities</a></i></li>
<li><i><a href="/wiki/Side_Effects_(Bass_book)" title="Side Effects (Bass book)">Side Effects</a></i> (2008)</li>
<li><i><a href="/wiki/The_Pharmaceutical_Journal" title="The Pharmaceutical Journal">The Pharmaceutical Journal</a></i></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%">other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/British_Approved_Name" title="British Approved Name">British Approved Name</a></li>
<li><a href="/wiki/British_Pharmacopoeia" title="British Pharmacopoeia">British Pharmacopoeia</a></li>
<li><a href="/wiki/DrugScope" title="DrugScope">DrugScope</a></li>
<li><a href="/wiki/European_and_Developing_Countries_Clinical_Trials_Partnership" title="European and Developing Countries Clinical Trials Partnership">European and Developing Countries Clinical Trials Partnership</a></li>
<li><a href="/wiki/European_Pharmacopoeia" title="European Pharmacopoeia">European Pharmacopoeia</a></li>
<li><a href="/wiki/List_of_pharmaceutical_companies" title="List of pharmaceutical companies">List of world's largest pharmaceutical companies</a></li>
<li><a href="/wiki/Pharmaceutical_Services_Negotiating_Committee" title="Pharmaceutical Services Negotiating Committee">Pharmaceutical Services Negotiating Committee</a></li>
<li><a href="/wiki/Wellcome_Trust" title="Wellcome Trust">Wellcome Trust</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><img alt="Category" data-file-height="31" data-file-width="36" height="14" src="//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x" title="Category" width="16"/> <b><a href="/wiki/Category:Pharmaceutical_industry_in_the_United_Kingdom" title="Category:Pharmaceutical industry in the United Kingdom">category</a></b></li></ul>
</div></td></tr></tbody></table></div>
<div aria-labelledby="23x15px&amp;#124;border_&amp;#124;alt=United_Kingdom&amp;#124;link=United_Kingdom_FTSE_100_companies_of_the_United_Kingdom_→_FTSE_250" class="navbox" role="navigation" style="padding:3px"><table class="nowraplinks collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th class="navbox-title" colspan="2" scope="col"><div class="plainlinks hlist navbar mini"><ul><li class="nv-view"><a href="/wiki/Template:FTSE_100_Index_constituents" title="Template:FTSE 100 Index constituents"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:FTSE_100_Index_constituents" title="Template talk:FTSE 100 Index constituents"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:FTSE_100_Index_constituents&amp;action=edit"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="Edit this template">e</abbr></a></li></ul></div><div id="23x15px&amp;#124;border_&amp;#124;alt=United_Kingdom&amp;#124;link=United_Kingdom_FTSE_100_companies_of_the_United_Kingdom_→_FTSE_250" style="font-size:114%;margin:0 4em"><span class="flagicon"><a href="/wiki/United_Kingdom" title="United Kingdom"><img alt="United Kingdom" class="thumbborder" data-file-height="600" data-file-width="1200" height="12" src="//upload.wikimedia.org/wikipedia/en/thumb/a/ae/Flag_of_the_United_Kingdom.svg/23px-Flag_of_the_United_Kingdom.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/a/ae/Flag_of_the_United_Kingdom.svg/35px-Flag_of_the_United_Kingdom.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/a/ae/Flag_of_the_United_Kingdom.svg/46px-Flag_of_the_United_Kingdom.svg.png 2x" width="23"/></a></span> <a href="/wiki/FTSE_100_Index" title="FTSE 100 Index">FTSE 100</a> companies of the United Kingdom   → <small><a class="mw-redirect" href="/wiki/FTSE_250" title="FTSE 250">FTSE 250</a></small></div></th></tr><tr><td class="navbox-list navbox-odd hlist" colspan="2" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/3i" title="3i">3i</a></li>
<li><a href="/wiki/Admiral_Group" title="Admiral Group">Admiral Group</a></li>
<li><a href="/wiki/Anglo_American_plc" title="Anglo American plc">Anglo American</a></li>
<li><a href="/wiki/Antofagasta_PLC" title="Antofagasta PLC">Antofagasta</a></li>
<li><a href="/wiki/Ashtead_Group" title="Ashtead Group">Ashtead Group</a></li>
<li><a href="/wiki/Associated_British_Foods" title="Associated British Foods">Associated British Foods</a></li>
<li><a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a></li>
<li><a href="/wiki/Aviva" title="Aviva">Aviva</a></li>
<li><a href="/wiki/BAE_Systems" title="BAE Systems">BAE Systems</a></li>
<li><a href="/wiki/BHP" title="BHP">BHP</a></li>
<li><a href="/wiki/BP" title="BP">BP</a></li>
<li><a href="/wiki/Barclays" title="Barclays">Barclays</a></li>
<li><a href="/wiki/Barratt_Developments" title="Barratt Developments">Barratt Developments</a></li>
<li><a href="/wiki/Berkeley_Group_Holdings" title="Berkeley Group Holdings">Berkeley Group Holdings</a></li>
<li><a href="/wiki/British_American_Tobacco" title="British American Tobacco">British American Tobacco</a></li>
<li><a href="/wiki/British_Land" title="British Land">British Land</a></li>
<li><a href="/wiki/BT_Group" title="BT Group">BT Group</a></li>
<li><a href="/wiki/Bunzl" title="Bunzl">Bunzl</a></li>
<li><a href="/wiki/Burberry" title="Burberry">Burberry</a></li>
<li><a href="/wiki/Carnival_Corporation_%26_plc" title="Carnival Corporation &amp; plc">Carnival</a></li>
<li><a href="/wiki/Centrica" title="Centrica">Centrica</a></li>
<li><a class="mw-redirect" href="/wiki/Coca-Cola_HBC_AG" title="Coca-Cola HBC AG">Coca-Cola HBC</a></li>
<li><a href="/wiki/Compass_Group" title="Compass Group">Compass Group</a></li>
<li><a href="/wiki/CRH_plc" title="CRH plc">CRH</a></li>
<li><a href="/wiki/Croda_International" title="Croda International">Croda International</a></li>
<li><a href="/wiki/DCC_plc" title="DCC plc">DCC</a></li>
<li><a href="/wiki/Diageo" title="Diageo">Diageo</a></li>
<li><a href="/wiki/Direct_Line_Group" title="Direct Line Group">Direct Line Group</a></li>
<li><a href="/wiki/EasyJet" title="EasyJet">easyJet</a></li>
<li><a href="/wiki/Evraz" title="Evraz">Evraz</a></li>
<li><a href="/wiki/Experian" title="Experian">Experian</a></li>
<li><a href="/wiki/Ferguson_plc" title="Ferguson plc">Ferguson</a></li>
<li><a href="/wiki/Fresnillo_plc" title="Fresnillo plc">Fresnillo</a></li>
<li><a class="mw-selflink selflink">GlaxoSmithKline</a></li>
<li><a href="/wiki/Glencore" title="Glencore">Glencore</a></li>
<li><a href="/wiki/GVC_Holdings" title="GVC Holdings">GVC Holdings</a></li>
<li><a href="/wiki/Halma_plc" title="Halma plc">Halma</a></li>
<li><a href="/wiki/Hammerson" title="Hammerson">Hammerson</a></li>
<li><a href="/wiki/Hargreaves_Lansdown" title="Hargreaves Lansdown">Hargreaves Lansdown</a></li>
<li><a href="/wiki/HSBC" title="HSBC">HSBC</a></li>
<li><a href="/wiki/Imperial_Brands" title="Imperial Brands">Imperial Brands</a></li>
<li><a href="/wiki/Informa" title="Informa">Informa</a></li>
<li><a href="/wiki/InterContinental_Hotels_Group" title="InterContinental Hotels Group">InterContinental Hotels Group</a></li>
<li><a href="/wiki/International_Airlines_Group" title="International Airlines Group">International Airlines Group</a></li>
<li><a href="/wiki/Intertek" title="Intertek">Intertek</a></li>
<li><a href="/wiki/ITV_plc" title="ITV plc">ITV</a></li>
<li><a href="/wiki/Johnson_Matthey" title="Johnson Matthey">Johnson Matthey</a></li>
<li><a href="/wiki/Just_Eat" title="Just Eat">Just Eat</a></li>
<li><a href="/wiki/Kingfisher_plc" title="Kingfisher plc">Kingfisher</a></li>
<li><a href="/wiki/Landsec" title="Landsec">Land Securities</a></li>
<li><a href="/wiki/Legal_%26_General" title="Legal &amp; General">Legal &amp; General</a></li>
<li><a href="/wiki/Lloyds_Banking_Group" title="Lloyds Banking Group">Lloyds Banking Group</a></li>
<li><a href="/wiki/London_Stock_Exchange_Group" title="London Stock Exchange Group">London Stock Exchange Group</a></li>
<li><a href="/wiki/Marks_%26_Spencer" title="Marks &amp; Spencer">Marks &amp; Spencer</a></li>
<li><a href="/wiki/Melrose_Industries" title="Melrose Industries">Melrose Industries</a></li>
<li><a href="/wiki/Micro_Focus" title="Micro Focus">Micro Focus International</a></li>
<li><a href="/wiki/Mondi" title="Mondi">Mondi</a></li>
<li><a href="/wiki/Morrisons" title="Morrisons">Morrisons</a></li>
<li><a href="/wiki/National_Grid_plc" title="National Grid plc">National Grid</a></li>
<li><a href="/wiki/Next_plc" title="Next plc">Next</a></li>
<li><a href="/wiki/NMC_Health" title="NMC Health">NMC Health</a></li>
<li><a href="/wiki/Ocado" title="Ocado">Ocado</a></li>
<li><a href="/wiki/Paddy_Power_Betfair" title="Paddy Power Betfair">Paddy Power Betfair</a></li>
<li><a href="/wiki/Pearson_plc" title="Pearson plc">Pearson</a></li>
<li><a href="/wiki/Persimmon_plc" title="Persimmon plc">Persimmon</a></li>
<li><a href="/wiki/Prudential_plc" title="Prudential plc">Prudential</a></li>
<li><a href="/wiki/Randgold_Resources" title="Randgold Resources">Randgold Resources</a></li>
<li><a href="/wiki/Royal_Bank_of_Scotland_Group" title="Royal Bank of Scotland Group">Royal Bank of Scotland</a></li>
<li><a href="/wiki/Reckitt_Benckiser" title="Reckitt Benckiser">Reckitt Benckiser</a></li>
<li><a href="/wiki/RELX_Group" title="RELX Group">RELX Group</a></li>
<li><a href="/wiki/Rentokil_Initial" title="Rentokil Initial">Rentokil Initial</a></li>
<li><a href="/wiki/Rightmove" title="Rightmove">Rightmove</a></li>
<li><a href="/wiki/Rio_Tinto_Group" title="Rio Tinto Group">Rio Tinto Group</a></li>
<li><a href="/wiki/Rolls-Royce_Holdings" title="Rolls-Royce Holdings">Rolls-Royce</a></li>
<li><a href="/wiki/Royal_Dutch_Shell" title="Royal Dutch Shell">Royal Dutch Shell</a></li>
<li><a href="/wiki/RSA_Insurance_Group" title="RSA Insurance Group">RSA Insurance Group</a></li>
<li><a href="/wiki/Sage_Group" title="Sage Group">Sage Group</a></li>
<li><a href="/wiki/Sainsbury%27s" title="Sainsbury's">J Sainsbury</a></li>
<li><a href="/wiki/Schroders" title="Schroders">Schroders</a></li>
<li><a href="/wiki/Scottish_Mortgage_Investment_Trust" title="Scottish Mortgage Investment Trust">Scottish Mortgage Investment Trust</a></li>
<li><a href="/wiki/Segro" title="Segro">Segro</a></li>
<li><a href="/wiki/Severn_Trent" title="Severn Trent">Severn Trent</a></li>
<li><a href="/wiki/Shire_(pharmaceutical_company)" title="Shire (pharmaceutical company)">Shire</a></li>
<li><a href="/wiki/DS_Smith" title="DS Smith">Smith, D.S.</a></li>
<li><a href="/wiki/Smith_%26_Nephew" title="Smith &amp; Nephew">Smith &amp; Nephew</a></li>
<li><a href="/wiki/Smiths_Group" title="Smiths Group">Smiths Group</a></li>
<li><a href="/wiki/Smurfit_Kappa" title="Smurfit Kappa">Smurfit Kappa</a></li>
<li><a href="/wiki/SSE_plc" title="SSE plc">SSE</a></li>
<li><a href="/wiki/Standard_Chartered" title="Standard Chartered">Standard Chartered</a></li>
<li><a href="/wiki/Standard_Life_Aberdeen" title="Standard Life Aberdeen">Standard Life Aberdeen</a></li>
<li><a href="/wiki/St._James%27s_Place_plc" title="St. James's Place plc">St. James's Place</a></li>
<li><a href="/wiki/Taylor_Wimpey" title="Taylor Wimpey">Taylor Wimpey</a></li>
<li><a href="/wiki/Tesco" title="Tesco">Tesco</a></li>
<li><a href="/wiki/TUI_Group" title="TUI Group">TUI</a></li>
<li><a href="/wiki/Unilever" title="Unilever">Unilever</a></li>
<li><a href="/wiki/United_Utilities" title="United Utilities">United Utilities</a></li>
<li><a href="/wiki/Vodafone" title="Vodafone">Vodafone</a></li>
<li><a href="/wiki/Whitbread" title="Whitbread">Whitbread</a></li>
<li><a href="/wiki/John_Wood_Group" title="John Wood Group">Wood Group</a></li>
<li><a href="/wiki/WPP_plc" title="WPP plc">WPP</a></li></ul>
</div></td></tr></tbody></table></div>
<div aria-labelledby="Philadelphia-area_corporations_(including_the_Delaware_Valley)" class="navbox" role="navigation" style="padding:3px"><table class="nowraplinks hlist collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th class="navbox-title" colspan="2" scope="col"><div class="plainlinks hlist navbar mini"><ul><li class="nv-view"><a href="/wiki/Template:Philadelphia_Corporations" title="Template:Philadelphia Corporations"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Philadelphia_Corporations" title="Template talk:Philadelphia Corporations"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Philadelphia_Corporations&amp;action=edit"><abbr style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;" title="Edit this template">e</abbr></a></li></ul></div><div id="Philadelphia-area_corporations_(including_the_Delaware_Valley)" style="font-size:114%;margin:0 4em"><a href="/wiki/List_of_companies_based_in_the_Philadelphia_area" title="List of companies based in the Philadelphia area">Philadelphia-area corporations</a> (including the <a href="/wiki/Delaware_Valley" title="Delaware Valley">Delaware Valley</a>)</div></th></tr><tr><td class="navbox-abovebelow" colspan="2"><div id="List_of_companies_based_in_the_Philadelphia_area"><b><a href="/wiki/List_of_companies_based_in_the_Philadelphia_area" title="List of companies based in the Philadelphia area">List of companies based in the Philadelphia area</a></b></div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%;line-height:1.2em;padding-top:0.25em;padding-bottom:0.25em;"><a href="/wiki/Philadelphia" title="Philadelphia">Philadelphia</a>-based <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a><br/>corporations <span style="font-weight:normal;">(rank in the 2017 list)</span></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Comcast" title="Comcast">Comcast</a> (31)</li>
<li><a href="/wiki/Aramark" title="Aramark">Aramark</a> (192)</li>
<li><a href="/wiki/Crown_Holdings" title="Crown Holdings">Crown Holdings</a> (333)</li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%;line-height:1.2em;padding-top:0.25em;padding-bottom:0.25em;"><a href="/wiki/Delaware_Valley" title="Delaware Valley">Delaware Valley</a>-based <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a><br/>corporations <span style="font-weight:normal;">(rank in the 2017 list)</span></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/AmerisourceBergen" title="AmerisourceBergen">AmerisourceBergen</a> (11)</li>
<li><a href="/wiki/DuPont" title="DuPont">DuPont</a> (113)</li>
<li><a href="/wiki/Lincoln_National_Corporation" title="Lincoln National Corporation">Lincoln National</a> (207)</li>
<li><a href="/wiki/Universal_Health_Services" title="Universal Health Services">Universal Health Services</a> (276)</li>
<li><a href="/wiki/Campbell_Soup_Company" title="Campbell Soup Company">Campbell Soup</a> (339)</li>
<li><a href="/wiki/UGI_Corporation" title="UGI Corporation">UGI</a> (457)</li>
<li><a class="mw-redirect" href="/wiki/Burlington_Coat_Factory" title="Burlington Coat Factory">Burlington Stores Inc.</a> (463)</li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%;line-height:1.2em;padding-top:0.25em;padding-bottom:0.25em;">Other notable Philadelphia-based<br/>businesses</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Amoroso%27s_Baking_Company" title="Amoroso's Baking Company">Amoroso's</a></li>
<li><a href="/wiki/Beneficial_Bank" title="Beneficial Bank">Beneficial Bank</a></li>
<li><a href="/wiki/Chemtura" title="Chemtura">Chemtura</a></li>
<li><a href="/wiki/Day_%26_Zimmermann" title="Day &amp; Zimmermann">Day &amp; Zimmermann</a></li>
<li><a href="/wiki/FMC_Corporation" title="FMC Corporation">FMC Corporation</a></li>
<li><a href="/wiki/Independence_Blue_Cross" title="Independence Blue Cross">Independence Blue Cross</a></li>
<li><a href="/wiki/Pennsylvania_Real_Estate_Investment_Trust" title="Pennsylvania Real Estate Investment Trust">Pennsylvania Real Estate Investment Trust</a></li>
<li><a href="/wiki/Pep_Boys" title="Pep Boys">Pep Boys</a></li>
<li><a href="/wiki/Philadelphia_Media_Network" title="Philadelphia Media Network">Philadelphia Media Network</a></li>
<li><a href="/wiki/Radian_Group" title="Radian Group">Radian Group</a></li>
<li><a href="/wiki/Urban_Outfitters" title="Urban Outfitters">Urban Outfitters</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%;line-height:1.2em;padding-top:0.25em;padding-bottom:0.25em;">Notable Philadelphia-based<br/>professional partnerships</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Ballard_Spahr" title="Ballard Spahr">Ballard Spahr</a></li>
<li><a href="/wiki/Blank_Rome" title="Blank Rome">Blank Rome</a></li>
<li><a href="/wiki/Cozen_O%27Connor" title="Cozen O'Connor">Cozen O'Connor</a></li>
<li><a href="/wiki/Dechert" title="Dechert">Dechert</a></li>
<li><a href="/wiki/Drinker_Biddle_%26_Reath" title="Drinker Biddle &amp; Reath">Drinker Biddle &amp; Reath</a></li>
<li><a href="/wiki/Duane_Morris" title="Duane Morris">Duane Morris</a></li>
<li><a href="/wiki/Morgan,_Lewis_%26_Bockius" title="Morgan, Lewis &amp; Bockius">Morgan, Lewis &amp; Bockius</a></li>
<li><a href="/wiki/Pepper_Hamilton" title="Pepper Hamilton">Pepper Hamilton</a></li>
<li><a class="mw-redirect" href="/wiki/Saul_Ewing" title="Saul Ewing">Saul Ewing</a></li>
<li><a href="/wiki/White_and_Williams_LLP" title="White and Williams LLP">White and Williams</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%;line-height:1.2em;padding-top:0.25em;padding-bottom:0.25em;">Other notable Delaware<br/>Valley-based businesses</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Actua_Corporation" title="Actua Corporation">Actua Corporation</a></li>
<li><a href="/wiki/Airgas" title="Airgas">Airgas</a></li>
<li><a class="mw-redirect" href="/wiki/AlliedBarton" title="AlliedBarton">AlliedBarton</a></li>
<li><a href="/wiki/Ametek" title="Ametek">Ametek</a></li>
<li><a href="/wiki/Aqua_America" title="Aqua America">Aqua America</a></li>
<li><a href="/wiki/Asplundh_Tree_Expert_Company" title="Asplundh Tree Expert Company">Asplundh</a></li>
<li><a href="/wiki/Bentley_Systems" title="Bentley Systems">Bentley Systems</a></li>
<li><a href="/wiki/Brandywine_Realty_Trust" title="Brandywine Realty Trust">Brandywine Realty Trust</a></li>
<li><a href="/wiki/Boscov%27s" title="Boscov's">Boscov's</a></li>
<li><a href="/wiki/Carpenter_Technology_Corporation" title="Carpenter Technology Corporation">Carpenter Technology</a></li>
<li><a href="/wiki/Cephalon" title="Cephalon">Cephalon</a></li>
<li><a href="/wiki/Chemours" title="Chemours">Chemours</a></li>
<li><a href="/wiki/Christiana_Care_Health_System" title="Christiana Care Health System">Christiana Care Health System</a></li>
<li><a class="mw-redirect" href="/wiki/Crozer_Keystone_Health_System" title="Crozer Keystone Health System">Crozer Keystone Health System</a></li>
<li><a href="/wiki/David%27s_Bridal" title="David's Bridal">David's Bridal</a></li>
<li><a href="/wiki/DuckDuckGo" title="DuckDuckGo">DuckDuckGo</a></li>
<li><a href="/wiki/EPAM_Systems" title="EPAM Systems">EPAM Systems</a></li>
<li><a href="/wiki/EnerSys" title="EnerSys">EnerSys</a></li>
<li><a href="/wiki/Liberty_Property_Trust" title="Liberty Property Trust">Liberty Property Trust</a></li>
<li><a href="/wiki/Penn_Mutual" title="Penn Mutual">Penn Mutual</a></li>
<li><a href="/wiki/Penn_National_Gaming" title="Penn National Gaming">Penn National Gaming</a></li>
<li><a href="/wiki/Rita%27s_Italian_Ice" title="Rita's Italian Ice">Rita's Italian Ice</a></li>
<li><a href="/wiki/SEI_Investments_Company" title="SEI Investments Company">SEI Investments</a></li>
<li><a class="mw-redirect" href="/wiki/SLM_Corporation" title="SLM Corporation">SLM</a></li>
<li><a href="/wiki/SunGard" title="SunGard">SunGard</a></li>
<li><a href="/wiki/Susquehanna_International_Group" title="Susquehanna International Group">Susquehanna International Group</a></li>
<li><a href="/wiki/The_Vanguard_Group" title="The Vanguard Group">Vanguard</a></li>
<li><a href="/wiki/Toll_Brothers" title="Toll Brothers">Toll Brothers</a></li>
<li><a href="/wiki/Triumph_Group" title="Triumph Group">Triumph Group</a></li>
<li><a href="/wiki/Unisys" title="Unisys">Unisys</a></li>
<li><a href="/wiki/ViroPharma" title="ViroPharma">ViroPharma</a></li>
<li><a href="/wiki/Vishay_Intertechnology" title="Vishay Intertechnology">Vishay Intertechnology</a></li>
<li><a href="/wiki/VWR_International" title="VWR International">VWR</a></li>
<li><a class="mw-redirect" href="/wiki/Wawa_Food_Market" title="Wawa Food Market">Wawa</a></li>
<li><a href="/wiki/Wilmington_Trust" title="Wilmington Trust">Wilmington Trust</a></li>
<li><a href="/wiki/W._L._Gore_and_Associates" title="W. L. Gore and Associates">W. L. Gore and Associates</a></li>
<li><a href="/wiki/WSFS_Bank" title="WSFS Bank">WSFS Bank</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%;line-height:1.2em;padding-top:0.25em;padding-bottom:0.25em;">Notable Delaware Valley-based<br/>US headquarters of<br/>foreign businesses</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Aberdeen_Asset_Management" title="Aberdeen Asset Management">Aberdeen Asset Management</a></li>
<li><a class="mw-redirect" href="/wiki/ACE_Limited" title="ACE Limited">ACE</a></li>
<li><a href="/wiki/AgustaWestland" title="AgustaWestland">AgustaWestland</a></li>
<li><a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a></li>
<li><a href="/wiki/Delaware_Investments" title="Delaware Investments">Delaware Investments</a></li>
<li><a class="mw-selflink selflink">GlaxoSmithKline</a></li>
<li><a href="/wiki/ING_Group" title="ING Group">ING Group</a></li>
<li><a href="/wiki/Marfrig" title="Marfrig">Keystone Foods</a></li>
<li><a class="mw-redirect" href="/wiki/SAP_AG" title="SAP AG">SAP America</a></li>
<li><a class="mw-redirect" href="/wiki/Siemens_Medical_Solutions" title="Siemens Medical Solutions">Siemens Medical</a></li>
<li><a class="mw-redirect" href="/wiki/Shire_plc" title="Shire plc">Shire Pharmaceuticals</a></li>
<li><a href="/wiki/Subaru_of_America" title="Subaru of America">Subaru</a></li>
<li><a href="/wiki/Teva_Pharmaceutical_Industries" title="Teva Pharmaceutical Industries">Teva Pharmaceuticals</a></li>
<li><a href="/wiki/TD_Bank,_N.A." title="TD Bank, N.A.">TD Bank</a></li></ul>
</div></td></tr><tr><th class="navbox-group" scope="row" style="width:1%;line-height:1.2em;padding-top:0.25em;padding-bottom:0.25em;">Notable Delaware Valley-based<br/>division headquarters of<br/>US corporations</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Acme_Markets" title="Acme Markets">Acme</a> (<a href="/wiki/Cerberus_Capital_Management" title="Cerberus Capital Management">Cerberus Capital Management</a>)</li>
<li><a class="mw-redirect" href="/wiki/Centocor" title="Centocor">Centocor</a> (<a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a>)</li>
<li><a href="/wiki/Colonial_Penn" title="Colonial Penn">Colonial Penn</a> (<a class="mw-redirect" href="/wiki/Conseco" title="Conseco">Conseco</a>)</li>
<li><a href="/wiki/Delmarva_Power" title="Delmarva Power">Delmarva Power</a> (<a href="/wiki/Exelon" title="Exelon">Exelon</a>)</li>
<li><a class="mw-redirect" href="/wiki/GSI_Commerce" title="GSI Commerce">GSI Commerce</a> (<a href="/wiki/EBay" title="EBay">eBay</a>)</li>
<li><a href="/wiki/Hercules_Inc." title="Hercules Inc.">Hercules</a> (<a href="/wiki/Ashland_Inc." title="Ashland Inc.">Ashland</a>)</li>
<li><a href="/wiki/MAB_Paints" title="MAB Paints">MAB Paints</a> (<a href="/wiki/Sherwin-Williams" title="Sherwin-Williams">Sherwin-Williams</a>)</li>
<li><a class="mw-redirect" href="/wiki/McNeil_Laboratories" title="McNeil Laboratories">McNeil Laboratories</a> (<a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">J&amp;J</a>)</li>
<li><a href="/wiki/Neoware" title="Neoware">Neoware</a> (<a href="/wiki/Hewlett-Packard" title="Hewlett-Packard">Hewlett-Packard</a>)</li>
<li><a href="/wiki/PECO_Energy_Company" title="PECO Energy Company">PECO</a> (<a href="/wiki/Exelon" title="Exelon">Exelon</a>)</li>
<li><a href="/wiki/QVC" title="QVC">QVC</a> (<a href="/wiki/Liberty_Media" title="Liberty Media">Liberty Media</a>)</li>
<li><a href="/wiki/Rohm_and_Haas" title="Rohm and Haas">Rohm and Haas</a> (<a class="mw-redirect" href="/wiki/Dow_Chemical" title="Dow Chemical">Dow Chemical</a>)</li>
<li><a href="/wiki/Sunoco" title="Sunoco">Sunoco</a> (<a href="/wiki/Energy_Transfer_Partners" title="Energy Transfer Partners">Energy Transfer</a>)</li>
<li><a href="/wiki/Tastykake" title="Tastykake">Tasty Baking</a> (<a href="/wiki/Flowers_Foods" title="Flowers Foods">Flowers Foods</a>)</li></ul>
</div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw1330
Cached time: 20181013110821
Cache expiry: 86400
Dynamic content: true
CPU time usage: 1.352 seconds
Real time usage: 1.527 seconds
Preprocessor visited node count: 7912/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 547041/2097152 bytes
Template argument size: 6794/2097152 bytes
Highest expansion depth: 21/40
Expensive parser function count: 5/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 321750/5000000 bytes
Number of Wikibase entities loaded: 4/400
Lua time usage: 0.611/10.000 seconds
Lua memory usage: 6.92 MB/50 MB
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 1141.764      1 -total
 73.97%  844.544     36 Template:Clade
 57.87%  660.721      2 Template:Reflist
 18.56%  211.951     39 Template:Cite_web
 11.82%  134.911     17 Template:Cite_journal
  9.97%  113.835      1 Template:Infobox_company
  9.57%  109.317     27 Template:Cite_news
  8.87%  101.243      1 Template:Infobox
  6.37%   72.765      8 Template:Navbox
  3.11%   35.467      8 Template:PMID
-->
<!-- Saved in parser cache with key enwiki:pcache:idhash:192517-0!canonical and timestamp 20181013110820 and revision id 861485001
 -->
</div><noscript><img alt="" height="1" src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" style="border: none; position: absolute;" title="" width="1"/></noscript></div> <div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=GlaxoSmithKline&amp;oldid=861485001">https://en.wikipedia.org/w/index.php?title=GlaxoSmithKline&amp;oldid=861485001</a>"					</div>
<div class="catlinks" data-mw="interface" id="catlinks"><div class="mw-normal-catlinks" id="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Biotechnology_companies_of_the_United_Kingdom" title="Category:Biotechnology companies of the United Kingdom">Biotechnology companies of the United Kingdom</a></li><li><a href="/wiki/Category:Companies_based_in_the_London_Borough_of_Hounslow" title="Category:Companies based in the London Borough of Hounslow">Companies based in the London Borough of Hounslow</a></li><li><a href="/wiki/Category:Companies_listed_on_the_New_York_Stock_Exchange" title="Category:Companies listed on the New York Stock Exchange">Companies listed on the New York Stock Exchange</a></li><li><a href="/wiki/Category:Dental_companies" title="Category:Dental companies">Dental companies</a></li><li><a href="/wiki/Category:GlaxoSmithKline" title="Category:GlaxoSmithKline">GlaxoSmithKline</a></li><li><a href="/wiki/Category:Medical_controversies" title="Category:Medical controversies">Medical controversies</a></li><li><a href="/wiki/Category:Multinational_companies_headquartered_in_England" title="Category:Multinational companies headquartered in England">Multinational companies headquartered in England</a></li><li><a href="/wiki/Category:Pharmaceutical_companies_established_in_2000" title="Category:Pharmaceutical companies established in 2000">Pharmaceutical companies established in 2000</a></li><li><a href="/wiki/Category:British_companies_established_in_2000" title="Category:British companies established in 2000">British companies established in 2000</a></li><li><a href="/wiki/Category:Pharmaceutical_companies_of_the_United_Kingdom" title="Category:Pharmaceutical companies of the United Kingdom">Pharmaceutical companies of the United Kingdom</a></li><li><a href="/wiki/Category:Vaccine_producers" title="Category:Vaccine producers">Vaccine producers</a></li><li><a href="/wiki/Category:Orphan_drug_companies" title="Category:Orphan drug companies">Orphan drug companies</a></li><li><a href="/wiki/Category:Life_sciences_industry" title="Category:Life sciences industry">Life sciences industry</a></li><li><a href="/wiki/Category:2000_establishments_in_the_United_Kingdom" title="Category:2000 establishments in the United Kingdom">2000 establishments in the United Kingdom</a></li><li><a href="/wiki/Category:Biotechnology_companies_established_in_2000" title="Category:Biotechnology companies established in 2000">Biotechnology companies established in 2000</a></li><li><a href="/wiki/Category:Companies_formed_by_merger" title="Category:Companies formed by merger">Companies formed by merger</a></li><li><a href="/wiki/Category:Companies_based_in_Philadelphia" title="Category:Companies based in Philadelphia">Companies based in Philadelphia</a></li></ul></div><div class="mw-hidden-catlinks mw-hidden-cats-hidden" id="mw-hidden-catlinks">Hidden categories: <ul><li><a href="/wiki/Category:Webarchive_template_wayback_links" title="Category:Webarchive template wayback links">Webarchive template wayback links</a></li><li><a href="/wiki/Category:Use_British_English_from_September_2013" title="Category:Use British English from September 2013">Use British English from September 2013</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_January_2018" title="Category:Use dmy dates from January 2018">Use dmy dates from January 2018</a></li><li><a href="/wiki/Category:OpenCorporates_groupings" title="Category:OpenCorporates groupings">OpenCorporates groupings</a></li></ul></div></div> <div class="visualClear"></div>
</div>
</div>
<div id="mw-navigation">
<h2>Navigation menu</h2>
<div id="mw-head">
<div aria-labelledby="p-personal-label" class="" id="p-personal" role="navigation">
<h3 id="p-personal-label">Personal tools</h3>
<ul>
<li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a accesskey="n" href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]">Talk</a></li><li id="pt-anoncontribs"><a accesskey="y" href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=GlaxoSmithKline" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a accesskey="o" href="/w/index.php?title=Special:UserLogin&amp;returnto=GlaxoSmithKline" title="You're encouraged to log in; however, it's not mandatory. [o]">Log in</a></li> </ul>
</div>
<div id="left-navigation">
<div aria-labelledby="p-namespaces-label" class="vectorTabs" id="p-namespaces" role="navigation">
<h3 id="p-namespaces-label">Namespaces</h3>
<ul>
<li class="selected" id="ca-nstab-main"><span><a accesskey="c" href="/wiki/GlaxoSmithKline" title="View the content page [c]">Article</a></span></li><li id="ca-talk"><span><a accesskey="t" href="/wiki/Talk:GlaxoSmithKline" rel="discussion" title="Discussion about the content page [t]">Talk</a></span></li> </ul>
</div>
<div aria-labelledby="p-variants-label" class="vectorMenu emptyPortlet" id="p-variants" role="navigation">
<input aria-labelledby="p-variants-label" class="vectorMenuCheckbox" type="checkbox"/>
<h3 id="p-variants-label">
<span>Variants</span>
</h3>
<div class="menu">
<ul>
</ul>
</div>
</div>
</div>
<div id="right-navigation">
<div aria-labelledby="p-views-label" class="vectorTabs" id="p-views" role="navigation">
<h3 id="p-views-label">Views</h3>
<ul>
<li class="collapsible selected" id="ca-view"><span><a href="/wiki/GlaxoSmithKline">Read</a></span></li><li class="collapsible" id="ca-edit"><span><a accesskey="e" href="/w/index.php?title=GlaxoSmithKline&amp;action=edit" title="Edit this page [e]">Edit</a></span></li><li class="collapsible" id="ca-history"><span><a accesskey="h" href="/w/index.php?title=GlaxoSmithKline&amp;action=history" title="Past revisions of this page [h]">View history</a></span></li> </ul>
</div>
<div aria-labelledby="p-cactions-label" class="vectorMenu emptyPortlet" id="p-cactions" role="navigation">
<input aria-labelledby="p-cactions-label" class="vectorMenuCheckbox" type="checkbox"/>
<h3 id="p-cactions-label"><span>More</span></h3>
<div class="menu">
<ul>
</ul>
</div>
</div>
<div id="p-search" role="search">
<h3>
<label for="searchInput">Search</label>
</h3>
<form action="/w/index.php" id="searchform">
<div id="simpleSearch">
<input accesskey="f" id="searchInput" name="search" placeholder="Search Wikipedia" title="Search Wikipedia [f]" type="search"/><input name="title" type="hidden" value="Special:Search"/><input class="searchButton mw-fallbackSearchButton" id="mw-searchButton" name="fulltext" title="Search Wikipedia for this text" type="submit" value="Search"/><input class="searchButton" id="searchButton" name="go" title="Go to a page with this exact name if it exists" type="submit" value="Go"/> </div>
</form>
</div>
</div>
</div>
<div id="mw-panel">
<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page" title="Visit the main page"></a></div>
<div aria-labelledby="p-navigation-label" class="portal" id="p-navigation" role="navigation">
<h3 id="p-navigation-label">Navigation</h3>
<div class="body">
<ul>
<li id="n-mainpage-description"><a accesskey="z" href="/wiki/Main_Page" title="Visit the main page [z]">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a accesskey="x" href="/wiki/Special:Random" title="Load a random article [x]">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikipedia store">Wikipedia store</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-interaction-label" class="portal" id="p-interaction" role="navigation">
<h3 id="p-interaction-label">Interaction</h3>
<div class="body">
<ul>
<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a accesskey="r" href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact page</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-tb-label" class="portal" id="p-tb" role="navigation">
<h3 id="p-tb-label">Tools</h3>
<div class="body">
<ul>
<li id="t-whatlinkshere"><a accesskey="j" href="/wiki/Special:WhatLinksHere/GlaxoSmithKline" title="List of all English Wikipedia pages containing links to this page [j]">What links here</a></li><li id="t-recentchangeslinked"><a accesskey="k" href="/wiki/Special:RecentChangesLinked/GlaxoSmithKline" rel="nofollow" title="Recent changes in pages linked from this page [k]">Related changes</a></li><li id="t-upload"><a accesskey="u" href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]">Upload file</a></li><li id="t-specialpages"><a accesskey="q" href="/wiki/Special:SpecialPages" title="A list of all special pages [q]">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=GlaxoSmithKline&amp;oldid=861485001" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=GlaxoSmithKline&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a accesskey="g" href="https://www.wikidata.org/wiki/Special:EntityPage/Q212322" title="Link to connected data repository item [g]">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=GlaxoSmithKline&amp;id=861485001" title="Information on how to cite this page">Cite this page</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-coll-print_export-label" class="portal" id="p-coll-print_export" role="navigation">
<h3 id="p-coll-print_export-label">Print/export</h3>
<div class="body">
<ul>
<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=GlaxoSmithKline">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:ElectronPdf&amp;page=GlaxoSmithKline&amp;action=show-download-screen">Download as PDF</a></li><li id="t-print"><a accesskey="p" href="/w/index.php?title=GlaxoSmithKline&amp;printable=yes" title="Printable version of this page [p]">Printable version</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-wikibase-otherprojects-label" class="portal" id="p-wikibase-otherprojects" role="navigation">
<h3 id="p-wikibase-otherprojects-label">In other projects</h3>
<div class="body">
<ul>
<li class="wb-otherproject-link wb-otherproject-commons"><a href="https://commons.wikimedia.org/wiki/Category:GlaxoSmithKline" hreflang="en">Wikimedia Commons</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-lang-label" class="portal" id="p-lang" role="navigation">
<h3 id="p-lang-label">Languages</h3>
<div class="body">
<ul>
<li class="interlanguage-link interwiki-ar"><a class="interlanguage-link-target" href="https://ar.wikipedia.org/wiki/%D8%BA%D9%84%D8%A7%D9%83%D8%B3%D9%88_%D8%B3%D9%85%D9%8A%D8%AB_%D9%83%D9%84%D8%A7%D9%8A%D9%86" hreflang="ar" lang="ar" title="غلاكسو سميث كلاين – Arabic">العربية</a></li><li class="interlanguage-link interwiki-bn"><a class="interlanguage-link-target" href="https://bn.wikipedia.org/wiki/%E0%A6%97%E0%A7%8D%E0%A6%B2%E0%A6%BE%E0%A6%95%E0%A7%8D%E0%A6%B8%E0%A7%8B%E0%A6%B8%E0%A7%8D%E0%A6%AE%E0%A6%BF%E0%A6%A5%E0%A6%95%E0%A7%8D%E0%A6%B2%E0%A6%BE%E0%A6%87%E0%A6%A8" hreflang="bn" lang="bn" title="গ্লাক্সোস্মিথক্লাইন – Bangla">বাংলা</a></li><li class="interlanguage-link interwiki-ca"><a class="interlanguage-link-target" href="https://ca.wikipedia.org/wiki/GlaxoSmithKline" hreflang="ca" lang="ca" title="GlaxoSmithKline – Catalan">Català</a></li><li class="interlanguage-link interwiki-cs"><a class="interlanguage-link-target" href="https://cs.wikipedia.org/wiki/GlaxoSmithKline" hreflang="cs" lang="cs" title="GlaxoSmithKline – Czech">Čeština</a></li><li class="interlanguage-link interwiki-da"><a class="interlanguage-link-target" href="https://da.wikipedia.org/wiki/GlaxoSmithKline" hreflang="da" lang="da" title="GlaxoSmithKline – Danish">Dansk</a></li><li class="interlanguage-link interwiki-de"><a class="interlanguage-link-target" href="https://de.wikipedia.org/wiki/GlaxoSmithKline" hreflang="de" lang="de" title="GlaxoSmithKline – German">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a class="interlanguage-link-target" href="https://es.wikipedia.org/wiki/GlaxoSmithKline" hreflang="es" lang="es" title="GlaxoSmithKline – Spanish">Español</a></li><li class="interlanguage-link interwiki-eo"><a class="interlanguage-link-target" href="https://eo.wikipedia.org/wiki/GlaxoSmithKline" hreflang="eo" lang="eo" title="GlaxoSmithKline – Esperanto">Esperanto</a></li><li class="interlanguage-link interwiki-fa"><a class="interlanguage-link-target" href="https://fa.wikipedia.org/wiki/%DA%AF%D9%84%D8%A7%DA%A9%D8%B3%D9%88%D8%A7%D8%B3%D9%85%DB%8C%D8%AA%E2%80%8C%DA%A9%D9%84%D8%A7%DB%8C%D9%86" hreflang="fa" lang="fa" title="گلاکسواسمیت‌کلاین – Persian">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a class="interlanguage-link-target" href="https://fr.wikipedia.org/wiki/GlaxoSmithKline" hreflang="fr" lang="fr" title="GlaxoSmithKline – French">Français</a></li><li class="interlanguage-link interwiki-ko"><a class="interlanguage-link-target" href="https://ko.wikipedia.org/wiki/%EA%B8%80%EB%9D%BD%EC%86%8C%EC%8A%A4%EB%AF%B8%EC%8A%A4%ED%81%B4%EB%9D%BC%EC%9D%B8" hreflang="ko" lang="ko" title="글락소스미스클라인 – Korean">한국어</a></li><li class="interlanguage-link interwiki-hi"><a class="interlanguage-link-target" href="https://hi.wikipedia.org/wiki/%E0%A4%97%E0%A5%8D%E0%A4%B2%E0%A5%88%E0%A4%95%E0%A5%8D%E0%A4%B8%E0%A5%8B_%E0%A4%B8%E0%A5%8D%E0%A4%AE%E0%A4%BF%E0%A4%A5%E0%A4%95%E0%A5%8D%E0%A4%B2%E0%A4%BE%E0%A4%87%E0%A4%A8" hreflang="hi" lang="hi" title="ग्लैक्सो स्मिथक्लाइन – Hindi">हिन्दी</a></li><li class="interlanguage-link interwiki-id"><a class="interlanguage-link-target" href="https://id.wikipedia.org/wiki/GlaxoSmithKline" hreflang="id" lang="id" title="GlaxoSmithKline – Indonesian">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-is"><a class="interlanguage-link-target" href="https://is.wikipedia.org/wiki/GlaxoSmithKline" hreflang="is" lang="is" title="GlaxoSmithKline – Icelandic">Íslenska</a></li><li class="interlanguage-link interwiki-it"><a class="interlanguage-link-target" href="https://it.wikipedia.org/wiki/GlaxoSmithKline" hreflang="it" lang="it" title="GlaxoSmithKline – Italian">Italiano</a></li><li class="interlanguage-link interwiki-he"><a class="interlanguage-link-target" href="https://he.wikipedia.org/wiki/%D7%92%D7%9C%D7%A7%D7%A1%D7%95_%D7%A1%D7%9E%D7%99%D7%AA%27_%D7%A7%D7%9C%D7%99%D7%99%D7%9F" hreflang="he" lang="he" title="גלקסו סמית' קליין – Hebrew">עברית</a></li><li class="interlanguage-link interwiki-kn"><a class="interlanguage-link-target" href="https://kn.wikipedia.org/wiki/%E0%B2%97%E0%B3%8D%E0%B2%B2%E0%B2%BE%E0%B2%95%E0%B3%8D%E0%B2%B8%E0%B3%8A_%E0%B2%B8%E0%B3%8D%E0%B2%AE%E0%B2%BF%E0%B2%A4%E0%B3%8D%E2%80%8C%E0%B2%95%E0%B3%8D%E0%B2%B2%E0%B3%88%E0%B2%A8%E0%B3%8D" hreflang="kn" lang="kn" title="ಗ್ಲಾಕ್ಸೊ ಸ್ಮಿತ್‌ಕ್ಲೈನ್ – Kannada">ಕನ್ನಡ</a></li><li class="interlanguage-link interwiki-lt"><a class="interlanguage-link-target" href="https://lt.wikipedia.org/wiki/GlaxoSmithKline" hreflang="lt" lang="lt" title="GlaxoSmithKline – Lithuanian">Lietuvių</a></li><li class="interlanguage-link interwiki-hu"><a class="interlanguage-link-target" href="https://hu.wikipedia.org/wiki/GlaxoSmithKline" hreflang="hu" lang="hu" title="GlaxoSmithKline – Hungarian">Magyar</a></li><li class="interlanguage-link interwiki-ms"><a class="interlanguage-link-target" href="https://ms.wikipedia.org/wiki/GlaxoSmithKline" hreflang="ms" lang="ms" title="GlaxoSmithKline – Malay">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-nl"><a class="interlanguage-link-target" href="https://nl.wikipedia.org/wiki/GlaxoSmithKline" hreflang="nl" lang="nl" title="GlaxoSmithKline – Dutch">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a class="interlanguage-link-target" href="https://ja.wikipedia.org/wiki/%E3%82%B0%E3%83%A9%E3%82%AF%E3%82%BD%E3%83%BB%E3%82%B9%E3%83%9F%E3%82%B9%E3%82%AF%E3%83%A9%E3%82%A4%E3%83%B3" hreflang="ja" lang="ja" title="グラクソ・スミスクライン – Japanese">日本語</a></li><li class="interlanguage-link interwiki-no"><a class="interlanguage-link-target" href="https://no.wikipedia.org/wiki/GlaxoSmithKline" hreflang="no" lang="no" title="GlaxoSmithKline – Norwegian">Norsk</a></li><li class="interlanguage-link interwiki-nn"><a class="interlanguage-link-target" href="https://nn.wikipedia.org/wiki/GlaxoSmithKline" hreflang="nn" lang="nn" title="GlaxoSmithKline – Norwegian Nynorsk">Norsk nynorsk</a></li><li class="interlanguage-link interwiki-pl"><a class="interlanguage-link-target" href="https://pl.wikipedia.org/wiki/GlaxoSmithKline" hreflang="pl" lang="pl" title="GlaxoSmithKline – Polish">Polski</a></li><li class="interlanguage-link interwiki-pt"><a class="interlanguage-link-target" href="https://pt.wikipedia.org/wiki/GlaxoSmithKline" hreflang="pt" lang="pt" title="GlaxoSmithKline – Portuguese">Português</a></li><li class="interlanguage-link interwiki-ro"><a class="interlanguage-link-target" href="https://ro.wikipedia.org/wiki/GlaxoSmithKline" hreflang="ro" lang="ro" title="GlaxoSmithKline – Romanian">Română</a></li><li class="interlanguage-link interwiki-ru"><a class="interlanguage-link-target" href="https://ru.wikipedia.org/wiki/GlaxoSmithKline" hreflang="ru" lang="ru" title="GlaxoSmithKline – Russian">Русский</a></li><li class="interlanguage-link interwiki-sco"><a class="interlanguage-link-target" href="https://sco.wikipedia.org/wiki/GlaxoSmithKline" hreflang="sco" lang="sco" title="GlaxoSmithKline – Scots">Scots</a></li><li class="interlanguage-link interwiki-si"><a class="interlanguage-link-target" href="https://si.wikipedia.org/wiki/%E0%B6%9C%E0%B7%8A%E0%B6%BD%E0%B7%90%E0%B6%9A%E0%B7%8A%E0%B7%83%E0%B7%9D%E0%B7%83%E0%B7%8A%E0%B6%B8%E0%B7%92%E0%B6%AD%E0%B7%8A%E0%B6%9A%E0%B7%8A%E0%B6%BD%E0%B6%BA%E0%B7%92%E0%B6%B1%E0%B7%8A" hreflang="si" lang="si" title="ග්ලැක්සෝස්මිත්ක්ලයින් – Sinhala">සිංහල</a></li><li class="interlanguage-link interwiki-sr"><a class="interlanguage-link-target" href="https://sr.wikipedia.org/wiki/GlaksoSmitKlajn" hreflang="sr" lang="sr" title="GlaksoSmitKlajn – Serbian">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a class="interlanguage-link-target" href="https://sh.wikipedia.org/wiki/GlaxoSmithKline" hreflang="sh" lang="sh" title="GlaxoSmithKline – Serbo-Croatian">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a class="interlanguage-link-target" href="https://fi.wikipedia.org/wiki/GlaxoSmithKline" hreflang="fi" lang="fi" title="GlaxoSmithKline – Finnish">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a class="interlanguage-link-target" href="https://sv.wikipedia.org/wiki/Glaxo_Smith_Kline" hreflang="sv" lang="sv" title="Glaxo Smith Kline – Swedish">Svenska</a></li><li class="interlanguage-link interwiki-tl"><a class="interlanguage-link-target" href="https://tl.wikipedia.org/wiki/GlaxoSmithKline" hreflang="tl" lang="tl" title="GlaxoSmithKline – Tagalog">Tagalog</a></li><li class="interlanguage-link interwiki-th"><a class="interlanguage-link-target" href="https://th.wikipedia.org/wiki/%E0%B9%81%E0%B8%81%E0%B8%A5%E0%B9%87%E0%B8%81%E0%B9%82%E0%B8%8B%E0%B8%AA%E0%B8%A1%E0%B8%B4%E0%B8%98%E0%B9%84%E0%B8%84%E0%B8%A5%E0%B8%99%E0%B9%8C" hreflang="th" lang="th" title="แกล็กโซสมิธไคลน์ – Thai">ไทย</a></li><li class="interlanguage-link interwiki-tr"><a class="interlanguage-link-target" href="https://tr.wikipedia.org/wiki/GlaxoSmithKline" hreflang="tr" lang="tr" title="GlaxoSmithKline – Turkish">Türkçe</a></li><li class="interlanguage-link interwiki-uk"><a class="interlanguage-link-target" href="https://uk.wikipedia.org/wiki/GlaxoSmithKline" hreflang="uk" lang="uk" title="GlaxoSmithKline – Ukrainian">Українська</a></li><li class="interlanguage-link interwiki-vi"><a class="interlanguage-link-target" href="https://vi.wikipedia.org/wiki/GlaxoSmithKline" hreflang="vi" lang="vi" title="GlaxoSmithKline – Vietnamese">Tiếng Việt</a></li><li class="interlanguage-link interwiki-zh-yue"><a class="interlanguage-link-target" href="https://zh-yue.wikipedia.org/wiki/%E8%91%9B%E8%98%AD%E7%B4%A0%E5%8F%B2%E5%85%8B" hreflang="zh-yue" lang="zh-yue" title="葛蘭素史克 – Cantonese">粵語</a></li><li class="interlanguage-link interwiki-zh"><a class="interlanguage-link-target" href="https://zh.wikipedia.org/wiki/%E8%91%9B%E8%98%AD%E7%B4%A0%E5%8F%B2%E5%85%8B" hreflang="zh" lang="zh" title="葛蘭素史克 – Chinese">中文</a></li> </ul>
<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a class="wbc-editpage" href="https://www.wikidata.org/wiki/Special:EntityPage/Q212322#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></span></div> </div>
</div>
</div>
</div>
<div id="footer" role="contentinfo">
<ul id="footer-info">
<li id="footer-info-lastmod"> This page was last edited on 27 September 2018, at 19:26<span class="anonymous-show"> (UTC)</span>.</li>
<li id="footer-info-copyright">Text is available under the <a href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License" rel="license">Creative Commons Attribution-ShareAlike License</a><a href="//creativecommons.org/licenses/by-sa/3.0/" rel="license" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>
<ul id="footer-places">
<li id="footer-places-privacy"><a class="extiw" href="https://foundation.wikimedia.org/wiki/Privacy_policy" title="wmf:Privacy policy">Privacy policy</a></li>
<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Cookie_statement">Cookie statement</a></li>
<li id="footer-places-mobileview"><a class="noprint stopMobileRedirectToggle" href="//en.m.wikipedia.org/w/index.php?title=GlaxoSmithKline&amp;mobileaction=toggle_view_mobile">Mobile view</a></li>
</ul>
<ul class="noprint" id="footer-icons">
<li id="footer-copyrightico">
<a href="https://wikimediafoundation.org/"><img alt="Wikimedia Foundation" height="31" src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88"/></a> </li>
<li id="footer-poweredbyico">
<a href="//www.mediawiki.org/"><img alt="Powered by MediaWiki" height="31" src="/static/images/poweredby_mediawiki_88x31.png" srcset="/static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x" width="88"/></a> </li>
</ul>
<div style="clear: both;"></div>
</div>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"1.352","walltime":"1.527","ppvisitednodes":{"value":7912,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":547041,"limit":2097152},"templateargumentsize":{"value":6794,"limit":2097152},"expansiondepth":{"value":21,"limit":40},"expensivefunctioncount":{"value":5,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":321750,"limit":5000000},"entityaccesscount":{"value":4,"limit":400},"timingprofile":["100.00% 1141.764      1 -total"," 73.97%  844.544     36 Template:Clade"," 57.87%  660.721      2 Template:Reflist"," 18.56%  211.951     39 Template:Cite_web"," 11.82%  134.911     17 Template:Cite_journal","  9.97%  113.835      1 Template:Infobox_company","  9.57%  109.317     27 Template:Cite_news","  8.87%  101.243      1 Template:Infobox","  6.37%   72.765      8 Template:Navbox","  3.11%   35.467      8 Template:PMID"]},"scribunto":{"limitreport-timeusage":{"value":"0.611","limit":"10.000"},"limitreport-memusage":{"value":7251343,"limit":52428800}},"cachereport":{"origin":"mw1330","timestamp":"20181013110821","ttl":86400,"transientcontent":true}}});mw.config.set({"wgBackendResponseTime":100,"wgHostname":"mw1323"});});</script>
</body>
</html>
